# Pharmaceutical Indications Reference

This file contains FDA indications data organized by product, with content summarized per UNII (Unique Ingredient Identifier). The products are separated by '---'

## Data Dictionary

- **ProductName**: The branded and generic product name separated by commas
- **UNII**: Unique Ingredient Identifier (FDA standard)
- **IndicationsSummary**: Combined indication text for all products with this UNII (XML tags removed)

## Data

ProductNames|UNII|IndicationsSummary
AAGYLUR,Depen,Penicillamine|GNN1DV99GX|
# Penicillamine Summary
DEPEN is indicated in the treatment of Wilson’s disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.
Penicillamine capsules are indicated in the treatment of Wilson's disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.
When it is more than 300 mg/day, treatment is indicated.
Treatment of asymptomatic patients has been carried out for over ten years.
This diet is not recommended in growing children and probably is contraindicated in pregnancy because of its low protein content (see PRECAUTIONS ).
---
Abiraterone,Abiraterone Acetate|EM5OCB9YJ6|
# Abiraterone Acetate Summary
Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone Acetate is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.
---
Acamprosate Calcium|59375N1D0U|
# Acamprosate Calcium Summary
Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.
---
Acarbose|T58MSI464G|
# Acarbose Summary
Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
Acebutolol Hydrochloride|B025Y34C54|
# Acebutolol Hydrochloride Summary
Hypertension Acebutolol HCl capsules are indicated for the management of hypertension in adults.
Ventricular Arrhythmias Acebutolol HCl capsules are indicated in the management of ventricular premature beats; it reduces the total number of premature beats, as well as the number of paired and multiform ventricular ectopic beats, and R-on-T beats.
---
Acetazolamide,acetazolamide sodium|429ZT169UH|
# Acetazolamide Sodium Summary
Acetazolamide is also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.
For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.
---
Acetazolamide|O3FX965V0I|
# Acetazolamide Summary
Acetazolamide Tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.
Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.
Acetazolamide tablets, USP are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.
---
ACETADOTE,Acetylcysteine|WYQ7N0BPYC|
# Acetylcysteine Summary
Acetylcysteine solution is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Acetylcysteine, administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen.
Pulmonary complications associated with surgery Tracheostomy care Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) Acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in adults and pediatric patients who weigh 5 kg or greater with acute ingestion or from repeated supratherapeutic ingestion (RSI).
---
Acitretin|LCH760E9T7|
# Acitretin Summary
Acitretin Capsules are indicated for the treatment of severe psoriasis in adults.
---
Acyclovir|X4HES1O11F|
# Acyclovir Summary
Acyclovir Ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.
Acyclovir is indicated for the treatment of chickenpox (varicella).
Chickenpox: Acyclovir tablets are indicated for the treatment of chickenpox (varicella).
Chickenpox: Acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella).
Chickenpox: Acyclovir is indicated for the treatment of chickenpox (varicella).
---
Adenosine|K72T3FS567|
# Adenosine Summary
Intravenous adenosine injection is indicated for the following.
---
ADMELOG,insulin lispro|GFX7QIS1II|
# Insulin Lispro Summary
ADMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
---
Adult Infuvite Multiple Vitamins,Embriva,Multivitamin with Fluoride,Pediatric Infuvite Multiple Vitamins,Virexa,cholecalciferol|1C6V77QF41|
# Cholecalciferol Summary
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,vitamin a palmitate|1D1K0N0VVC|
# Vitamin A Palmitate Summary
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,dexpanthenol|1O6C93RI7Z|
# Dexpanthenol Summary
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,riboflavin 5'-phosphate sodium|20RD1DZH99|
# Riboflavin 5'-Phosphate Sodium Summary
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
Adult Infuvite Multiple Vitamins,Multivitamin with Fluoride,Pediatric Infuvite Multiple Vitamins,niacinamide|25X51I8RD4|
# Niacinamide Summary
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,biotin|6SO6U10H04|
# Biotin Summary
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
ADVAIR HFA,Fluticasone Propionate and Salmeterol,salmeterol xinafoate|6EW8Q962A5|
# Salmeterol Xinafoate Summary
ADVAIR HFA is indicated for treatment of asthma in adult and adolescent patients aged 12 years and older.
Limitations: Fluticasone Propionate/Salmeterol MDPI is not indicated for the relief of acute bronchospasm.
Limitations: Limitations of Use Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older.
---
Afirmelle,Amethyst,Aubra EQ,Ayuna,Balcoltra,Balziva,Chateal EQ,Dasetta 1/35,drospirenone and ethinyl estradiol,Elinest,Ethinyl Estradiol,Etonogestrel and Ethinyl Estradiol,FEMLYV,Kelnor 1/50,Larin Fe 1.5/30,Larin Fe 1/20,levonorgestrel and ethinyl estradiol,Levora,Low-Ogestrel,Lutera,NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL,Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate,Norethindrone and Ethinyl Estradiol,NUVARING,PIMTREA,SETLAKIN,Simpesse,SRONYX,Twirla|423D2T571U|
# Ethinyl Estradiol Summary
TWIRLA is indicated as a method of contraception for use in women of reproductive potential with a BMI &lt; 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate.
Blisovi ™ 24 Fe is indicated for use by women to prevent pregnancy [see CLINICAL STUDIES ( 14 )].
Levonorgestrel and ethinyl estradiol tablets are indicated for use by females of reproductive potential to prevent pregnancy.
DASETTA ™ 1/35 has not been studied for and is not indicated for use in emergency contraception.
TWIRLA is contraindicated in women with a BMI ≥ 30 kg/m 2 [see Contraindications ( 4 )] .
---
Afirmelle,Amethyst,Aubra EQ,Ayuna,Balcoltra,Chateal EQ,levonorgestrel and ethinyl estradiol,Levora,Lutera,SETLAKIN,Simpesse,SRONYX,Twirla,levonorgestrel|5W7SIA7YZW|
# Levonorgestrel Summary
9 Kurvelo is indicated for use by females of reproductive potential to prevent pregnancy.
SETLAKIN is indicated for use by females of reproductive potential to prevent pregnancy.
Balcoltra is indicated for use by females of reproductive potential to prevent pregnancy.
TWIRLA is contraindicated in women with a BMI ≥ 30 kg/m 2 [see Contraindications ( 4 )] .
TWIRLA is indicated as a method of contraception for use in women of reproductive potential with a BMI &lt; 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate.
---
AIRSUPRA,budesonide,Uceris|Q3OKS62Q6X|
# Budesonide Summary
AIRSUPRA is indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.
Budesonide rectal foam is indicated for the induction of remission in patients with active mild to moderate distal ulcerative colitis extending up to 40 cm from the anal verge.
Budesonide extended-release tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.
---
AJOVY,fremanezumab|PF8K38CG54|
# Fremanezumab Summary
AJOVY is indicated for:
the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more.
---
Alclometasone dipropionate|S56PQL4N1V|
# Alclometasone Dipropionate Summary
Alclometasone Dipropionate Cream USP, 0.05% is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Alclometasone dipropionate cream is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Alclometasone Dipropionate Ointment USP, 0.05% is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
ALDURAZYME,laronidase|WP58SVM6R4|
# Laronidase Summary
ALDURAZYME ® is indicated for the treatment of: adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and patients with the Scheie form of MPS I who have moderate to severe symptoms.
---
Alhemo,concizumab|68603V9EAF|
# Concizumab Summary
hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors hemophilia A (congenital factor VIII deficiency) with or without FVIII inhibitors Alhemo is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with:
---
Allopurinol|63CZ7GJN5I|
# Allopurinol Summary
Limitations: The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) Limitations of Use Allopurinol tablets are not recommended for the treatment of asymptomatic hyperuricemia.
Limitations: Limitations of Use Allopurinol Tablets are not recommended for the treatment of asymptomatic hyperuricemia.
---
Alogliptin and Pioglitazone,alogliptin benzoate|EEN99869SC|
# Alogliptin Benzoate Summary
Alogliptin and pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .
---
Alosetron,Alosetron Hydrochloride|2F5R1A46YW|
# Alosetron Hydrochloride Summary
chronic IBS symptoms (generally lasting 6 months or longer), Diarrhea-predominant IBS is severe if it includes diarrhea and one or more of the following: Alosetron tablets are indicated only for women with severe diarrhea-predominant irritable bowel syndrome (IBS) who have: frequent bowel urgency or fecal incontinence,
---
Alprazolam,Alprazolam ODT C-IV,AlprazolamExtended Release,Xanax|YU55MQ3IZY|
# Alprazolam Summary
Alprazolam orally disintegrating tablets, USP are also indicated for the treatment of panic disorder, with or without agoraphobia.
Alprazolam tablets are indicated for the: XANAX is indicated for the: 1.1 Generalized Anxiety Disorder The efficacy of alprazolam in the treatment of panic disorder was established in 2 short-term, placebo-controlled trials [see Clinical Studies (14.2)].
Alprazolam orally disintegrating tablets, USP are indicated for the treatment of generalized anxiety disorder.
treatment of panic disorder (PD), with or without agoraphobia in adults.
acute treatment of generalized anxiety disorder (GAD) in adults.
---
Alunbrig,brigatinib|HYW8DB273J|
# Brigatinib Summary
ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test [see Dosage and Administration (2.1) ] .
---
ALYFTREK,tezacaftor|8RW88Y506K|
# Tezacaftor Summary
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene (see Table 5 ) [see Clinical Pharmacology (12.1) ].
---
ALYFTREK,vanzacaftor|COM1POP492|
# Vanzacaftor Summary
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene (see Table 5 ) [see Clinical Pharmacology (12.1) ].
---
ALYFTREK,deutivacaftor|SHA6U5FJZL|
# Deutivacaftor Summary
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene (see Table 5 ) [see Clinical Pharmacology (12.1) ].
---
Amantadine,Amantadine Hydrochloride|M6Q1EO9TD0|
# Amantadine Hydrochloride Summary
Influenza A Treatment Amantadine Hydrochloride Oral Solution, USP is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus.
Amantadine hydrochloride capsules, USP are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus.
Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus.
There is no clinical evidence indicating that amantadine hydrochloride tablets are effective in the prophylaxis or treatment of viral respiratory tract illnesses other than those caused by influenza A virus strains.
---
Ambrisentan,Letairis|HW6NV07QEC|
# Ambrisentan Summary
Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: In combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability [see Clinical Studies (14.2) ].
Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients : Letairis is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients:
---
Amcinonide|423W026MA9|
# Amcinonide Summary
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Amikacin Sulfate|N6M33094FD|
# Amikacin Sulfate Summary
Limitations: Aminoglycosides, including Amikacin Sulfate Injection are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics having less potential toxicity.
Amikacin Sulfate Injection is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli , species of indole-positive and indole-negative Proteus , Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter ( Mima-Herellea ) species.
---
Aminocaproic Acid|U6F3787206|
# Aminocaproic Acid Summary
Aminocaproic Acid Injection, is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures), and portacaval shunt; hematological disorders such as aplastic anemia; acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usually a normal physiological phenomenon, may frequently be associated with life-threatening complications following severe trauma, anoxia, and shock. Symptomatic of such complications is surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (See...
---
Amiodarone Hydrochloride|976728SY6Z|
# Amiodarone Hydrochloride Summary
Amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.
Amiodarone Hydrochloride Tablets is indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.
Amiodarone hydrochloride is indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.
---
Amitriptyline Hydrochloride,Perphenazine and Amitriptyline Hydrochloride|26LUD4JO9K|
# Amitriptyline Hydrochloride Summary
Perphenazine and amitriptyline hydrochloride tablets are recommended for treatment of (1) patients with moderate to severe anxiety and/or agitation and depressed mood, (2) patients with depression in whom anxiety and/or agitation are severe, and (3) patients with depression and anxiety in association with chronic physical disease.
---
Amlodipine and Atorvastatin,Atorvastatin calcium,atorvastatin calcium trihydrate|48A5M73Z4Q|
# Atorvastatin Calcium Trihydrate Summary
Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD Atorvastatin calcium tablets are indicated: Amlodipine is indicated for the treatment of hypertension, to lower blood pressure.
---
Amlodipine and Atorvastatin,Amlodipine Besylate,Exforge HCT,Olmesartan medoxomil Amlodipine and Hydrochlorothiazide|864V2Q084H|
# Amlodipine Besylate Summary
Amlodipine and atorvastatin tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate.
Amlodipine Hypertension In patients with recently documented CAD by angiography and without heart failure or an ejection fraction &lt;40%, amlodipine besylate is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.
Amlodipine besylate tablets, USP are indicated for the treatment of confirmed or suspected vasospastic angina.
Amlodipine is indicated for the symptomatic treatment of chronic stable angina.
---
Ammonia N 13,ammonia n-13|9OQO0E343Z|
# Ammonia N-13 Summary
Ammonia N 13 Injection is indicated for diagnostic Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.
---
Ammonium Lactate|67M901L9NQ|
# Ammonium Lactate Summary
Ammonium Lactate Cream, 12% is indicated for the treatment of ichthyosis vulgaris and xerosis.
---
Amoxicillin and Clavulanate Potassium,amoxicillin sodium|544Y3D6MYH|
# Amoxicillin Sodium Summary
Limitations: Limitations of Use acute bacterial sinusitis Amoxicillin and Clavulanate Potassium Extended Release Tablets is not indicated for the treatment of infections due to S.
Amoxicillin and Clavulanate Potassium Extended Release Tablets is indicated for the treatment of infections in adults and pediatric patients weighing greater than or equal to 40 kg who are able to swallow tablets with: community-acquired pneumonia or Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium Extended Release Tablets and other antibacterial drugs, Amoxicillin and Clavulanate Potassium Extended Release Tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
---
Amoxicillin,Amoxicillin and Clavulanate Potassium,Amoxicillin/Clav Pot|804826J2HU|
# Amoxicillin Summary
Limitations: Limitations of Use When susceptibility test results show no susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium tablets should not be used.
(H.pylori) with clarithromycin and lansoprazole : Adult Patients Only Amoxicillin and clavulanate potassium tablets are indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Dual therapy for H.pylori
Triple therapy for Helicobacter pylori (H.pylori) with clarithromycin and lansoprazole Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp.
---
Amoxicillin and Clavulanate Potassium,Amoxicillin/Clav Pot,clavulanate potassium|Q42OMW3AT8|
# Clavulanate Potassium Summary
Amoxicillin and clavulanate potassium tablets are indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections - caused by beta‑lactamase‑producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
Limitations: Limitations of Use When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, Amoxicillin and Clavulanate Potassium Tablets should not be used.
Limitations: Limitations of Use Urinary Tract Infections - caused by beta‑lactamase‑producing isolates of E.
---
Amphotericin B liposome,amphotericin b|7XU7A7DROE|
# Amphotericin B Summary
Amphotericin B liposome for injection is indicated for the following: Empirical therapy for presumed fungal infection in febrile, neutropenic patients.
Treatment of Cryptococcal Meningitis in HIV-infected patients (see DESCRIPTION OF CLINICAL STUDIES ).
Treatment of visceral leishmaniasis.
---
Ampicillin,ampicillin trihydrate|HXQ6A1N7R6|
# Ampicillin Trihydrate Summary
Ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: Infections of the gastrointestinal tract: Shigella, S.
Ampicillin capsules are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: Infections of the respiratory tract: Nonpenicillinase- producing H.
---
Ampicillin,Ampicillin and Sulbactam,Ampicillin sodium,Ampicillin Sodium and Sulbactam Sodium|JFN36L5S8K|
# Ampicillin Sodium Summary
While ampicillin and sulbactam for injection is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with ampicillin and sulbactam for injection due to its ampicillin content.
Ampicillin for Injection, USP is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: Septicemia and Endocarditis caused by susceptible Gram-positive organisms including Streptococcus spp., penicillin G-susceptible staphylococci, and enterococci .
* Ampicillin and Sulbactam for Injection, USP, is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
---
Ampicillin and Sulbactam,Ampicillin Sodium and Sulbactam Sodium,sulbactam sodium|DKQ4T82YE6|
# Sulbactam Sodium Summary
Ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
Ampicillin and sulbactam for injection, USP is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
While ampicillin and sulbactam for injection, USP is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with ampicillin and sulbactam for injection, USP due to its ampicillin content.
Ampicillin and Sulbactam for Injection, USP, is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
---
Anagrelide,anagrelide hydrochloride|VNS4435G39|
# Anagrelide Hydrochloride Summary
Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
---
Analpram HC,EPIFOAM,PROCTOFOAMHC,pramoxine hydrochloride|88AYB867L5|
# Pramoxine Hydrochloride Summary
INIDCATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Proctofoam ® HC is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the anal region.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Anzupgo,delgocitinib|9L0Q8KK220|
# Delgocitinib Summary
ANZUPGO is indicated for the topical treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable.
---
Apidra,Apidra SoloStar,insulin glulisine|7XIY785AZD|
# Insulin Glulisine Summary
APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
---
Argatroban|IY90U61Z3S|
# Argatroban Summary
Argatroban injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT).
Argatroban injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
---
Aripiprazole|82VFR53I78|
# Aripiprazole Summary
Schizophrenia Schizophrenia [see Clinical Studies ( 14.1 )] Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Aripiprazole oral tablets are indicated for the treatment of: Aripiprazole tablets are indicated for the treatment of: Aripiprazole Oral Solution are indicated for the treatment of: Irritability Associated with Autistic Disorder [see Clinical Studies ( 14.4 )] Schizophrenia [see Clinical Studies (14.1) ] Irritability Associated with Autistic Disorder [see Clinical Studies (14.4) ] Adjunctive Treatment of Major Depressive Disorder Treatment of Tourette’s Disorder [see Clinical Studies ( 14.5 )] Adjunctive Treatment of Major Depressive Disorder [see Clinical Studies ( 14.3 )] Acute Treatment of Manic and Mixed Episodes associated with Bipolar...
---
Armodafinil,Nuvigil|V63XWA605I|
# Armodafinil Summary
Limitations: Limitations of Use NUVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).
In OSA, armodafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.
Armodafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).
If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating armodafinil tablets for excessive sleepiness.
---
Armour Thyroid,Thyroid|6RV024OAUQ|
# Thyroid Summary
Armour Thyroid (thyroid tablets, USP) are indicated: As pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer.
Thyroid Tablets are indicated:
---
Arnuity Ellipta,fluticasone furoate|JS86977WNV|
# Fluticasone Furoate Summary
ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older.
Limitations: ARNUITY ELLIPTA is NOT indicated for the relief of acute bronchospasm.
Limitations: Limitations of Use
---
ASENAPINE|JKZ19V908O|
# Asenapine Summary
Asenapine sublingual tablet(s) is indicated for: Bipolar I disorder [see Clinical Studies ( 14.2 )] Adjunctive treatment to lithium or valproate in adults
---
Aspirin and Extended-Release Dipyridamole,dipyridamole|64ALC7F90C|
# Dipyridamole Summary
Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
---
Aspirin and Extended-Release Dipyridamole,Butalbital, aspirin, and caffeine,aspirin|R16CO5Y76E|
# Aspirin Summary
Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
Butalbital, aspirin, and caffeine capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of butalbital, aspirin, and caffeine capsules in the treatment of multiple recurrent headaches is unavailable.
---
Atazanavir Sulfate|4MT4VIE29P|
# Atazanavir Sulfate Summary
Atazanavir capsule is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 15 kg.
Limitations: Limitations of Use:
Atazanavir capsules are not recommended for use in pediatric patients below the age of 3 months due to the risk of kernicterus [see Use in Specific Populations (8.4) ].
---
Atenolol,Atenolol and Chlorthalidone,TENORETIC|50VV3VW0TI|
# Atenolol Summary
Atenolol tablets USP are indicated for the treatment of hypertension, to lower blood pressure.
Angina Pectoris Due to Coronary Atherosclerosis: Atenolol is indicated for the long-term management of patients with angina pectoris.
Atenolol and Chlorthalidone Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
Atorvastatin calcium,atorvastatin|A0JWA85V8F|
# Atorvastatin Summary
To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD Atorvastatin calcium tablets is indicated: As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH).
---
Atorvastatin Calcium,soybean lecithin|1DI56QDM62|
# Soybean Lecithin Summary
To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD Atorvastatin calcium tablets are indicated: As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia.
---
Atorvastatin Calcium,polyethylene glycol, unspecified|3WJQ0SDW1A|
# Polyethylene Glycol, Unspecified Summary
To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD Atorvastatin calcium tablets are indicated: As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia.
---
Atorvastatin Calcium,xanthan gum|TTV12P4NEE|
# Xanthan Gum Summary
As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia Atorvastatin calcium tablets are indicated:
---
ATORVASTATIN CALCIUM,atorvastatin calcium propylene glycol solvate|YRZ789OWMI|
# Atorvastatin Calcium Propylene Glycol Solvate Summary
As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Atorvastatin Calcium Tablets are indicated: 1.
As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia.
---
Atovaquone|Y883P1Z2LT|
# Atovaquone Summary
1 INDICATIONS AND USAGE
---
Avar-e Green,Avar-e LS,Exact-Rx SODIUM SULFACETAMIDE and SULFER 10%/5% Cleanser,Sodium Sulfacetamide 10% and Sulfur 5% Cleanser,Sodium Sulfacetamide 8%  Sulfur 4% CLEANSER,Sodium Sulfacetamide 9.8% Sulfur 4.8% Cleanser,SULFACETAMIDE SODIUM, SULFUR,sulfur|70FD1KFU70|
# Sulfur Summary
This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Sodium Sulfacetamide 10% &amp; Sulfur 5% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
is indicated for he topical control of acne vulgaris, acne rosacea and Sodium Sulfacetamide 8% and Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
---
Azasan,Azathioprine|MRK240IY2L|
# Azathioprine Summary
AZASAN is indicated as an adjunct for the prevention of rejection in renal homotransplantation.
It is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms.
Azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation.
Rheumatoid Arthritis: Azathioprine Tablets are indicated for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms.
Rheumatoid Arthritis: AZASAN is indicated for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms.
---
Azelastine Hydrochloride,Azelastine Hydrochloride and Fluticasone Propionate,DYMISTA|0L591QR10I|
# Azelastine Hydrochloride Summary
Azelastine hydrochloride ophthalmic solution is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
Azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older.
Azelastine hydrochloride and fluticasone propionate nasal spray is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older.
---
AZITHROMYCIN,azithromycin monohydrate|JTE4MNN1MD|
# Azithromycin Monohydrate Summary
Azithromycin for oral suspension USP is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
[see Dosage and Administration (2) ] Azithromycin for injection is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions listed below.
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
---
Azopt,Brinzolamide|9451Z89515|
# Brinzolamide Summary
AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
Brinzolamide ophthalmic suspension 1% is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
---
BabyBIG,human botulinum neurotoxin a/b immune globulin|X641Y30OA7|
# Human Botulinum Neurotoxin A/B Immune Globulin Summary
BabyBIG ® , Botulism Immune Globulin Intravenous (Human), is indicated for the treatment of infant botulism caused by toxin type A or B in patients below one year of age.
---
BACLOFEN,Gablofen,Lioresal (baclofen)|H789N3FKE8|
# Baclofen Summary
Limitations: Baclofen tablets, USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
LIORESAL INTRATHECAL (baclofen injection) is indicated for use in the management of severe spasticity.
Limitations: Baclofen tablets USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
Baclofen injection is indicated for use in the management of severe spasticity in adult and pediatric patients age 4 years and above.
---
Baqsimi,glucagon|76LA80IG2G|
# Glucagon Summary
BAQSIMI™ is indicated for the treatment of severe hypoglycemia in adults and pediatric patients aged 1 year and older with diabetes.
---
Bendamustine Hydrochloride|981Y8SX18M|
# Bendamustine Hydrochloride Summary
Non-Hodgkin Lymphoma (NHL) Bendamustine hydrochloride injection is indicated for the treatment of adult patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
---
BENLYSTA,belimumab|73B0K5S26A|
# Belimumab Summary
Limitations: Active systemic lupus erythematosus (SLE) who are receiving standard therapy, and Limitations of Use The efficacy of BENLYSTA has not been evaluated in patients with severe active central nervous system (CNS) lupus.
BENLYSTA is indicated for the treatment of patients 5 years of age and older with:
---
Benznidazole|YC42NRJ1ZD|
# Benznidazole Summary
Benznidazole Tablets are indicated in pediatric patients 2 to 12 years of age for the treatment of Chagas disease (American trypanosomiasis) caused by Trypanosoma cruzi .
---
Benzonatate|5P4DHS6ENR|
# Benzonatate Summary
Benzonatate capsules, USP are indicated for the symptomatic relief of cough.
Benzonatate Capsule is indicated for the symptomatic relief of cough.
Benzonatate is indicated for the symptomatic relief of cough.
---
Benztropine Mesylate|WMJ8TL7510|
# Benztropine Mesylate Summary
Benztropine Mesylate Tablets, USP are indicated for use as an adjunct in the therapy of all forms of parkinsonism.
Benztropine mesylate tablets are indicated for use as an adjunct in the therapy of all forms of parkinsonism.
---
Besponsa,inotuzumab ozogamicin|P93RUU11P7|
# Inotuzumab Ozogamicin Summary
BESPONSA is indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult and pediatric patients 1 year and older .
---
Betamethasone Dipropionate,Clotrimazole and Betamethasone Dipropionate,DIPROLENE|826Y60901U|
# Betamethasone Dipropionate Summary
Betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older.
Clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older.
Betamethasone dipropionate cream (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older.
---
Betamethasone Sodium Phosphate and Betamethasone Acetate,CELESTONE SOLUSPAN,betamethasone sodium phosphate|7BK02SCL3W|
# Betamethasone Sodium Phosphate Summary
The intralesional administration of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques; necrobiosis lipoidica diabeticorum.
When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: When oral therapy is not feasible, the intramuscular use of CELESTONE ® SOLUSPAN ® Injectable Suspension is indicated as follows: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia).
For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.
---
Betamethasone Sodium Phosphate and Betamethasone Acetate,CELESTONE SOLUSPAN,betamethasone acetate|TI05AO53L7|
# Betamethasone Acetate Summary
When oral therapy is not feasible, the intramuscular use of CELESTONE ® SOLUSPAN ® Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: The intralesional administration of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques; necrobiosis lipoidica diabeticorum.
---
Betamethasone valerate|9IFA5XM7R2|
# Betamethasone Valerate Summary
Betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Betaseron,interferon beta-1b|TTD90R31WZ|
# Interferon Beta-1B Summary
BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Bethanechol Chloride|H4QBZ2LO84|
# Bethanechol Chloride Summary
Bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
---
Bexarotene|A61RXM4375|
# Bexarotene Summary
Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
---
BEYFORTUS,nirsevimab|VRN8S9CW5V|
# Nirsevimab Summary
BEYFORTUS is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in: Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
---
Bicalutamide|A0Z3NAU9DP|
# Bicalutamide Summary
Bicalutamide tablets 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.
---
Biktarvy,bictegravir sodium|4L5MP1Y7W7|
# Bictegravir Sodium Summary
BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: with no antiretroviral treatment history, or with an antiretroviral treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir, or
---
bimatoprost|QXS94885MZ|
# Bimatoprost Summary
Bimatoprost ophthalmic solution, 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
Bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
Bimatoprost ophthalmic solution 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
---
Biopar delta-FORTE,intrinsic factor|70BT6OQT2Q|
# Intrinsic Factor Summary
Biopar TM delta ﻿-FORTE is specifically indicated as a primary and adjunctive treatment in pernicious anemia patients having idiosyncrasy or sensitivity to parenteral administration - or when parental therapy is refused;
---
Biopar delta-FORTE,cobalamin|8406EY2OQA|
# Cobalamin Summary
Biopar TM delta ﻿-FORTE is specifically indicated as a primary and adjunctive treatment in pernicious anemia patients having idiosyncrasy or sensitivity to parenteral administration - or when parental therapy is refused;
---
Biopar delta-FORTE,levoleucovorin|990S25980Y|
# Levoleucovorin Summary
Biopar TM delta ﻿-FORTE is specifically indicated as a primary and adjunctive treatment in pernicious anemia patients having idiosyncrasy or sensitivity to parenteral administration - or when parental therapy is refused;
---
Biopar delta-FORTE,dihydrofolic acid|KXP0KNM559|
# Dihydrofolic Acid Summary
Biopar TM delta ﻿-FORTE is specifically indicated as a primary and adjunctive treatment in pernicious anemia patients having idiosyncrasy or sensitivity to parenteral administration - or when parental therapy is refused;
---
Bisoprolol Fumarate and Hydrochlorothiazide,bisoprolol fumarate|UR59KN573L|
# Bisoprolol Fumarate Summary
Bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension.
---
Bivalirudin|TN9BEX005G|
# Bivalirudin Summary
Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
---
BRENZAVVY,bexagliflozin|EY00JF42FV|
# Bexagliflozin Summary
BRENZAVVY is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations: Limitations of Use BRENZAVVY is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
---
ALPHAGAN P,Brimonidine,Brimonidine tartrate,Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution|4S9CL2DY2H|
# Brimonidine Tartrate Summary
Brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Brimonidine tartrate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Brimonidine tartrate ophthalmic solution 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Brimonidine topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older.
---
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,Dorzolamide Hydrochloride and Timolol Maleate,Timolol maleate,Timolol Maleate Ophthalmic Gel Forming Solution,Timoptic in Ocudose|P8Y54F701R|
# Timolol Maleate Summary
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day.
Preservative-free timolol maleate ophthalmic solution USP in the unit dose vial is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
---
Brinsupri,brensocatib|25CG88L0BB|
# Brensocatib Summary
BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.
---
BRIUMVI,ublituximab|U59UGK3IPC|
# Ublituximab Summary
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
brivaracetam,Briviact|U863JGG2IA|
# Brivaracetam Summary
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
---
BROMFENAC,BROMFENAC SODIUM|8ECV571Y37|
# Bromfenac Sodium Summary
Bromfenac ophthalmic solution 0.09% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Bromfenac ophthalmic solution 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
---
Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide,brompheniramine maleate|IXA7C9ZN03|
# Brompheniramine Maleate Summary
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
---
Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide,pseudoephedrine hydrochloride|6V9V2RYJ8N|
# Pseudoephedrine Hydrochloride Summary
Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
---
Bumetanide,Bumex,Enbumyst|0Y2S3XUQ5H|
# Bumetanide Summary
Bumetanide Injection, USP is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
ENBUMYST is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome in adults.
Bumex tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
Bumetanide tablets, USP are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
---
Bupivacaine Hydrochloride,Marcaine,MARCAINE WITH EPINEPHRINE,Sensorcaine|7TQO7W3VT8|
# Bupivacaine Hydrochloride Summary
Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.
Limitations: Limitations of Use Not all blocks are indicated for use with MARCAINE / MARCAINE WITH EPINEPHRINE given clinically significant risks associated with use [see Dosage and Administration (2.2), Contraindications (4), Warnings and Precautions (5.1, 5.4, 5.5, 5.7, 5.9)].
Bupivacaine Hydrochloride in Dextrose Injection, USP is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia).
---
Buprenorphine and Naloxone,naloxone|36B82AMQ7N|
# Naloxone Summary
Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence.
---
Buprenorphine,Buprenorphine and Naloxone,buprenorphine transdermal system|40D3SCR4GZ|
# Buprenorphine Summary
Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence.
Buprenorphine transdermal system is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate.
SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
---
Buprenorphine,Buprenorphine and Naloxone,Buprenorphine HCl,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE|56W8MW3EN1|
# Buprenorphine Hydrochloride Summary
Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence.
Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence.
Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction.
Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction.
Buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence.
---
Buprenorphine and Naloxone,buprenorphine hydrochloride and naloxone hydrochloride dihydrate,naloxone hydrochloride dihydrate|5Q187997EE|
# Naloxone Hydrochloride Dihydrate Summary
Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence.
Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence.
Buprenorphine and naloxone sublingual tablet is indicated for the maintenance treatment of opioid dependence.
---
AUVELITY,bupropion,Bupropion Hydrochloride,BUPROPION HYDROCHLORIDE (SR),Bupropion HydrochlorideSR,Forfivo XL,WELLBUTRINSR|ZG7E5POY8O|
# Bupropion Hydrochloride Summary
Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM).
Bupropion hydrochloride extended-release tablets (SR) is indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM).
Bupropion hydrochloride extended-release tablets (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM).
The efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies ( 14 )].
---
Buspirone Hydrochloride|207LT9J9OC|
# Buspirone Hydrochloride Summary
Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
Buspirone hydrochloride tablets, USP are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
---
Busulfan,BUSULFEX|G1LN9045DK|
# Busulfan Summary
Busulfan injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
BUSULFEX is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
---
Butalbital, Acetaminophen and Caffeine,Butalbital, Acetaminophen, and Caffeine,Butalbital, Acetaminophen, Caffeine,Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate,Butalbital, aspirin, and caffeine,Fioricet,Fioricet with Codeine,caffeine|3G6A5W338E|
# Caffeine Summary
Have not been tolerated, or are not expected to be tolerated, Fioricet is indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Limitations: Because of the risks of addiction, abuse, and misuse with opioids and butalbital, even at recommended doses [see Warnings and Precautions ( 5.1 )], reserve FIORICET with CODEINE for use in patients for whom alternative treatment options [e.g., non-opioid, non-barbiturate analgesics]: Limitations of Use Have not provided adequate analgesia or are not expected to provide adequate analgesia.
---
BUTALBITAL AND ACETAMINOPHEN,Butalbital, Acetaminophen and Caffeine,Butalbital, Acetaminophen, and Caffeine,Butalbital, Acetaminophen, Caffeine,Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate,Butalbital, aspirin, and caffeine,Fioricet,Fioricet with Codeine,butalbital|KHS0AZ4JVK|
# Butalbital Summary
Because of the risks of addiction, abuse, and misuse with opioids and butalbital, even at recommended doses [see Warnings and Precautions ( 5.1 )], reserve Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for use in patients for whom alternative treatment options [e.g., non-opioid, non-barbiturate analgesics]: Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are indicated for the management of the symptom complex of tension (or muscle contraction) headache when non-opioid analgesic and alternative treatments are inadequate.
Fioricet is indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable.
---
Acetaminophen and Codeine Phosphate,Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate,Fioricet with Codeine,codeine phosphate|GSL05Y1MN6|
# Codeine Phosphate Summary
Limitations: Have not been tolerated, or are not expected to be tolerated, Limitations of Use Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate.
Limitations: Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids and butalbital, even at recommended doses [see Warnings and Precautions ( 5.1 )], reserve FIORICET with CODEINE for use in patients for whom alternative treatment options [e.g., non-opioid, non-barbiturate analgesics]: Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate.
---
Butorphanol Tartrate|2L7I72RUHN|
# Butorphanol Tartrate Summary
Butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations: Limitations of Use : Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy [see WARNINGS ] , reserve opioid analgesics, including butorphanol tartrate, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
Limitations: Limitations of Use
---
Byetta,Exenatide|9P1872D4OL|
# Exenatide Summary
Limitations: Limitations of Use Exenatide injection is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
Cabenuva,Rilpivirine|FI96A8X663|
# Rilpivirine Summary
CABENUVA is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35 kg to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA &lt;50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine [see Microbiology ( 12.4 ), Clinical Studies ( 14.1 )] .
---
Cabenuva,Cabotegravir|HMH0132Z1Q|
# Cabotegravir Summary
CABENUVA is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35 kg to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA &lt;50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine [see Microbiology ( 12.4 ), Clinical Studies ( 14.1 )] .
---
Cabergoline|LL60K9J05T|
# Cabergoline Summary
Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
CABERGOLINE is an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults.
Cabergoline Tablets, USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
---
caffeine citrate|U26EO4675Q|
# Caffeine Citrate Summary
Caffeine citrate is indicated for the short term treatment of apnea of prematurity in infants between 28 and &lt;33 weeks gestational age.
---
Calcitriol|FXC9231JVH|
# Calcitriol Summary
Predialysis Patients Calcitriol capsule is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis.
Hypoparathyroidism Patients Calcitriol capsule is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis.
---
Calcium Acetate|Y882YXF34X|
# Calcium Acetate Summary
Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD) Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
---
Calcium Gluconate,Calcium Gluconate in Sodium Chloride,calcium gluconate monohydrate|CZN0MI5R31|
# Calcium Gluconate Monohydrate Summary
Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
Calcium Gluconate in Sodium Chloride Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
Limitations: Limitations of Use
---
CAMCEVI,leuprolide mesylate|8E3C3C493W|
# Leuprolide Mesylate Summary
CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.
---
Campath,LEMTRADA,alemtuzumab|3A189DH42V|
# Alemtuzumab Summary
CAMPATH is indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
LEMTRADA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults.
Because of its safety profile, the use of LEMTRADA should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS [see Warnings and Precautions (5) ] .
---
Cangrelor|6AQ1Y404U7|
# Cangrelor Summary
Cangrelor for injection is indicated as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with a P2Y 12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor [see Clinical Studies (14.1) ].
---
CAPLYTA,lumateperone|70BSQ12069|
# Lumateperone Summary
CAPLYTA is indicated for: Treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults, as monotherapy and as adjunctive therapy with lithium or valproate [see Clinical Studies (14.2) ] .
Treatment of schizophrenia in adults [see Clinical Studies (14.1) ] .
Adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14.3 ) ].
---
CAPRELSA,vandetanib|YO460OQ37K|
# Vandetanib Summary
CAPRELSA is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
---
Captopril|9G64RSX1XD|
# Captopril Summary
Heart Failure: Captopril tablets, USP are indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis.
Diabetic Nephropathy: Captopril tablets, USP are indicated for the treatment of diabetic nephropathy (proteinuria &gt; 500 mg/day) in patients with type I insulin-dependent diabetes mellitus and retinopathy.
Left Ventricular Dysfunction After Myocardial Infarction: Captopril tablets, USP are indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction ≤ 40% and to reduce the incidence of overt heart failure and subsequent hospitalizations for congestive heart failure in these patients.
Hypertension: Captopril tablets, USP, are indicated for the treatment of hypertension.
---
Carbamazepine|33CM23913M|
# Carbamazepine Summary
Epilepsy Trigeminal Neuralgia Carbamazepine tablets are indicated in the treatment of the pain associated with true trigeminal neuralgia.
Epilepsy Carbamazepine tablets are indicated for use as an anticonvulsant drug.
Trigeminal Neuralgia Carbamazepine extended-release tablet is indicated for use as an anticonvulsant drug.
Evidence supporting efficacy of carbamazepine extended-release tablet as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Carbamazepine extended-release tablet is indicated in the treatment of the pain associated with true trigeminal neuralgia.
---
Carbidopa and levodopa,Carbidopa-levodopa,CARBIDOPA, LEVODOPA AND ENTACAPONE,RYTARY,carbidopa|MNX7R8C5VO|
# Carbidopa Summary
Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Carbidopa, levodopa and entacapone tablets, are indicated for the treatment of Parkinson’s disease.
RYTARY is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Carbidopa, levodopa and entacapone tablets can be used: Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
---
Carbidopa and levodopa,Carbidopa-levodopa,CARBIDOPA, LEVODOPA AND ENTACAPONE,Inbrija,RYTARY,levodopa|46627O600J|
# Levodopa Summary
RYTARY is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Carbidopa, levodopa and entacapone tablets, are indicated for the treatment of Parkinson’s disease.
Carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
---
CARBIDOPA, LEVODOPA AND ENTACAPONE,Entacapone|4975G9NM6T|
# Entacapone Summary
Carbidopa, levodopa and entacapone tablets, are indicated for the treatment of Parkinson’s disease.
Carbidopa, levodopa and entacapone tablets can be used: Entacapone tablets, USP are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease (see CLINICAL PHARMACOLOGY, Clinical Studies ).
---
Carbinoxamine Maleate,Carbinoxamine Maleate Extended-Release Oral Suspension|02O55696WH|
# Carbinoxamine Maleate Summary
Vasomotor rhinitis Carbinoxamine maleate is effective for the symptomatic treatment of: Carbinoxamine Maleate extended-release oral suspension is indicated for adults and pediatric patients 2 years of age and older for the symptomatic treatment of: Dermatographism Seasonal and perennial allergic rhinitis Seasonal and perennial allergic rhinitis.
---
carboprost tromethamine|U4526F86FJ|
# Carboprost Tromethamine Summary
Carboprost tromethamine injection is indicated for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.
Failure of expulsion of the fetus during the course of treatment by another method; Carboprost tromethamine injection is indicated for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.
Prior treatment should include the use of intravenously administered oxytocin, manipulative techniques such as uterine massage and, unless contraindicated, intramuscular ergot preparations.
---
CardioGen-82,rubidium chloride rb-82|F0Z746KRKQ|
# Rubidium Chloride Rb-82 Summary
CardioGen-82, used to produce Rubidium Chloride Rb 82 Injection, is indicated for positron emission tomography (PET) of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.
---
CAREALL Muscle RubUltra Strength,Orthaphen,levomenthol|BZ1R15MTK7|
# Levomenthol Summary
Diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s).
---
CAREALL Muscle RubUltra Strength,Orthaphen,Xiclofen,methyl salicylate|LAV5U5022Y|
# Methyl Salicylate Summary
Diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s).
Xiclofen TM Ointment is indicated in adults over the age of 12 years old for the treatment of signs and symptoms of osteoarthritis of the joints, and of acute and chronic pain in muscles and joints associated with muscle soreness, strains, sprains, arthritis, simple backache, muscle stiffness, and more.
---
Carisoprodol,Carisoprodol Tablets, USP, 350 mg,Soma|21925K482H|
# Carisoprodol Summary
Carisoprodol Tablets, USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.
Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.
Carisoprodol tablets, USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.
---
Carmustine|U68WG3173Y|
# Carmustine Summary
Carmustine for injection, USP is indicated as palliative therapy as a single agent or in established combination therapy in the following: Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs.
Carmustine for injection is indicated as palliative therapy as a single agent or in established combination therapy in the following:
---
Cefadroxil|280111G160|
# Cefadroxil Summary
Cefadroxil Capsules USP are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: Note: Culture and susceptibility tests should be initiated prior to and during therapy.
Cefadroxil capsules are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases:
---
Cefazolin,cefazolin sodium|P380M0454Z|
# Cefazolin Sodium Summary
Cefazolin for Injection, USP is indicated in the treatment of the following serious infections due to susceptible organisms: The prophylactic administration of Cefazolin for Injection should usually be discontinued within a 24 hour period after the surgical procedure.
Cefazolin for Injection, USP is indicated for the treatment of the following serious infections due to susceptible organisms: If there are signs of infection, specimens for cultures should be obtained for the identification of the causative organism so that appropriate therapy may be instituted (see DOSAGE AND ADMINISTRATION ).
---
Cefdinir|CI0FAO63WC|
# Cefdinir Summary
Cefdinir capsules, USP are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.
Cefdinir capsules are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.
---
Ceftriaxone Sodium|023Z5BR09K|
# Ceftriaxone Sodium Summary
Ceftriaxone for injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: SKIN AND SKIN STRUCTURE INFECTIONS caused by Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes , Viridans group streptococci, Escherichia coli, Enterobacter cloacae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Morganella morganii,* Pseudomonas aeruginosa, Serratia marcescens, Acinetobacter calcoaceticus, Bacteroides fragilis* or Peptostreptococcus species.
Therefore, when cephalosporins are used in the treatment of patients with pelvic inflammatory disease and Chlamydia trachomatis is one of the suspected pathogens, appropriate antichlamydial coverage should be added.
---
CELECOXIB,VYSCOXA|JCX84Q7J1L|
# Celecoxib Summary
Celecoxib capsules are indicated Celecoxib capsule are indicated Carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib.
Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see Warnings and Precautions (5) ] Celecoxib is indicated In adults for the management of the signs and symptoms of: VYSCOXA is indicated
---
CellCept,mycophenolate mofetil hydrochloride|UXH81S8ZVB|
# Mycophenolate Mofetil Hydrochloride Summary
CELLCEPT [mycophenolate mofetil (MMF)] is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants.
---
Cenobamate,Xcopri,XcopriMaintenance Pack,XcopriTitration Pack|P85X70RZWS|
# Cenobamate Summary
XCOPRI is indicated for the treatment of partial-onset seizures in adult patients.
---
CEREBYX,fosphenytoin sodium|7VLR55452Z|
# Fosphenytoin Sodium Summary
CEREBYX is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery.
---
Cerezyme,imiglucerase|Q6U6J48BWY|
# Imiglucerase Summary
Cerezyme is indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia bone disease hepatomegaly or splenomegaly thrombocytopenia
---
CERIANNA,fluoroestradiol f-18|T32277KB09|
# Fluoroestradiol F-18 Summary
CERIANNA is indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
---
Cetirizine Hydrochloride,QUZYTTIR|64O047KTOA|
# Cetirizine Hydrochloride Summary
Chronic Urticaria Cetirizine hydrochloride oral solution, USP is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age.
Perennial Allergic Rhinitis Perennial Allergic Rhinitis: Cetirizine hydrochloride oral solution is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age.
QUZYTTIR ® is indicated for the treatment of acute urticaria in adults and children 6 months of age and older.
---
Cetrorelix,Cetrotide,cetrorelix acetate|W9Y8L7GP4C|
# Cetrorelix Acetate Summary
Cetrotide ® (cetrorelix acetate for injection) is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
Cetrorelix acetate for injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
---
Chenodal,chenodiol|0GEI24LG0J|
# Chenodiol Summary
Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age.
---
Chlordiazepoxide Hydrochloride,Chlordiazepoxide Hydrochloride and Clidinium Bromide|MFM6K1XWDK|
# Chlordiazepoxide Hydrochloride Summary
Chlordiazepoxide HCl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.
Chlordiazepoxide Hydrochloride and Clidinium Bromide is indicated to control emotional and somatic factors in gastrointestinal disorders.
Chlordiazepoxide hydrochloride and clidinium bromide capsules is indicated to control emotional and somatic factors in gastrointestinal disorders.
Chlordiazepoxide Hydrochloride and Clidinium Bromide may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
---
Chlordiazepoxide Hydrochloride and Clidinium Bromide,clidinium bromide|91ZQW5JF1Z|
# Clidinium Bromide Summary
Chlordiazepoxide Hydrochloride and Clidinium Bromide is indicated to control emotional and somatic factors in gastrointestinal disorders.
Chlordiazepoxide hydrochloride and clidinium bromide capsules is indicated to control emotional and somatic factors in gastrointestinal disorders.
Chlordiazepoxide hydrochloride and clidinium bromide capsules are indicated to control emotional and somatic factors in gastrointestinal disorders.
Chlordiazepoxide Hydrochloride and Clidinium Bromide may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
---
CHLOROQUINE PHOSPHATE|6E17K3343P|
# Chloroquine Phosphate Summary
Limitations: Limitations of Use in Malaria: Chloroquine phosphate tablets do not prevent relapses in patients with vivax or ovale malaria because it is not effective against exoerythrocytic forms of the parasites.
Chloroquine phosphate tablets are indicated for the:
Treatment of uncomplicated malaria due to susceptible strains of P.
Concomitant therapy with an 8-aminoquinoline drug is necessary for treatment of the hypnozoite liver stage forms of P.
---
Chlorpromazine Hydrochloride|9WP59609J6|
# Chlorpromazine Hydrochloride Summary
For the treatment of schizophrenia.
For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance.
---
Atenolol and Chlorthalidone,Chlorthalidone,TENORETIC|Q0MQD1073Q|
# Chlorthalidone Summary
Limitations: This fixed dose combination drug is not indicated for initial therapy of hypertension.
Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.
Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.
Atenolol and Chlorthalidone Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure.
Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia.
---
Chlorzoxazone|H0DE420U8G|
# Chlorzoxazone Summary
Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
---
CHOLESTYRAMINE,CHOLESTYRAMINE LIGHT,Prevalite|4B33BGI082|
# Cholestyramine Summary
1) Cholestyramine for Oral Suspension, USP powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet.
Limitations: Cholestyramine for Oral Suspension, USP powder may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern.
1) Cholestyramine for Oral Suspension, USP Light powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet.
---
Choletec,mebrofenin|7PV0B6ED98|
# Mebrofenin Summary
Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
---
CICLOPIROX|19W019ZDRJ|
# Ciclopirox Summary
Seborrheic Dermatitis Ciclopirox gel is indicated for the topical treatment of seborrheic dermatitis of the scalp.
Ciclopirox Gel, 0.77% is indicated for the topical treatment of seborrheic dermatitis of the scalp.
Ciclopirox topical solution, 8% (nail lacquer), as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum .
The comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures.
---
Ciclopirox Olamine|50MD4SB4AP|
# Ciclopirox Olamine Summary
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur .
Ciclopirox olamine cream is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum , Trichophyton mentagrophytes , Epidermophyton floccosum , and Microsporum canis ; candidiasis (moniliasis) due to Candida albicans ; and tinea (pityriasis) versicolor due to Malassezia furfur .
---
Cilostazol|N7Z035406B|
# Cilostazol Summary
Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance.
---
CINQAIR,reslizumab|35A26E427H|
# Reslizumab Summary
Limitations: CINQAIR is not indicated for treatment of other eosinophilic conditions.
Limitations: CINQAIR is not indicated for the relief of acute bronchospasm or status asthmaticus [see Warnings and Precautions ( 5.2 )] .
CINQAIR ® is indicated for the add-on maintenance treatment of patients with severe asthma aged 18 years and older with an eosinophilic phenotype [see Clinical Studies ( 14 )] .
---
APONVIE,CINVANTI,aprepitant|1NF15YR6UY|
# Aprepitant Summary
CINVANTI, in combination with other antiemetic agents, is indicated in adults for the prevention of: APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults.
---
CIPRO HC,ciprofloxacin hydrochloride and hydrocortisone,CIPROHC,Hydrocortisone,Hydrocortisone Rectal Suspension (Retention),Neomycin and Polymyxin B Sulfates and Hydrocortisone,Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension,PROCTOZONE-HC|WI4X0X7BPJ|
# Hydrocortisone Summary
CIPRO ® HC OTIC is indicated for the treatment of acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains of Pseudomonas aeruginosa , Staphylococcus aureus , and Proteus mirabilis .
Miscellaneous Regional enteritis Psoriatic arthritis Idiopathic thrombocytopenic purpura in adults Hydrocortisone tablets are indicated in the following conditions.
Endocrine Disorders Non suppurative thyroiditis Leukemias and lymphomas in adults Severe erythema multiforme (Stevens-Johnson syndrome) Hydrocortisone Topical Solution 2.5% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
CILOXAN,CIPRO HC,ciprofloxacin,ciprofloxacin hydrochloride and hydrocortisone,CIPROHC,ciprofloxacin hydrochloride|4BA73M5E37|
# Ciprofloxacin Hydrochloride Summary
Staphylococcus aureus Ciprofloxacin tablets are indicated in adult patients for treatment of skin and skin structure infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Morganella morganii, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus aureus, methicillin-susceptible Staphylococcus epidermidis, or Streptococcus pyogenes.
Ciprofloxacin tablets are indicated in adult patients for treatment of bone and joint infections caused by Enterobacter cloacae, Serratia marcescens, or Pseudomonas aeruginosa.
1.8 Plague Ciprofloxacin tablets are indicated in adults and pediatric patients from birth to 17 years of age for inhalational anthrax (post-exposure) to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis.
---
Cisatracurium Besylate|80YS8O1MBS|
# Cisatracurium Besylate Summary
Limitations: to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU Cisatracurium besylate injection is indicated: Limitations of Use Cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action.
---
CISplatin|Q20Q21Q62J|
# Cisplatin Summary
Cisplatin Injection is indicated as therapy to be employed as follows:
---
Citalopram,citalopram hydrobromide|I1E9D14F36|
# Citalopram Hydrobromide Summary
Citalopram is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] .
Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] .
Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] .
---
Cladribine,Mavenclad|47M74X9YT5|
# Cladribine Summary
Limitations: Limitations of Use Cladribine tablets are indicated for the treatment of relapsing form of multiple sclerosis (MS), to include relapsing-remitting disease in adults.
Because of its safety profile, use of cladribine tablets is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS [ see Warnings and Precautions (5) ].
MAVENCLAD is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults.
Cladribine tablets are not recommended for use in patients with clinically isolated syndrome (CIS) because of its safety profile [ see Warnings and Precautions (5) ].
---
Clarithromycin|H1250JIK0A|
# Clarithromycin Summary
Limitations: 1.9 Limitations of Use Clarithromycin tablets are indicated [see Indications and Usage (1.9)] for the treatment of mild to moderate infections caused by susceptible isolates due to: There is resistance to macrolides in certain bacterial infections caused by Streptococcus pneumoniae and Staphylococcus aureus.
Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae [see Indications and Usage (1.9)].
Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to Streptococcus pyogenes as an alternative in individuals who cannot use first line therapy.
---
CLEMSZA,clemastine fumarate|19259EGQ3D|
# Clemastine Fumarate Summary
Clemastine Fumarate Tablets USP, 2.68 mg are indicated for the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus, and lacrimation.
Clemastine Fumarate Tablets USP, 2.68 mg are also indicated for the relief of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
It should be noted that clemastine fumarate is indicated for the dermatologic indications at the 2.68 mg dosage level only.
---
Cleocin,Cleocin Phosphate,CLEOCIN PHOSPHATE (0009-6582) (STANDALONE),Cleocin T,Clindagel,Clindamycin Phoaphate Topical Solution USP, 1%,Clindamycin Phosphate,Clindamycin Phosphate 1.2% and Tretinoin 0.025%,Clindamycin phosphate and benzoyl peroxide,Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%,ONEXTON,ZIANA|EH6D7113I8|
# Clindamycin Phosphate Summary
The mean percent reductions in lesion counts at the end of treatment in this study are shown in the following table: Clindamycin phosphate and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older.
CLEOCIN Vaginal Cream 2%, is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis).
CLEOCIN PHOSPHATE is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below: Gynecological infections including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.
---
Cleocin Hydrochloride,CLINDAMYCIN HYDROCHLORIDE|T20OQ1YN1W|
# Clindamycin Hydrochloride Summary
Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
Clindamycin hydrochloride capsules are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
Clindamycin hydrochloride capsules, USP are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci.
Clindamycin hydrochloride capsules are also indicated in the treatment of seri­ous infections due to susceptible strains of streptococci, pneumococci, and staphylococci.
---
Cleocin Pediatric,Clindamycin Palmitate Hydrochloride|VN9A8JM7M7|
# Clindamycin Palmitate Hydrochloride Summary
Clindamycin palmitate hydrochloride for oral solution is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
CLEOCIN PEDIATRIC (clindamycin palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci.
---
Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%,Clindamycin Phosphate and Benzoyl Peroxide,Epsolay,Erythromycin and Benzoyl Peroxide,ONEXTON,Twyneo,benzoyl peroxide|W9WZN9A0GM|
# Benzoyl Peroxide Summary
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/3.75% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
Erythromycin and Benzoyl Peroxide Topical Gel USP is indicated for the topical treatment of acne vulgaris.
Clindamycin phosphate and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older.
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older.
EPSOLAY is indicated for the treatment of inflammatory lesions of rosacea in adults.
---
Clinolipid,Smoflipid,olive oil|6UYK2W1W1E|
# Olive Oil Summary
CLINOLIPID is indicated in adults and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
SMOFlipid is indicated in adult and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
Clobazam,SYMPAZAN|2MRO291B4U|
# Clobazam Summary
Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Clobazam tablets are indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
SYMPAZAN ® is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients 2 years of age or older.
---
CLOBETASOL PROPIONATE,Clobetasol Propionate Cream 0.05%Clobetasol Propionate Cream 0.05%,Clobetasol Propionate Cream USP, 0.05%Clobetasol Propionate Cream USP, 0.05%|779619577M|
# Clobetasol Propionate Summary
Clobetasol propionate cream USP, 0.05% is super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Clobetasol Propionate Ointment USP, 0.05% is super-high potency corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Clobetasol propionate ointment USP, 0.05% is super-high potency corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
This product is not recommended for use in pediatric patients under 12 years of age.
Clobetasol Propionate Topical Solution, 0.05% is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.
---
Clomiphene Citrate,MiloPhene|1B8447E7YI|
# Clomiphene Citrate Summary
(See DOSAGE AND ADMINISTRATION and PRECAUTIONS .) Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy.
Clomiphene citrate is indicated only in patients with demonstrated ovulatory dysfunction who meet the conditions described below: Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy.
There are no adequate or well-controlled studies that demonstrate the effectiveness of clomiphene citrate in the treatment of male infertility.
Clomiphene citrate therapy cannot be expected to substitute for specific treatment of other causes of ovulatory failure.
---
Clomipramine Hydrochloride|2LXW0L6GWJ|
# Clomipramine Hydrochloride Summary
Clomipramine hydrochloride capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
The effectiveness of Clomipramine hydrochloride capsules for the treatment of OCD was demonstrated in multicenter, placebo-controlled, parallel-group studies, including two 10-week studies in adults and one 8-week study in children and adolescents 10 to 17 years of age.
---
Clonazepam|5PE9FDE8GB|
# Clonazepam Summary
Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.
Panic Disorder: Clonazepam tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.
Clonazepam tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.
Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures.
Clonazepam tablets are useful alone or as an adjunct in the treatment of the Lennox- Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures.
---
Clonidine|MN3L5RMN02|
# Clonidine Summary
Clonidine transdermal system is indicated in the treatment of hypertension.
---
Clonidine Hydrochloride|W76I6XXF06|
# Clonidine Hydrochloride Summary
Clonidine hydrochloride tablets, USP are indicated in the treatment of hypertension.
Clonidine hydrochloride tablets are indicated in the treatment of hypertension.
Clonidine hydrochloride extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies ( 14 )] .
Clonidine hydrochloride is indicated in the treatment of hypertension.
Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ] .
---
Clorazepate Dipotassium|63FN7G03XY|
# Clorazepate Dipotassium Summary
Clorazepate dipotassium tablets are indicated for the symptomatic relief of acute alcohol withdrawal.
Clorazepate dipotassium tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
Clorazepate dipotassium tablets are indicated as adjunctive therapy in the management of partial seizures.
---
Clotrimazole,Clotrimazole and Betamethasone Dipropionate|G07GZ97H65|
# Clotrimazole Summary
Clotrimazole is also available as a nonprescription item which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis.
Clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older.
Clotrimazole cream USP is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur .
---
CNJ-016,human vaccinia virus immune globulin|7UB4J759TD|
# Human Vaccinia Virus Immune Globulin Summary
VIGIV (vaccinia immune globulin intravenous, human) is indicated for the treatment and/or modification of the following conditions: Eczema vaccinatum Progressive vaccinia Vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions
Severe generalized vaccinia VIGIV is not considered to be effective in the treatment of postvaccinial encephalitis.
---
Colchicine|SML2Y3J35T|
# Colchicine Summary
Limitations: Limitations of Use: The safety and effectiveness of colchicine capsules for acute treatment of gout flares during prophylaxis has not been studied.
Colchicine capsules are indicated for prophylaxis of gout flares in adults.
---
COLESTIPOL HYDROCHLORIDE|X7D10K905G|
# Colestipol Hydrochloride Summary
Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet.
---
AIRSUPRA,Albuterol Sulfate,Albuterol Sulfate Inhalation Solution,Albuterol Sulfate Inhalation Solution, 0.5%,Combivent Respimat,IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE|021SEF3731|
# Albuterol Sulfate Summary
COMBIVENT RESPIMAT is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
Albuterol inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm.
---
Condylox,podofilox|L36H50F353|
# Podofilox Summary
Condylox Gel 0.5% is indicated for the topical treatment of anogenital warts (external genital warts and perianal warts).
Limitations: This product is not indicated in the treatment of mucous membrane warts (see PRECAUTIONS ).
---
Cortisporin TC,thonzonium bromide|JI2B19CR0R|
# Thonzonium Bromide Summary
Cortisporin ® TC Otic is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics.
---
Cortisporin TC,colistin sulfate|WP15DXU577|
# Colistin Sulfate Summary
Cortisporin ® TC Otic is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics.
---
COSELA,trilaciclib dihydrochloride|4BX07W725T|
# Trilaciclib Dihydrochloride Summary
COSELA is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC).
---
Cosyntropin|72YY86EA29|
# Cosyntropin Summary
Cosyntropin for injection is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.
---
Creon,Viokace,Zenpep,pancrelipase lipase|8MYC33932O|
# Pancrelipase Lipase Summary
CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults.
---
cromolyn sodium,Cromolyn Sodium Inhalation Solution,Cromolyn Sodium Oral Solution (Concentrate),Gastrocrom|Q2WXR1I0PK|
# Cromolyn Sodium Summary
Cromolyn Sodium Oral Solution (Concentrate) is indicated in the management of patients with mastocytosis.
Cromolyn Sodium, USP is indicated in the management of patients with mastocytosis.
GASTROCROM is indicated in the management of patients with mastocytosis.
---
Curosurf,poractant alfa|KE3U2023NP|
# Poractant Alfa Summary
CUROSURF ® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants.
---
Adult Infuvite Multiple Vitamins,Cyanocobalamin,Multivitamin with Fluoride,Pediatric Infuvite Multiple Vitamins|P6YC3EG204|
# Cyanocobalamin Summary
Cyanocobalamin is indicated for vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Malignancy of pancreas or bowel Folic acid deficiency Fish tapeworm infestation Multivitamin with Fluoride Chewable tablets are prescription product for the clinical dietary management of metabolic processes of caries prophylaxis and provides supplementation of the diet with ten essential vitamins.
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
---
CYCLOBENZAPRINE HYDROCHLORIDE,TONMYA|0VE05JYS2P|
# Cyclobenzaprine Hydrochloride Summary
Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Limitations: Limitations of Use: Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Cyclobenzaprine hydrochloride tablets USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.
---
CYPROHEPTADINE HYDROCHLORIDE|NJ82J0F8QC|
# Cyproheptadine Hydrochloride Summary
Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. Vasomotor rhinitis Amelioration of allergic reactions to blood or plasma Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma Cold urticaria Dermatographism Allergic conjunctivitis due to inhalant allergens and foods Cold urticaria Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Perennial and seasonal allergic rhinitis
---
Cystografin,Cystografin Dilute,diatrizoate meglumine|3X9MR4N98U|
# Diatrizoate Meglumine Summary
Cystografin Dilute is indicated for retrograde cystourethrography.
Cystografin is indicated for retrograde cystourethrography.
---
Cysview,hexaminolevulinate hydrochloride|D4F329SL1O|
# Hexaminolevulinate Hydrochloride Summary
Cysview is indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for carcinoma of the bladder.
---
Cytalux,pafolacianine sodium|4HUF3V875C|
# Pafolacianine Sodium Summary
CYTALUX is indicated as an adjunct for intraoperative identification of: Malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.
---
Cytarabine|04079A1RDZ|
# Cytarabine Summary
Cytarabine Injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients.
Intrathecal administration of Cytarabine Injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia.
It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia.
---
Dacarbazine|7GR28W0FJI|
# Dacarbazine Summary
Dacarbazine for Injection, USP is indicated in the treatment of metastatic malignant melanoma.
In addition, dacarbazine is also indicated for Hodgkin's disease as a second-line therapy when used in combination with other effective agents.
---
Dalfampridine|BH3B64OKL9|
# Dalfampridine Summary
Dalfampridine Extended-Release Tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS).
Dalfampridine extended-release tablet is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS).
---
DANYELZA,naxitamab|9K8GNJ2874|
# Naxitamab Summary
DANYELZA is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.
---
ACZONE,Dapsone|8W5C518302|
# Dapsone Summary
Dermatitis herpetiformis: (D.H.) Dapsone gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Dapsone gel, 5%, is indicated for the topical treatment of acne vulgaris.
ACZONE ® Gel, 5%, is indicated for the topical treatment of acne vulgaris.
---
Daptomycin|NWQ5N31VKK|
# Daptomycin Summary
.
---
Darifenacin,darifenacin hydrobromide|CR02EYQ8GV|
# Darifenacin Hydrobromide Summary
Darifenacin extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
---
Dasatinib,PHYRAGO|RBZ1571X5H|
# Dasatinib Summary
Dasatinib tablets are indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
Dasatinib tablet is indicated for the treatment of adult patients with Ph+ CML in chronic phase.
Dasatinib tablets are indicated for the treatment of adult patients with PHYRAGO is indicated for the treatment of pediatric patients 1 year of age and older with Additional pediatric use information is approved for Bristol-Myers Squibb Company’s Sprycel (dasatinib) tablets.
---
CHLORHEXIDINE GLUCONATE,DASH Chlorhexidine Gluconate 0.12% Oral Rinse,Major Oral Rinse|MOR84MUD8E|
# Chlorhexidine Gluconate Summary
Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing.
Chlorhexidine gluconate oral rinse, 0.12% is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing.
---
Daurismo,glasdegib|K673DMO5H9|
# Glasdegib Summary
DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.
---
DAWNZERA,donidalorsen sodium|Y30VEG5PH1|
# Donidalorsen Sodium Summary
DAWNZERA™ is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
---
Balziva,Dasetta 1/35,DEBLITANE,Jencycla,Norethindrone and Ethinyl Estradiol,SHAROBEL,norethindrone|T18F433X4S|
# Norethindrone Summary
Progestin-only oral contraceptives are indicated for the prevention of pregnancy.
Efficacy WYMZYA TM Fe is indicated for use by females of reproductive potential to prevent pregnancy.
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
Jencycla Tablets have not been studied for and are not indicated for use in emergency contraception.
SHAROBEL ™ Tablets have not been studied for and are not indicated for use in emergency contraception.
---
Decitabine|776B62CQ27|
# Decitabine Summary
Decitabine for injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
---
Dehydrated Alcohol,Gattex,PDI Alcohol Prep Pad Sterile,alcohol|3K9958V90M|
# Alcohol Summary
Dehydrated alcohol injection is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy.
GATTEX ® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support .
---
Delflex,EXTRANEAL,magnesium chloride|02F3473H9O|
# Magnesium Chloride Summary
DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis.
DELFLEX® is indicated in the treatment of chronic kidney failure patients being maintained on peritoneal dialysis EXTRANEAL (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of kidney failure in patients requiring long-term kidney replacement therapy.
---
Demeclocycline Hydrochloride|29O079NTYT|
# Demeclocycline Hydrochloride Summary
In acute intestinal amebiasis, demeclocycline hydrochloride tablets USP may be a useful adjunct to amebicides. Demeclocycline hydrochloride tablets USP is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Brucellosis due to Brucella species (in conjunction with streptomycin); Campylobacter fetus infections caused by Campylobacter fetus ; (Note: Tetracyclines, including demeclocycline, are not the drugs of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, tetracyclines, including demeclocycline hydrochloride, are alternative drugs in the treatment of the following infections: Tularemia due to Francisella tularensis ; Listeriosis due to Listeria monocytogenes ; Bartonellosis due to Bartonella bacilliformis ; Respiratory tract infections caused by Haemophilus influenzae ;...
---
Desipramine Hydrochloride|1Y58DO4MY1|
# Desipramine Hydrochloride Summary
Desipramine hydrochloride tablets are indicated for the treatment of depression.
Desipramine hydrochloride tablets, USP are indicated for the treatment of depression.
Desipramine hydrochloride tablets is indicated for the treatment of depression.
Desipramine hydrochloride tablets, USP is indicated for the treatment of depression.
---
DESMOPRESSIN ACETATE|XB13HYU18U|
# Desmopressin Acetate Summary
Limitations: Limitations of Use: Desmopressin nasal spray is indicated as antidiuretic replacement therapy in the management of central diabetes insipidus in adults and pediatric patients 4 years of age and older Use in patients with an impaired level of consciousness, Use in patients with conditions that compromise the intranasal route of administration (e.g., severe nasal congestion and blockage, nasal mucosa atrophy, severe atrophic rhinitis, recent nasal surgery such as transsphenoidal hypophysectomy) [see Warnings and Precautions ( 5.2 )].
Limitations: Treatment of nephrogenic diabetes insipidus, Treatment of primary nocturnal enuresis [see Warnings and Precautions ( 5.1 )], Desmopressin nasal spray is not indicated for:
---
Desonide,Desonide Ointment, 0.05%|J280872D1O|
# Desonide Summary
Desonide Ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Desonide Cream and Lotion are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
---
Desoximetasone|4E07GXB7AU|
# Desoximetasone Summary
Desoximetasone cream USP, 0.25% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Desoximetasone ointment USP, 0.25% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Desvenlafaxine,desvenlafaxine succinate|ZB22ENF0XR|
# Desvenlafaxine Succinate Summary
Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )].
Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )] .
Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )] .
Desvenlafaxine extended-release tablets, is indicated for the treatment of adults with major depressive disorder (MDD) [ see Clinical Studies (14) ].
---
Dexamethasone Sodium Phosphate,Labetalol Hydrochloride,PaxLyte,citric acid monohydrate|2968PHW8QP|
# Citric Acid Monohydrate Summary
Rheumatoid arthritis May also be useful in cystic tumors of an aponeurosis or tendon (ganglia) Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy Loeffler’s syndrome not manageable by other means Intravenous or Intramuscular Injection Exfoliative dermatitis Shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected For palliative management of: Acquired (autoimmune) hemolytic anemia Idiopathic thrombocytopenic purpura in adults (IV only; IM administration is contraindicated) When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: • Cerebral Edema associated with primary or metastatic brain...
---
AMANTADINE HYDROCHLORIDE,DASH Chlorhexidine Gluconate 0.12% Oral Rinse,Dexamethasone Sodium Phosphate,Labetalol Hydrochloride,Lidocaine Hydrochloride,Liraglutide,Midazolam,Rolvedon,WEGOVY,sodium hydroxide|55X04QC32I|
# Sodium Hydroxide Summary
• Diagnostic testing of adrenocortical hyperfunction Adults and pediatric patients aged 12 years and older with obesity Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing.
• Allergic States for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults.
Acquired (autoimmune) hemolytic anemia Idiopathic thrombocytopenic purpura in adults (IV only; IM administration is contraindicated) For palliative management of: Liraglutide injection contains liraglutide.
---
Dexamethasone Sodium Phosphate|AI9376Y64P|
# Dexamethasone Sodium Phosphate Summary
When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: Drug hypersensitivity reactions Diagnostic testing of adrenocortical hyperfunction.
When the strength and dosage form of the drug lend the preparation to the treatment of the condition, those products labeled for intra-articular or soft tissue administration are indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Acute and subacute bursitis.
administration is contraindicated).
Acquired (autoimmune) hemolytic anemia Idiopathic thrombocytopenic purpura in adults (IV only; IM administration is contraindicated) Berylliosis Symptomatic Sarcoidosis.
---
Dexmedetomidine,dexmedetomidine hydrochloride|1018WH7F9I|
# Dexmedetomidine Hydrochloride Summary
1.1 Intensive Care Unit Sedation Dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting.
1.2 Procedural Sedation Dexmedetomidine injection is indicated for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
1.2 Procedural Sedation Dexmedetomidine injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures.
---
Dexrazoxane,dexrazoxane hydrochloride|5346058Q7S|
# Dexrazoxane Hydrochloride Summary
Dexrazoxane for injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m 2 and who will continue to receive doxorubicin therapy to maintain tumor control.
---
Amphetamine Sulfate,Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate|6DPV8NK46S|
# Amphetamine Sulfate Summary
Mixed Salts of a Single Entity Amphetamine Product are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Amphetamine Sulfate Tablets, USP, are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Amphetamine sulfate tablets, USP are indicated for: Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
---
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate,dextroamphetamine saccharate|G83415V073|
# Dextroamphetamine Saccharate Summary
Mixed Salts of a Single Entity Amphetamine Product are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (Mixed salts of a single entity amphetamine product) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed salts of single entity amphetamine product) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
---
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate,amphetamine aspartate monohydrate|O1ZPV620O4|
# Amphetamine Aspartate Monohydrate Summary
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Mixed Salts of a Single Entity Amphetamine Product are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (Mixed salts of a single entity amphetamine product) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed salts of single entity amphetamine product) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
---
DEXEDRINESPANSULE,Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate,Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate,Dextroamphetamine Sulfate,Dextroamphetamine SulfateExtended-Release|JJ768O327N|
# Dextroamphetamine Sulfate Summary
Need for Comprehensive Treatment Program Dextroamphetamine sulfate tablets, USP are indicated for: Mixed Salts of a Single Entity Amphetamine Product are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Dextroamphetamine sulfate extended-release capsules are indicated in: Attention Deficit Disorder with Hyperactivity Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
---
DELFLEX,Dextrose,Dextrose and Sodium Chloride,Dextrose Monohydrate,Kabiven,Lactated Ringers and Dextrose,Perikabiven,Potassium Chloride in Lactated Ringers and Dextrose|LX22YL083G|
# Dextrose Monohydrate Summary
Intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use: Dextrose Injection is indicated as source of water and calories and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 mL) drug product packaged in a vial with a 20 mm closure.
DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis.
---
Diazepam,Valium,Valtoco|Q3JTX2Q7TU|
# Diazepam Summary
Diazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
Valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
VALTOCO ® is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 2 years of age and older.
---
Diazoxide|O5CB12L4FN|
# Diazoxide Summary
Diazoxide Oral Suspension is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy.
---
Diclofenac Epolamine|X5F8EKL9ZG|
# Diclofenac Epolamine Summary
DICLOFENAC EPOLAMINE TOPICAL SYSTEM 1.3% is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years and older.
---
Diclofenac Potassium,ZIPSOR|L4D5UA6CB4|
# Diclofenac Potassium Summary
for relief of the signs and symptoms of rheumatoid arthritis Diclofenac Potassium Capsules is indicated for relief of mild to moderate acute pain in adult patients.
for relief of mild to moderate pain Diclofenac potassium tablets are indicated: For relief of the signs and symptoms of osteoarthritis ZIPSOR is indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older.
Diclofenac potassium capsules are indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older.
for treatment of primary dysmenorrhea Pediatric use information is approved for Assertio Therapeutics Inc's ZIPSOR (diclofenac potassium) Capsules.
---
ARTHROTEC,Diclofenac Sodium,Diclofenac Sodium 1.5%,Diclofenac Sodium and Misoprostol,Diclofenac Sodium/MisoprostolDICLOFENAC-SODIUM-MISOPROSTOL,Diclofenac SodiumDelayed Release,Diclolidol Kit,Diclona,Orthaphen,Xiclofen|QTG126297Q|
# Diclofenac Sodium Summary
For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis Diclofenac sodium topical gel is indicated for the topical treatment of actinic keratoses (AK).
• For relief of the signs and symptoms of osteoarthritis Diclofenac sodium topical gel is indicated for the topical treatment of actinic keratosis (AK).
Diclofenac is indicated: Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets.
Diclofenac sodium delayed-release tablets are indicated: For the temporary relief of arthritis pain ONLY in the following areas: Diclofenac sodium topical solution is indicated for the treatment of the pain of osteoarthritis of the knee(s).
---
ARTHROTEC,Cytotec,Diclofenac Sodium and Misoprostol,Diclofenac Sodium/MisoprostolDICLOFENAC-SODIUM-MISOPROSTOL,Misoprostol|0E43V0BB57|
# Misoprostol Summary
Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications.
Misoprostol is indicated for reducing the risk of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.
---
Dicyclomine hydrochloride|CQ903KQA31|
# Dicyclomine Hydrochloride Summary
Dicyclomine hydrochloride tablets are indicated for the treatment of patients with functional bowel/irritable bowel syndrome.
Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.
Dicyclomine hydrochloride capsules are indicated for the treatment of patients with functional bowel/irritable bowel syndrome.
---
Diethylpropion Hydrochloride,Diethylpropion HydrochlorideER|19V2PL39NG|
# Diethylpropion Hydrochloride Summary
Diethylpropion hydrochloride tablets USP, 25 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
Diethylpropion hydrochloride extended release tablets, 75 mg are indicated for use as monotherapy only.
Diethylpropion hydrochloride tablets USP, 25 mg are indicated for use as monotherapy only.
---
Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%,Adapalene Gel USP, 0.3%,Differin,adapalene|1L4806J2QF|
# Adapalene Summary
DIFFERIN ® Cream is indicated for the topical treatment of acne vulgaris.
ADAPALENE Gel, 0.3% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
Adapalene and benzoyl peroxide gel 0.1% / 2.5% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
---
Diflorasone Diacetate|7W2J09SCWX|
# Diflorasone Diacetate Summary
Diflorasone diacetate cream USP, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Difluprednate,Difluprednate Ophthalmic Emulsion|S8A06QG2QE|
# Difluprednate Summary
Difluprednate ophthalmic emulsion 0.05%, a topical corticosteroid, is indicated for the treatment of inflammation and pain associated with ocular surgery.
Difluprednate ophthalmic emulsion (0.05%) is indicated for the treatment of inflammation and pain associated with ocular surgery.
1.1 Ocular Surgery Difluprednate ophthalmic emulsion (0.05%) is indicated for the treatment of endogenous anterior uveitis.
---
Dihydroergotamine mesylate|81AXN7R2QT|
# Dihydroergotamine Mesylate Summary
Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches with or without aura.
---
Cardizem CD,CartiaXT,Diltiazem HCl CD,Diltiazem Hydrochloride|OLH94387TE|
# Diltiazem Hydrochloride Summary
Diltiazem hydrochloride extended-release capsules, USP (once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension.
DILT-XR [Diltiazem Hydrochloride Extended-Release Capsules, USP (Once-a-day dosage)] are indicated for the management of chronic stable angina.
Diltiazem hydrochloride extended-release capsules, USP (once-a-day dosage) are indicated for the treatment of hypertension.
Diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the treatment of hypertension.
---
dimethyl fumarate|FO2303MNI2|
# Dimethyl Fumarate Summary
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Dimethyl fumarate delayed-release capsules is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Diovan HCT,Exforge HCT,VALSARTAN AND HYDROCHLOROTHIAZIDE,valsartan|80M03YXJ7I|
# Valsartan Summary
Limitations: Limitations of Use Figure 2: Probability of Achieving Diastolic Blood Pressure &lt; 90 mmHg at Week 8 Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits.
Exforge HCT (amlodipine, valsartan, and hydrochlorothiazide) is indicated for the treatment of hypertension, to lower blood pressure.
Replacement Therapy Diovan HCT (valsartan and hydrochlorothiazide, USP) is indicated for the treatment of hypertension, to lower blood pressure.
---
Dipentum,olsalazine sodium|Y7JEW0XG7I|
# Olsalazine Sodium Summary
DIPENTUM is indicated for the maintenance of remission of ulcerative colitis in adult patients who are intolerant of sulfasalazine.
---
Diphenhydramine,Diphenhydramine Hydrochloride|TC2D6JAD40|
# Diphenhydramine Hydrochloride Summary
For active treatment of motion sickness.
For use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents, mild cases of parkinsonism in other age groups and in other cases of parkinsonism in combination with centrally acting anticholinergic agents.
---
Atropine,Atropine Sulfate,Diphenoxylate Hydrochloride and Atropine Sulfate,Phenohytro|03J5ZE7KA5|
# Atropine Sulfate Summary
Diphenoxylate hydrochloride and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older.
Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest.
Atropine Sulfate Injection is indicated for temporary blockade of severe or life‑threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest.
---
Diphenoxylate Hydrochloride and Atropine Sulfate,diphenoxylate hydrochloride|W24OD7YW48|
# Diphenoxylate Hydrochloride Summary
Diphenoxylate hydrochloride and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older.
---
Divalproex Sodium D/R,divalproex sodium|644VL95AO6|
# Divalproex Sodium Summary
Divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder.
1.1 Mania Divalproex sodium delayed-release tablets are indicated for prophylaxis of migraine headaches.
1.3 Migraine Divalproex sodium delayed-release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures.
There is no evidence that divalproex sodium delayed-release tablets are useful in the acute treatment of migraine headaches.
Divalproex sodium delayed-release tablets are also indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures.
---
DOCTORS CHOICE,KIDS CHOICE,stannous fluoride|3FTR44B32Q|
# Stannous Fluoride Summary
Aids in the prevention of dental decay.
---
Dofetilide 0.125mg,Dofetilide 0.25mg,Dofetilide 0.5mg,dofetilide|R4Z9X1N2ND|
# Dofetilide Summary
Dofetilide capsule is indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm.
Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence) Dofetilide capsule is indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm.
---
DOJOLVI,triheptanoin|2P6O7CFW5K|
# Triheptanoin Summary
DOJOLVI is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
---
Donepezil,donepezil hydrochloride|3O2T2PJ89D|
# Donepezil Hydrochloride Summary
Donepezil hydrochloride tablets are indicated for the treatment of dementia of the Alzheimer’s type.
Donepezil hydrochloride is indicated for the treatment of dementia of the Alzheimer's type.
Donepezil hydrochloride tablets are indicated for the treatment of dementia of the Alzheimer's type.
---
DOPamine Hydrochloride,Dopamine Hydrochloride in Dextrose|7L3E358N9L|
# Dopamine Hydrochloride Summary
Dopamine HCl Injection is indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output.
Dopamine Hydrochloride in Dextrose Injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output.
---
Dorzolamide Hydrochloride,Dorzolamide Hydrochloride and Timolol Maleate|QZO5366EW7|
# Dorzolamide Hydrochloride Summary
Dorzolamide Hydrochloride Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5% (preservative free) is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time).
Dorzolamide hydrochloride-timolol maleate ophthalmic solution (preservative-free) is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time).
---
Doxepin Hydrochloride|3U9A0FE9N5|
# Doxepin Hydrochloride Summary
Doxepin Hydrochloride Capsules, USP are recommended for the treatment of: Doxepin hydrochloride capsules are indicated for the treatment of major depressive disorder (MDD) in adults.
Doxepin tablets are indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
Doxepin hydrochloride capsule is indicated for the treatment of major depressive disorder (MDD) in adults.
Owing to lack of clinical experience in the pediatric population, doxepin hydrochloride capsules are not recommended for use in children under 12 years of age.
Owing to lack of clinical experience in the pediatric population, doxepin is not recommended for use in children under 12 years of age.
---
Doxycyclate Hyclate,Doxycycline,Doxycycline Hyclate|19XTS3T51U|
# Doxycycline Hyclate Summary
Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Acinetobacter species.
Doxycycline is indicated for treatment of infections caused by the following gram-negative bacteria, when bacteriologic testing indicates appropriate susceptibility to the drug: Inclusion conjunctivitis caused by Chlamydia trachomatis .
Doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram-negative bacteria, when bacteriologic testing indicates appropriate susceptibility to the drug: · Plague due to Yersinia pestis .
Tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.
---
DOXYCYCLINE,Doxycycline Monohydrate,ORACEA|N12000U13O|
# Doxycycline Summary
Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory infections caused by Streptococcus pneumoniae.
Acinetobacter species Doxycycline is indicated for the treatment of the following infections: Inclusion conjunctivitis caused by Chlamydia trachomatis .
Doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: Brucellosis due to Brucella species (in conjunction with streptomycin).
---
doxycycline hyclate,doxycycline anhydrous|334895S862|
# Doxycycline Anhydrous Summary
Doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Campylobacter fetus .
Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Doxycycline for Injection, USP is indicated in infections caused by the following microorganisms: Streptococcus pneumoniae .
Doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence.
Tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.
When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to:
---
DICLEGIS,Doxylamine succinate and pyridoxine hydrochloride,doxylamine succinate|V9BI9B5YI2|
# Doxylamine Succinate Summary
Limitations: Limitations of Use Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
DICLEGIS is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
---
Adult Infuvite Multiple Vitamins,DICLEGIS,Doxylamine succinate and Pyridoxine hydrochloride,Multivitamin with Fluoride,Pediatric Infuvite Multiple Vitamins,pyridoxine hydrochloride|68Y4CF58BV|
# Pyridoxine Hydrochloride Summary
Limitations: Limitations of Use Multivitamin with 1.0 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 6-16 years of age in areas where the water fluoride level is less than 0.3 ppm.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
DICLEGIS is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
---
drospirenone and ethinyl estradiol,drospirenone|N295J34A25|
# Drospirenone Summary
Drospirenone and ethinyl estradiol tablets are indicated for use by females of reproductive potential to prevent pregnancy.
---
DROXIA,HYDREA,HYDROXYUREA,XROMI|X6Q56QN5QC|
# Hydroxyurea Summary
DROXIA is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises.
Hydroxyurea capsules are indicated for the treatment of: Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.
HYDREA is indicated for the treatment of: XROMI is indicated to reduce the frequency of painful crises and reduce the need for blood transfusions in pediatric patients aged 6 months of age to less than 2 years, with sickle cell anemia with recurrent moderate to severe painful crises.
---
Cymbalta,Duloxetine,Duloxetine D/R,Duloxetine Hydrochloride,DuloxetineDelayed-Release|9044SC542W|
# Duloxetine Hydrochloride Summary
Duloxetine delayed-release capsules are indicated for the treatment of: • Major depressive disorder in adults • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults • Chronic musculoskeletal pain in adults Chronic musculoskeletal pain in adults Diabetic peripheral neuropathic pain in adults Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Generalized Anxiety Disorder [see Clinical Studies ( 14.2 )] .
---
Amphetamine,Amphetamine Extended-Release,Dyanavel XR|CK833KGX7E|
# Amphetamine Summary
DYANAVEL XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14) ].
Amphetamine extended-release orally disintegrating tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies ( 14 )].
Amphetamine extended-release orally disintegrating tablets are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies ( 14 )] .
---
E-Z-Disk,barium sulfate|25BB7EKE2E|
# Barium Sulfate Summary
E-Z-DISK is indicated for the evaluation of esophageal patency in adults and pediatric patients aged 12 years and older.
---
EBGLYSS,lebrikizumab|U9JLP7V031|
# Lebrikizumab Summary
EBGLYSS is indicated for the treatment of adults and pediatric patients 12 years of age and older who weigh at least 40 kg with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
---
Econazole Nitrate|H438WYN10E|
# Econazole Nitrate Summary
Econazole nitrate topical foam, 1%, is indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older.
Econazole nitrate cream is indicated for topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor.
---
Edluar,Zolpidem Tartrate|WY6W63843K|
# Zolpidem Tartrate Summary
Zolpidem tartrate extended-release tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Zolpidem tartrate extended-release tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
---
Efavirenz, emtricitabine and tenofovir disoproxil fumarate,efavirenz|JE6H2O27P8|
# Efavirenz Summary
Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
---
Efavirenz, emtricitabine and tenofovir disoproxil fumarate,tenofovir disoproxil fumarate|OTT9J7900I|
# Tenofovir Disoproxil Fumarate Summary
Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
---
EKTERLY,sebetralstat|O5ZD2TU2B7|
# Sebetralstat Summary
EKTERLY® is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
---
eletriptan hydrobromide|M41W832TA3|
# Eletriptan Hydrobromide Summary
Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults.
Limitations: Limitations of Use: • Use only if a clear diagnosis of migraine has been established.
---
Ellence,epirubicin hydrochloride|22966TX7J5|
# Epirubicin Hydrochloride Summary
ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14.1) ] .
---
Elrexfio,elranatamab|L0HR9A577V|
# Elranatamab Summary
ELREXFIO is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
---
Embriva,potassium iodide|1C4QK22F9J|
# Potassium Iodide Summary
Prenatal and Postnatal prescriptive Folic Acid
---
Adult Infuvite Multiple Vitamins,Embriva,Folic Acid,Multivitamin with Fluoride,PaxLyte,Pediatric Infuvite Multiple Vitamins,Virexa|935E97BOY8|
# Folic Acid Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
Prenatal and Postnatal prescriptive Folic Acid Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
---
Embriva,Virexa,methylcobalamin|BR1SN1JS2W|
# Methylcobalamin Summary
Prenatal and Postnatal prescriptive Folic Acid Virexa is a multivitamin with folic acid dispensed by prescription only.
---
Embriva,calcium carbonate|H0G9379FGK|
# Calcium Carbonate Summary
Prenatal and Postnatal prescriptive Folic Acid
---
Embriva,ferrous gluconate|U1B11I423Z|
# Ferrous Gluconate Summary
Prenatal and Postnatal prescriptive Folic Acid
---
Embriva,thiamine|X66NSO3N35|
# Thiamine Summary
Prenatal and Postnatal prescriptive Folic Acid
---
Deflazacort,Deflazacort Oral Suspension,EMFLAZA,JAYTHARI Oral Suspension|KR5YZ6AE4B|
# Deflazacort Summary
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
---
Enalapril maleate|9O25354EPJ|
# Enalapril Maleate Summary
Enalapril maleate tablets USP are indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis.
Enalapril maleate tablets USP are indicated for the treatment of hypertension.
---
ENTECAVIR|5968Y6H45M|
# Entecavir Summary
Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease
---
ENTECAVIR,entecavir anhydrous|NNU2O4609D|
# Entecavir Anhydrous Summary
Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
---
Ephedrine Sulfate|U6X61U5ZEG|
# Ephedrine Sulfate Summary
Ephedrine sulfate injection is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
---
Epidiolex,cannabidiol|19GBJ60SN5|
# Cannabidiol Summary
EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.
---
Auvi-Q,epinephrine,Lidocaine Hydrochloride and Epinephrine,neffy|YKH834O4BH|
# Epinephrine Summary
Epinephrine injection is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
Lidocaine Hydrochloride and Epinephrine Injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.
---
Ergocalciferol,VITAMIN D|VS041H42XC|
# Ergocalciferol Summary
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Ergocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
---
ERLEADA,apalutamide|4T36H88UA7|
# Apalutamide Summary
ERLEADA is indicated for the treatment of patients with Non-metastatic castration-resistant prostate cancer (nmCRPC) Metastatic castration-sensitive prostate cancer (mCSPC)
---
erythromycin,Erythromycin and Benzoyl Peroxide|63937KV33D|
# Erythromycin Summary
Erythromycins are indicated for the treatment of the following infections caused by Chlamydia trachomati s: conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections during pregnancy.
When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of uncomplicated urethral, endocervical, or rectal infections in adults due to Chlamydia trachomati s.
Erythromycin and Benzoyl Peroxide Topical Gel USP is indicated for the topical treatment of acne vulgaris.
Erythrasma: In the treatment of infections due to Corynebacterium minutissimum .
When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of nongonococcal urethritis caused by Ureaplasma urealyticum .
---
Escitalopram,ESCITALOPRAM OXALATE|5U85DBW7LO|
# Escitalopram Oxalate Summary
Escitalopram is indicated for the treatment of: generalized anxiety disorder (GAD) in adults.
Escitalopram tablets are indicated for the treatment of: Additional pediatric use information is approved for AbbVie Inc.’s LEXAPRO (escitalopram) tablets.
---
Eslicarbazepine acetate|BEA68ZVB2K|
# Eslicarbazepine Acetate Summary
Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
---
Esterified Estrogens and Methyltestosterone,estrogens, esterified|3ASP8Q3768|
# Estrogens, Esterified Summary
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH are indicated in the treatment of: Moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone.
Esterified Estrogens and Methyltestosterone Full and Half-Strength Tablets are indicated in the:
Treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone.
---
Esterified Estrogens and Methyltestosterone,methyltestosterone|V9EFU16ZIF|
# Methyltestosterone Summary
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH are indicated in the treatment of: Moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone.
(There is no evidence that estrogens are effective for nervous symptoms or depression without associated vasomotor symptoms, and they should not be used to treat such conditions.) Esterified Estrogens and Methyltestosterone Full and Half-Strength Tablets are indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone.
---
Estradiol,Estradiol Vaginal Cream|4TI98Z838E|
# Estradiol Summary
) Estradiol vaginal cream, USP, 0.01% is indicated in the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.
ESTRADIOL TRANSDERMAL SYSTEM is indicated for: Prevention of osteoporosis.
Estradiol tablets are indicated in the: Estradiol transdermal system continuous delivery (once-weekly) is indicated for:
Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure.
Treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease.
---
Estradiol,ESTRADIOL VAGINAL,estradiol hemihydrate|CXY7B3Q98Z|
# Estradiol Hemihydrate Summary
Estradiol Vaginal Cream 0.01% is indicated in the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.
---
Estradiol Valerate|OKG364O896|
# Estradiol Valerate Summary
Estradiol Valerate Injection, USP is indicated in the: Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).
Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause.
When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
---
Eszopiclone|UZX80K71OE|
# Eszopiclone Summary
Eszopiclone tablets are indicated for the treatment of insomnia.
---
Ethacrynic Acid|M5DP350VZV|
# Ethacrynic Acid Summary
Intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable.
Ethacrynic Acid Tablets USP are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
Ethacrynic Acid Tablets USP, are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.
---
ETHAMBUTOL HYDROCHLORIDE|QE4VW5FO07|
# Ethambutol Hydrochloride Summary
ETHAMBUTOL HCl is indicated for the treatment of pulmonary tuberculosis.
Ethambutol plus isoniazid Ethambutol hydrochloride is indicated for the treatment of pulmonary tuberculosis.
---
Ethosuximide|5SEH9X1D1D|
# Ethosuximide Summary
Ethosuximide is indicated for the control of absence (petit mal) epilepsy.
---
Etodolac|2M36281008|
# Etodolac Summary
Etodolac Capsules and Tablets are indicated: For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For acute and long-term use in the management of signs and symptoms of the following: Carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac.
Etodolac tablets are indicated: For the management of acute pain Etodolac tablets, USP are indicated: Osteoarthritis Carefully consider the potential benefits and risks of Etodolac Tablets and other treatment options before deciding to use Etodolac Tablets.
Etodolac capsules are indicated:
---
Etoposide|6PLQ3CP4P3|
# Etoposide Summary
Etoposide Injection is indicated in the management of the following neoplasms:
---
etravirine|0C50HW4FO1|
# Etravirine Summary
Etravirine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients and pediatric patients 2 years of age and older [see Microbiology (12.4) and Clinical Studies (14) ] .
---
Eucrisa,crisaborole|Q2R47HGR7P|
# Crisaborole Summary
EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
---
Evkeeza,evinacumab|T8B2ORP1DW|
# Evinacumab Summary
EVKEEZA is indicated as an adjunct to diet and exercise and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to reduce LDL-C in adults and pediatric patients, aged 1 year and older, with homozygous familial hypercholesterolemia (HoFH).
---
EVRYSDI,risdiplam|76RS4S2ET1|
# Risdiplam Summary
EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
---
Avar-e Green,Avar-e LS,Exact-Rx SODIUM SULFACETAMIDE and SULFER 10%/5% Cleanser,Exact-Rx Sodium Sulfacetamide Wash 10%,OVACE Plus,OvacePlus,OvacePlusPlus,Sodium Sulfacetamide,Sodium Sulfacetamide 10% and Sulfur 5% Cleanser,Sodium Sulfacetamide 10% wash,Sodium Sulfacetamide 8%  Sulfur 4% CLEANSER,Sodium Sulfacetamide 9.8% Sulfur 4.8% Cleanser,Sulfacetamide Sodium,SULFACETAMIDE SODIUM, SULFUR|4NRT660KJQ|
# Sulfacetamide Sodium Summary
is indicated for he topical control of acne vulgaris, acne rosacea and INDICATIONS AND USAGE: SODIUM SULFACETAMIDE 10% CLEANSING GEL is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff).
It also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides.
This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
indicated for the treatment of secondary bacterial infections of Sodium Sulfacetamide 8% and Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
---
Avalide,Benazepril Hydrochloride and Hydrochlorothiazide,bisoprolol fumarate and hydrochlorothiazide,Diovan HCT,Exforge HCT,Hydrochlorothiazide,Irbesartan and Hydrochlorothiazide,Lisinopril and Hydrochlorothiazide,Lisinopril/HCTZ,Lotensin HCT,Olmesartan medoxomil Amlodipine and Hydrochlorothiazide,Olmesartan Medoxomil and Hydrochlorothiazide,Spironolactone and Hydrochlorothiazide,TELMISARTAN AND HYDROCHLOROTHIAZIDE,Triamterene and Hydrochlorothiazide,VALSARTAN AND HYDROCHLOROTHIAZIDE|0J48LPH2TH|
# Hydrochlorothiazide Summary
Exforge HCT (amlodipine, valsartan, and hydrochlorothiazide) is indicated for the treatment of hypertension, to lower blood pressure.
Thiazides are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy (see PRECAUTIONS , Pregnancy ).
Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
Lisinopril and Hydrochlorothiazide Tablets is indicated for the treatment of hypertension, to lower blood pressure.
Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure.
---
Exondys 51,eteplirsen|AIW6036FAS|
# Eteplirsen Summary
EXONDYS 51 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.
---
EXPAREL,bupivacaine|Y8335394RO|
# Bupivacaine Summary
Local analgesia via infiltration in patients aged 6 years and older Regional analgesia via a sciatic nerve block in the popliteal fossa in adults Regional analgesia via an interscalene brachial plexus nerve block in adults Regional analgesia via an adductor canal block in adults EXPAREL is indicated to produce postsurgical:
---
EXTRANEAL,icodextrin|2NX48Z0A9G|
# Icodextrin Summary
EXTRANEAL (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of kidney failure in patients requiring long-term kidney replacement therapy.
---
AHZANTIVE,EYLEA HD,aflibercept-mrbb|15C2VL427D|
# Aflibercept-Mrbb Summary
EYLEA HD is indicated for the treatment of: 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR) 1 INDICATIONS AND USAGE AHZANTIVE is indicated for the treatment of:
---
Fabrazyme,agalsidase beta|RZD65TSM9U|
# Agalsidase Beta Summary
FABRAZYME ® is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease.
---
Famotidine,Ibuprofen and famotidine,Ibuprofen Famotidine|5QZO15J2Z8|
# Famotidine Summary
Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: GERD with or without esophagitis and ulcerations.
Ibuprofen and famotidine tablet, a combination of the NSAID ibuprofen and the histamine H 2 -receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications.
Famotidine tablets are indicated in adults for the: • erosive esophagitis due to GERD, diagnosed by biopsy.
treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
---
FANAPT,iloperidone|VPO7KJ050N|
# Iloperidone Summary
FANAPT ® is indicated for: Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] .
Treatment of schizophrenia in adults [see Clinical Studies (14.1) ].
---
Febuxostat|101V0R1N2E|
# Febuxostat Summary
Febuxostat tablets are xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.
Limitations: Limitations of Use: Febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia.
---
FEIBA,anti-inhibitor coagulant complex|CS849DUN3M|
# Anti-Inhibitor Coagulant Complex Summary
Perioperative management Control and prevention of bleeding episodes FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for: Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
Limitations: FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulation factor IX.
---
Felbamate|X72RBB02N8|
# Felbamate Summary
Limitations: Felbamate is not indicated as a first line antiepileptic treatment (see Warnings ).
If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgement, Felbamate can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children.
---
Felodipine|OL961R6O2C|
# Felodipine Summary
Felodipine extended-release tablets are indicated for the treatment of hypertension.
---
ANTARA,Fenofibrate|U202363UOS|
# Fenofibrate Summary
Limitations: Limitations of Use a Coronary heart disease or peripheral vascular disease (including symptomatic carotid artery disease).
Fenofibrate tablets are indicated as adjunctive therapy to diet: Markedly elevated levels of serum TG (e.g., &gt; 2,000 mg/dL) may increase the risk of developing pancreatitis.
Limitations: Antara is indicated as adjunctive therapy to diet: VLDL = very low density lipoprotein Drug therapy is not indicated for patients with Type I hyperlipoproteinemia, who have elevations of chylomicrons and plasma triglycerides, but who have normal levels of very low density lipoprotein (VLDL).
Fenofibrate capsules are also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia).
Treatment of Hypercholesterolemia Markedly elevated levels of serum triglycerides (e.g.
---
FENOFIBRIC ACID|BGF9MN2HU1|
# Fenofibric Acid Summary
Fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet: to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia when use of recommended LDL-C lowering therapy is not possible.
Limitations: Limitations of Use Markedly elevated levels of serum TG (e.g., &gt; 2,000 mg/dL) may increase the risk of developing pancreatitis.
---
FENOPROFEN CALCIUM|0X2CW1QABJ|
# Fenoprofen Calcium Summary
Fenoprofen calcium is indicated for: Relief of mild to moderate pain in adults Relief of the signs and symptoms of rheumatoid arthritis Relief of the signs and symptoms of osteoarthritis
---
Fensolvi,Leuprolide Acetate,Lupron Depot,Lupron Depot-PED|37JNS02E7V|
# Leuprolide Acetate Summary
FENSOLVI ® is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).
Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.
LUPRON DEPOT 7.5 mg for 1-month administration, 22.5 mg for 3-month administration, 30 mg for 4-month administration, and 45 mg for 6-month administration (leuprolide acetate) are indicated for the treatment of advanced prostate cancer.
LUPRON DEPOT-PED is indicated for the treatment of pediatric patients with central precocious puberty (CPP).
---
FENTANYL,Fentanyl system|UF599785JZ|
# Fentanyl Summary
Limitations: Limitations of Use Patients considered opioid-tolerant are those who are taking, for one week or longer, at least 60 mg morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid.
Limitations: Fentanyl transdermal system is not indicated as an as-needed (prn) analgesic.
Fentanyl transdermal system is indicated for the management of severe and persistent pain in opioid-tolerant patients, that requires an extended treatment period with a daily opioid analgesic in opioid-tolerant patients, and for which alternative treatment options are inadequate.
---
Fentanyl Citrate|MUN5LYG46H|
# Fentanyl Citrate Summary
Fentanyl Citrate Injection is indicated for: use as an anesthetic agent with oxygen in selected high-risk patients, such as those undergoing open heart surgery or certain complicated neurological or orthopedic procedures.
---
Ferrlecit,sodium ferric gluconate complex|CC9149U2QX|
# Sodium Ferric Gluconate Complex Summary
Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.
---
Fetzima,levomilnacipran hydrochloride|371U2ZK31U|
# Levomilnacipran Hydrochloride Summary
FETZIMA ® is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )].
---
Azelaic Acid,Finacea|F2VW3D43YT|
# Azelaic Acid Summary
FINACEA Gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
Azelaic acid gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
---
Finasteride|57GNO57U7G|
# Finasteride Summary
Finasteride tablets is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY .
Limitations: Finasteride tablets is not indicated for use in women.
---
Fingolimod,Gilenya,fingolimod hydrochloride|G926EC510T|
# Fingolimod Hydrochloride Summary
Fingolimod Capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
GILENYA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
Fingolimod is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
---
Flavoxate Hydrochloride|9C05J6089W|
# Flavoxate Hydrochloride Summary
Flavoxate hydrochloride tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
Limitations: Flavoxate hydrochloride tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.
---
Flecainide Acetate|M8U465Q1WQ|
# Flecainide Acetate Summary
paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms In patients without structural heart disease, Flecainide Acetate Tablets USP are indicated for the prevention of: paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms Because of the proarrhythmic effects of Flecainide Acetate Tablets USP, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks.
Use of Flecainide Acetate Tablets USP for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital.
---
Diflucan,Fluconazole|8VZV102JFY|
# Fluconazole Summary
Fluconazole tablets are indicated for the treatment of: Vaginal candidiasis (vaginal yeast infections due to Candida ).
Fluconazole is indicated for the treatment of: Cryptococcal meningitis.
DIFLUCAN (fluconazole) is indicated for the treatment of: Oropharyngeal and esophageal candidiasis.
In open noncomparative studies of relatively small numbers of patients, fluconazole tablets were also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia.
In open noncomparative studies of relatively small numbers of patients, DIFLUCAN was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia.
---
Flucytosine|D83282DT06|
# Flucytosine Summary
Flucytosine Capsules USP is indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus .
Flucytosine capsules are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus .
Flucytosine capsules should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to flucytosine (see MICROBIOLOGY ).
Flucytosine Capsules USP should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to Flucytosine Capsules USP (See MICROBIOLOGY ).
---
FludeoxyglucoseF18,fludeoxyglucose f-18|0Z5B2CJX4D|
# Fludeoxyglucose F-18 Summary
Fludeoxyglucose F18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging.
---
Fludrocortisone Acetate|V47IF0PVH4|
# Fludrocortisone Acetate Summary
Fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.
Fludrocortisone acetate tablets are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
---
Flunisolide|QK4DYS664X|
# Flunisolide Summary
Flunisolide Nasal Solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis.
---
fluocinolone acetonide,Fluocinolone Acetonide Topical Solution USP, 0.01%,FLUOCINOLONE ACETONIDEOil|0CD5FD6S2M|
# Fluocinolone Acetonide Summary
atopic dermatitis in adults Fluocinolone acetonide oil ear drops is indicated for the topical treatment of chronic eczematous external otitis in adults and pediatric patients 2 years of age and older.
Fluocinolone acetonide topical oil is indicated for the treatment of psoriasis of the scalp in adults.
Fluocinolone acetonide topical oil, 0.01% is indicated for the treatment of psoriasis of the scalp in adults.
moderate to severe atopic dermatitis in pediatric patients 3 months of age and older Fluocinolone acetonide scalp oil is indicated for the treatment of psoriasis of the scalp in adults.
---
FLUOCINONIDE|2W4A77YPAN|
# Fluocinonide Summary
Fluocinonide topical solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Fluocinonide Cream USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Fluocinonide topical solution, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Fluorouracil|U3P01618RT|
# Fluorouracil Summary
Pancreatic Adenocarcinoma Fluorouracil is indicated for the treatment of patients with: Fluorouracil injection is indicated for the treatment of patients with: Fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses.
In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites.
---
Fluoxetine,fluoxetine hydrochloride|I9W7N6B1KJ|
# Fluoxetine Hydrochloride Summary
Limitations: Fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression.
Fluoxetine capsules and Olanzapine in Combination are indicated for the treatment of: Panic Disorder, with or without agoraphobia.
Limitations: Fluoxetine capsules monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression.
Acute treatment of Panic Disorder, with or without agoraphobia [see Clinical Studies (14.4) ] .
Acute treatment of depressive episodes associated with Bipolar I Disorder.
---
fluphenazine hydrochloride,Fluphenazine Hydrochoride|ZOU145W1XL|
# Fluphenazine Hydrochloride Summary
Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders.
Fluphenazine hydrochloride tablets, USP are indicated in the management of manifestations of psychotic disorders.
---
ADVAIR HFA,Azelastine Hydrochloride and Fluticasone Propionate,DYMISTA,Fluticasone Propionate,Fluticasone Propionate and Salmeterol,FLUTICASONE PROPIONATEDISKUS,Fluticasone PropionateHFA|O2GMZ0LF5W|
# Fluticasone Propionate Summary
Fluticasone propionate nasal spray is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older.
Limitations: Important Limitation of Use Fluticasone Propionate/Salmeterol MDPI is not indicated for the relief of acute bronchospasm.
Limitations: ADVAIR HFA is not indicated for the relief of acute bronchospasm.
Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older.
ADVAIR HFA is indicated for treatment of asthma in adult and adolescent patients aged 12 years and older.
---
Fluvastatin,fluvastatin sodium|PYF7O1FV7F|
# Fluvastatin Sodium Summary
Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other non-pharmacologic measures alone has been inadequate.
---
Flyrcado,flurpiridaz f-18|TY3V24C029|
# Flurpiridaz F-18 Summary
FLYRCADO is indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease (CAD) to evaluate for myocardial ischemia and infarction.
---
FML,fluorometholone|SV0CSG527L|
# Fluorometholone Summary
FML ® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
---
Dexmethylphenidate Hydrochloride,Focalin,FocalinXR|1678OK0E08|
# Dexmethylphenidate Hydrochloride Summary
Focalin XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )] .
Focalin is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )] .
Limitations: Limitations of Use The use of Focalin XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), Use in Specific Populations ( 8.4 )].
Dexmethylphenidate hydrochloride tablets is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)].
---
Fomepizole|83LCM6L2BY|
# Fomepizole Summary
Fomepizole is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis ( see DOSAGE AND ADMINISTRATION ).
---
Forteo,Teriparatide|10T9CSU89I|
# Teriparatide Summary
FORTEO is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy.
Teriparatide Injection is indicated: For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.
---
FORZINITY,elamipretide hydrochloride|E40WZ3BK2D|
# Elamipretide Hydrochloride Summary
FORZINITY is indicated to improve muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30 kg.
---
FOCINVEZ,Fosaprepitant,fosaprepitant dimeglumine|D35FM8T64X|
# Fosaprepitant Dimeglumine Summary
Limitations: Limitations of Use FOCINVEZ, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: Fosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin.
Limitations: Limitations of Use • Fosaprepitant for injection has not been studied for the treatment of established nausea and vomiting.
Fosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of:
---
Fosfomycin Tromethamine|7FXW6U30GY|
# Fosfomycin Tromethamine Summary
(See PRECAUTIONS and CLINICAL STUDIES sections.) Fosfomycin tromethamine granules for oral solution is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis .
Limitations: Fosfomycin tromethamine granules for oral solution is not indicated for the treatment of pyelonephritis or perinephric abscess.
---
Fosinopril sodium|NW2RTH6T2N|
# Fosinopril Sodium Summary
Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ).
Fosinopril sodium tablets are indicated for the treatment of hypertension.
---
FOTIVDA,tivozanib hydrochloride|8A9H4VK35Z|
# Tivozanib Hydrochloride Summary
FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
---
Frindovyx,cyclophosphamide|8N3DW7272P|
# Cyclophosphamide Summary
Malignant Diseases neuroblastoma (disseminated disease) adenocarcinoma of the ovary retinoblastoma leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) FRINDOVYX is indicated for the treatment of adult and pediatric patients with: multiple myeloma carcinoma of the breast
---
frovatriptan succinate|D28J6W18HY|
# Frovatriptan Succinate Summary
Limitations: Frovatriptan succinate tablets are not indicated for the prevention of migraine attacks.
Limitations: Limitations of Use Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults.
---
Fulvestrant|22X328QOC4|
# Fulvestrant Summary
Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy, or Monotherapy Fulvestrant injection is indicated for the treatment of: HR-positive, HER2-negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy.
Combination Therapy Fulvestrant injection is indicated for the treatment of: HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women in combination with ribociclib as initial endocrine based therapy or following disease progression on endocrine therapy.
---
Furosemide,LASIX ONYU|7LXU5N7ZO5|
# Furosemide Summary
Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.
Edema: Furosemide Injection is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.
Furosemide Injection is indicated as adjunctive therapy in acute pulmonary edema.
Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.
Lasix ONYU is indicated for the treatment of edema in adult patients with chronic heart failure.
---
Gabapentin,Neurontin|6CW7F3G59X|
# Gabapentin Summary
Gabapentin Capsules, USP are indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin tablet is indicated for the management of postherpetic neuralgia.
---
Gadoterate Meglumine|L0ND3981AG|
# Gadoterate Meglumine Summary
Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.
---
Galafold,migalastat hydrochloride|CLY7M0XD20|
# Migalastat Hydrochloride Summary
GALAFOLD is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene ( GLA ) variant based on in vitro assay data [see Dosage and Administration (2.1) and Clinical Pharmacology (12.1) ] .
---
Galantamine,Galantamine Hydrobromide|MJ4PTD2VVW|
# Galantamine Hydrobromide Summary
Galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
Galantamine tablets are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.
---
GALLIUM CITRATE GA-67,gallium chloride ga-67|A04B19O2B0|
# Gallium Chloride Ga-67 Summary
Gallium Citrate Ga 67 Injection may be useful to demonstrate the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma. Positive gallium Ga-67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Gallium Citrate Ga 67 Injection may be useful as an aid in detecting some acute inflammatory lesions.
---
GALZIN,zinc acetate|FM5526K07A|
# Zinc Acetate Summary
Zinc acetate therapy is indicated for maintenance treatment of patients with Wilson’s disease who have been initially treated with a chelating agent (See PRECAUTIONS: Monitoring Patients ).
---
Ganirelix Acetate|56U7906FQW|
# Ganirelix Acetate Summary
Ganirelix acetate injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
---
Gattex,teduglutide|7M19191IKG|
# Teduglutide Summary
GATTEX ® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support .
---
GaviLyte - CTM,sodium sulfate anhydrous|36KCS0R750|
# Sodium Sulfate Anhydrous Summary
GaviLyte- C with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination.
---
GaviLyte - CTM,PEG-3350, Electrolytes, and Ascorbate,Pouch A,polyethylene glycol 3350|G2M7P15E5P|
# Polyethylene Glycol 3350 Summary
GaviLyte- C with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination.
Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
---
Gemfibrozil|Q8X02027X3|
# Gemfibrozil Summary
Limitations: GEMFIBROZIL IS ALSO NOT INDICATED FOR THE TREATMENT OF PATIENTS WITH LOW HDL-CHOLESTEROL AS THEIR ONLY LIPID ABNORMALITY.
Gemfibrozil Tablets are indicated as adjunctive therapy to diet for: 1.
Limitations: Drug therapy is not indicated for patients with Type I hyperlipoproteinemia, who have elevations of chylomicrons and plasma triglycerides, but who have normal levels of very low density lipoprotein (VLDL).
Treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them.
---
Geodon,ziprasidone mesylate|3X6SAX83JZ|
# Ziprasidone Mesylate Summary
GEODON is indicated for the treatment of schizophrenia in adults [see Clinical Studies (14.1) ] .
GEODON is indicated as monotherapy for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder [see Clinical Studies (14.2) ] .
GEODON is indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies (14.2) ] .
---
Geodon,ziprasidone|6UKA5VEJ6X|
# Ziprasidone Summary
Bipolar I Disorder (Acute Mixed or Manic Episodes and Maintenance Treatment as an Adjunct to Lithium or Valproate) Acute Treatment of Agitation in Schizophrenia GEODON is indicated for the treatment of schizophrenia in adults [see Clinical Studies (14.1) ] .
GEODON is indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies (14.2) ] .
GEODON intramuscular is indicated for the treatment of acute agitation in schizophrenic adult patients for whom treatment with ziprasidone is appropriate and who need intramuscular antipsychotic medication for rapid control of agitation [see Clinical Studies (14.1) ] .
---
GIVLAARI,givosiran sodium|5XE21E41RT|
# Givosiran Sodium Summary
GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP).
---
Glatiramer Acetate|5M691HL4BO|
# Glatiramer Acetate Summary
Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Glimepiride,pioglitazone and glimepiride|6KY687524K|
# Glimepiride Summary
Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1)] .
Limitations: Limitations of Use Glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies ( 14.1 ) ].
---
Glipizide,Glipizide and Metformin HCl|X7WDT95N5C|
# Glipizide Summary
Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glipizide and Metformin HCl Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
---
GLYBURIDE,glyburide-metformin hydrochloride|SX6K58TVWC|
# Glyburide Summary
Glyburide and metformin hydrochloride tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glyburide tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glyburide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
GLYCOPYRROLATE,Glycopyrrolate Oral Solution|V92SO9WP2I|
# Glycopyrrolate Summary
Glycopyrrolate oral solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).
Limitations: Limitations of Use Glycopyrrolate tablets are indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer.
Limitations: Glycopyrrolate Injection is not indicated as monotherapy for the treatment of peptic ulcer because effectiveness in peptic ulcer healing has not been established.
In Peptic Ulcer For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.
---
GOCOVRI,amantadine|BF4C9Z1J53|
# Amantadine Summary
For the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications GOCOVRI ® is indicated: As adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episodes
---
Gonal-f,follitropin|076WHW89TW|
# Follitropin Summary
GONAL-f is indicated for:
---
Griseofulvin,Ultramicrosize Griseofulvin|32HRV3E3D5|
# Griseofulvin Summary
Coccidioidomycosis Trichophyton megnini Trichophyton tonsurans Trichophyton crateriform Trichophyton sulphureum Tinea capitis Candidiasis (Moniliasis) Trichophyton gallinae Trichophyton rubrum Griseofulvin tablets, USP are indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely: Microsporum gypseum Histoplasmosis Ultramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton...
---
Guanfacine,Guanfacine extended-release,GUANFACINE HYDROCHLORIDE|PML56A160O|
# Guanfacine Hydrochloride Summary
Guanfacine tablets, USP are indicated in the management of hypertension.
Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14 )] .
Guanfacine Extended-Release Tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ].
Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies ( 14 )] .
---
Guanfacine Hydrochloride,GuanfacineExtended-Release,guanfacine|30OMY4G3MK|
# Guanfacine Summary
Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [ see Clinical Studies ( 14 ) ].
Guanfacine tablets are indicated in the management of hypertension.
---
HALOG,halcinonide|SI86V6QNEG|
# Halcinonide Summary
HALOG SOLUTION (Halcinonide Topical Solution, USP) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Haloperidol,haloperidol lactate|6387S86PK3|
# Haloperidol Lactate Summary
Haloperidol Oral Solution is indicated for the control of tics and vocal utterances of Tourette’s Disorder in children and adults.
Haloperidol Oral Solution is indicated for use in the management of manifestations of psychotic disorders.
Haloperidol Oral Solution is effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation).
Haloperidol is also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance.
---
Haloperidol|J6292F8L3D|
# Haloperidol Summary
Haloperidol is indicated for use in the management of manifestations of psychotic disorders.
Haloperidol tablets, USP are indicated for use in the management of manifestations of psychotic disorders.
Haloperidol tablets are indicated for the control of tics and vocal utterances of Tourette’s Disorder in children and adults.
Haloperidol tablets are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation).
Haloperidol tablets are also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.
---
HALOPERIDOL DECANOATE|AC20PJ4101|
# Haloperidol Decanoate Summary
Haloperidol decanoate injection, 50 mg/mL and haloperidol decanoate injection, 100 mg/mL are indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy.
Haloperidol decanoate injection is indicated for the treatment of schizophrenia in adults who were previously taking a stable dosage of an immediate-release oral haloperidol product.
Haloperidol Decanoate Injection is indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy.
---
HEMGENIX,etranacogene dezaparvovec|Z5XCD5Q9RL|
# Etranacogene Dezaparvovec Summary
HEMGENIX is an adeno-associated virus vector-based gene therapy indicated for treatment of adults with Hemophilia B (congenital Factor IX deficiency) who: Have repeated, serious spontaneous bleeding episodes.
---
Heparin Sodium,Heparin Sodium and Dextrose,Heparin Sodium in Sodium Chloride|ZZ45AB24CA|
# Heparin Sodium Summary
Prophylaxis and treatment of pulmonary embolism; Atrial fibrillation with embolization; Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation; Heparin Sodium Injection is indicated for: Heparin Sodium in 0.9% Sodium Chloride Injection at the concentration of 2 USP units/mL is indicated as an anticoagulant to maintain catheter patency.
Prophylaxis and treatment of peripheral arterial embolism; Heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures.
Prophylaxis and treatment of venous thrombosis and pulmonary embolism; Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.
---
Hetastarch in Sodium Chloride,hetastarch|875Y4127EA|
# Hetastarch Summary
6% Hetastarch in 0.9% Sodium Chloride Injection is indicated in the treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable.
---
Humatin,paromomycin sulfate|845NU6GJPS|
# Paromomycin Sulfate Summary
Paromomycin sulfate is indicated for intestinal amebiasis–acute and chronic (NOTE-It is not effective in extraintestinal amebiasis); management of hepatic coma–as adjunctive therapy.
---
hydrALAZINE Hydrochloride|FD171B778Y|
# Hydralazine Hydrochloride Summary
Essential hypertension, alone or as an adjunct. Severe essential hypertension when the drug cannot be given orally or when there is an urgent need to lower blood pressure.
---
Acetaminophen,ACETAMINOPHEN AND CODEINE PHOSPHATE,BUTALBITAL AND ACETAMINOPHEN,Butalbital, Acetaminophen and Caffeine,Butalbital, Acetaminophen, and Caffeine,Butalbital, Acetaminophen, Caffeine,Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate,Combogesic,ENDOCET,Fioricet,Fioricet with Codeine,Hydrocodone Bitartrate and Acetaminophen,Hydrocodone/APAP,Oxycodone and Acetaminophen,oxycodone hydrochloride and acetaminophen,Prolate,TRAMADOL HCL AND ACETAMINOPHEN,Tramadol Hydrochloride and Acetaminophen|362O9ITL9D|
# Acetaminophen Summary
Limitations: Limitations of Use Have not been tolerated or are not expected to be tolerated, the reduction of fever in adult and pediatric patients.
Limitations: Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration ( see WARNINGS ), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) Have not provided adequate analgesia or are not expected to provide adequate analgesia.
Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
---
Hydrocodone Bitartrate and Acetaminophen,Hydrocodone/APAP,hydrocodone bitartrate|NO70W886KK|
# Hydrocodone Bitartrate Summary
Limitations: Limitations of Use: Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
have not been tolerated or are not expected to be tolerated, have not provided adequate analgesia or are not expected to provide adequate analgesia Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
---
Analpram HC,Cortifoam,Cortisporin TC,EPIFOAM,Hydrocortisone Acetate,Hydrocortisone Acetate Cream,MiCort HC Cream,PROCTOFOAMHC|3X7931PO74|
# Hydrocortisone Acetate Summary
Hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani.
Proctofoam ® HC is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the anal region.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Cortifoam ® is indicated as adjunctive therapy in the topical treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas.
---
hydrocortisone valerate cream,hydrocortisone valerate|68717P8FUZ|
# Hydrocortisone Valerate Summary
Hydrocortisone valerate cream USP, 0.2% is medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.
---
hydromorphone hydrochloride|L960UP2KRW|
# Hydromorphone Hydrochloride Summary
Hydromorphone hydrochloride extended-release tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids.
Limitations: Hydromorphone hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic.
Hydromorphone hydrochloride oral solution and hydromorphone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
---
hydroquinone|XV74C1N1AE|
# Hydroquinone Summary
HYDROQUINONE USP, 4% SKIN BLEACHING CREAM is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.
---
Hydroxychloroquine sulfate|8Q2869CNVH|
# Hydroxychloroquine Sulfate Summary
Hydroxychloroquine sulfate tablets are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported.
Hydroxychloroquine sulfate tablets are indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults.
Hydroxychloroquine sulfate tablets are indicated for the treatment of uncomplicated malaria due to P.
Hydroxychloroquine sulfate tablets are not recommended for the treatment of complicated malaria.
Prior to prescribing hydroxychloroquine sulfate tablets for the treatment or prophylaxis of malaria, consult the Centers for Disease Control and Prevention (CDC) Malaria website (http://www.cdc.gov/malaria).
---
Hydroxyzine Hydrochloride,hydroxyzine dihydrochloride|76755771U3|
# Hydroxyzine Dihydrochloride Summary
Hydroxyzine hydrochloride intramuscular solution is useful in treating the following types of patients when intramuscular administration is indicated: Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus.
Hydroxyzine has been found to be particularly useful for this latter phase of therapy in its ability to render the disturbed patient more amenable to psychotherapy in long term treatment of the psychoneurotic and psychotic, although it should not be used as the sole treatment of psychosis or of clearly demonstrated cases of depression.
---
hydroxyzine pamoate|M20215MUFR|
# Hydroxyzine Pamoate Summary
Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol®) and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. The effectiveness of hydroxyzine as an antianxiety agent for long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically...
---
HYFTOR,sirolimus|W36ZG6FT64|
# Sirolimus Summary
HYFTOR is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.
---
HYMPAVZI,marstacimab|0UB3OA67O7|
# Marstacimab Summary
hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors, or HYMPAVZI is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with:
---
Adalimumab,HYRIMOZ|FYS6T7F842|
# Adalimumab Summary
Limitations: Limitations of Use: Adalimumab-adaz is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
Adalimumab-adaz is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients.
HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients.
HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
---
HYRNUO,sevabertinib|2A7VPM5RWH|
# Sevabertinib Summary
HYRNUO is indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 ( ERBB2 ) tyrosine kinase domain (TKD) activating mutations, as detected by an FDA-approved test [see Dosage and Administration (2.1) ] , and who have received a prior systemic therapy.
---
Ibrance,palbociclib|G9ZF61LE7G|
# Palbociclib Summary
IBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: fulvestrant in patients with disease progression following endocrine therapy.
an aromatase inhibitor as initial endocrine-based therapy; or IBRANCE is indicated in combination with inavolisib and fulvestrant for the treatment of adult patients with endocrine-resistant, PIK3CA -mutated, HR-positive, HER2-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy.
---
Combogesic,IBU,Ibuprofen,Ibuprofen and famotidine,Ibuprofen Famotidine|WK2XYI10QM|
# Ibuprofen Summary
Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea.
Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
Ibuprofen tablets are indicated for relief of mild to moderate pain.
For treatment of primary dysmenorrhea.
In Pediatric Patients, Ibuprofen Oral Suspension is indicated: IBU tablets are also indicated for the treatment of primary dysmenorrhea.
---
Icosapent Ethyl|6GC8A4PAYH|
# Icosapent Ethyl Summary
Limitations: Limitations of Use: The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.
Icosapent ethyl capsules are indicated:
---
IGALMI,dexmedetomidine|67VB76HONO|
# Dexmedetomidine Summary
IGALMI is indicated for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
---
IMDELLTRA,IMDELLTRA (AMG757),tarlatamab|74X82ST8Q1|
# Tarlatamab Summary
IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
---
Imipramine Hydrochloride|BKE5Q1J60U|
# Imipramine Hydrochloride Summary
Childhood Enuresis -May be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. In patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. The effectiveness of treatment may decrease with continued drug administration. Depression -For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. One to three weeks of treatment may be needed before optimal therapeutic effects are evident.
---
indomethacin|XXE1CET956|
# Indomethacin Summary
Indomethacin Capsules is indicated for: 1.
Indomethacin extended-release capsules, USP are not recommended for the treatment of acute gouty arthritis.
---
INLEXZO,gemcitabine|B76N6SBZ8R|
# Gemcitabine Summary
INLEXZO is indicated for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.
---
Clinolipid,Intralipid,Kabiven,NutriLipid I.V. Fat Emulsion,Perikabiven,Smoflipid,soybean oil|241ATL177A|
# Soybean Oil Summary
Intralipid ® is indicated as a source of calories and essential fatty acids for adult and pediatric patients requiring parenteral nutrition and as a source of essential fatty acids for prevention of essential fatty acid deficiency (EFAD).
Nutrilipid ® 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated.
SMOFlipid is indicated in adult and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
AtroventHFA,Combivent Respimat,Ipratropium Bromide,IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,Ipratroprium Bromide|J697UZ2A9J|
# Ipratropium Bromide Summary
Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older.
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
COMBIVENT RESPIMAT is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
---
Avalide,Irbesartan,Irbesartan and Hydrochlorothiazide|J0E2756Z7N|
# Irbesartan Summary
AVALIDE ® (irbesartan and hydrochlorothiazide) tablets are indicated for the treatment of hypertension.
Figure 2b: Probability of Achieving DBP &lt;80 mmHg in Patients from Initial Therapy Studies V (Week 8) and VI (Week 7)* 1.1 Hypertension Irbesartan tablets are indicated for the treatment of hypertension, to lower blood pressure.
Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension.
The above graphs provide a rough approximation of the likelihood of reaching a targeted blood pressure goal (e.g., Week 8 sitting systolic blood pressure ≤140 mmHg) for the treatment groups.
---
IRESSA,gefitinib|S65743JHBS|
# Gefitinib Summary
IRESSA is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test [see Clinical Studies (14) ] .
---
Camptosar,Irinotecan Hydrochloride|042LAQ1IIS|
# Irinotecan Hydrochloride Summary
•Irinotecan hydrochloride injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
•Irinotecan hydrochloride injection is indicated as a component of first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic carcinoma of the colon or rectum.
CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
---
Iron Sucrose|FZ7NYF5N8L|
# Iron Sucrose Summary
Iron sucrose injection is indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD).
---
Isoflurane|CYS9AKD70P|
# Isoflurane Summary
Isoflurane, USP liquid for inhalation may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia. Isoflurane USP may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.
---
Isoniazid|V83O1VOZ8L|
# Isoniazid Summary
Single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy.
Single-drug treatment of active tuberculosis with isoniazid, or any other medication, is inadequate therapy.
---
ALCOHOL PREP PADS,Alcohol Swab,AVONEX,Dukal Alcohol Prep,Isopropyl Alcohol,Leuprolide Acetate,RYONCIL|ND2M416302|
# Isopropyl Alcohol Summary
Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.
RYONCIL is indicated for the treatment of steroid refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.
AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Isoproterenol hydrochloride|DIA2A74855|
# Isoproterenol Hydrochloride Summary
Isoproterenol hydrochloride injection is indicated: To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output • For bronchospasm occurring during anesthesia • To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output For bronchospasm occurring during anesthesia Isoproterenol hydrochloride is indicated:
---
Isosorbide Dinitrate|IA7306519N|
# Isosorbide Dinitrate Summary
Isosorbide Dinitrate Tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease.
Isosorbide dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease.
---
isosorbide mononitrate|LX1OH63030|
# Isosorbide Mononitrate Summary
Isosorbide Mononitrate Tablets are indicated for the prevention and treatment of angina pectoris due to coronary artery disease.
Isosorbide Mononitrate Extended-Release Tablets are indicated for the prevention of angina pectoris due to coronary artery disease.
Isosorbide mononitrate extended-release tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease.
---
Isturisa,osilodrostat phosphate|Y6581YAW9V|
# Osilodrostat Phosphate Summary
ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
---
IVRA,Melphalan hydrochloride|1VXP4V453T|
# Melphalan Hydrochloride Summary
Multiple Myeloma-Palliative Treatment Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
IVRA is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
---
IXEMPRA,ixabepilone|K27005NP0A|
# Ixabepilone Summary
IXEMPRA is indicated as a single agent for the treatment of patients with metastatic or locally advanced breast cancer whose tumors are resistant or refractory to anthracyclines, taxanes, and capecitabine [see Clinical Studies ( 14 )].
IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated.
---
Jatenzo,Kyzatrex,testosterone undecanoate|H16A5VCT9C|
# Testosterone Undecanoate Summary
Limitations: Limitations of use: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter syndrome, chemotherapy, or toxic damage from alcohol or heavy metals.
JATENZO (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Safety and efficacy of JATENZO in males less than 18 years old have not been established [ see Use in Specific Populations ( 8.4 ) ].
KYZATREX® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:
---
Jevtana,cabazitaxel|51F690397J|
# Cabazitaxel Summary
JEVTANA ® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.
---
JOURNAVX,suzetrigine|LOG73M21H5|
# Suzetrigine Summary
JOURNAVX is indicated for the treatment of moderate to severe acute pain in adults.
---
JUBLIA,efinaconazole|J82SB7FXWB|
# Efinaconazole Summary
JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes .
---
Dovato,Juluca,Tivicay,Tivicay PD,Triumeq,Triumeq PD,dolutegravir sodium|1Q1V9V5WYQ|
# Dolutegravir Sodium Summary
JULUCA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of JULUCA.
TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg.
---
Kabiven,Perikabiven,isoleucine|04Y7590D77|
# Isoleucine Summary
Limitations: Limitations of Use: KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,threonine|2ZD004190S|
# Threonine Summary
Limitations: Limitations of Use: PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,aspartic acid|30KYC7MIAI|
# Aspartic Acid Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,glutamic acid|3KX376GY7L|
# Glutamic Acid Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,serine|452VLY9402|
# Serine Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,sodium acetate|4550K0SC9B|
# Sodium Acetate Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,phenylalanine|47E5O17Y3R|
# Phenylalanine Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,histidine|4QD397987E|
# Histidine Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use: PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,tryptophan|8DUH1N11BX|
# Tryptophan Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,arginine|94ZLA3W45F|
# Arginine Summary
Limitations: Limitations of Use: PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,proline|9DLQ4CIU6V|
# Proline Summary
Limitations: Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
Kabiven,Perikabiven,leucine|GMW67QNF9C|
# Leucine Summary
Limitations: Limitations of Use: KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,valine|HG18B9YRS7|
# Valine Summary
Limitations: Limitations of Use: PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Calcium Chloride,DELFLEX,EXTRANEAL,Kabiven,LACTATED RINGER,Lactated Ringers,Lactated Ringers and Dextrose,Perikabiven,Potassium Chloride in Lactated Ringers and Dextrose,Ringers|M4I0D6VV5M|
# Calcium Chloride Summary
DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis.
Limitations: Limitations of Use DELFLEX® is indicated in the treatment of chronic kidney failure patients being maintained on peritoneal dialysis EXTRANEAL (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of kidney failure in patients requiring long-term kidney replacement therapy.
Lactated Ringer’s Injection is indicated for use as a source of water and electrolytes or as an alkalinizing agent in adults and pediatric patients.
---
Kabiven,Perikabiven,alanine|OF5P57N2ZX|
# Alanine Summary
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,sodium glycerophosphate anhydrous|YP1H63LJ2K|
# Sodium Glycerophosphate Anhydrous Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
KANUMA,sebelipase alfa|K4YTU42T8G|
# Sebelipase Alfa Summary
KANUMA ® is indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency.
---
Kelnor 1/50,ethynodiol diacetate|62H10A1236|
# Ethynodiol Diacetate Summary
Kelnor 1/50 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
---
Kerendia,finerenone|DE2O63YV8R|
# Finerenone Summary
Kerendia is indicated to reduce the risk of:
---
KESIMPTA,ofatumumab|M95KG522R0|
# Ofatumumab Summary
KESIMPTA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Ketalar,KETAMINE HYDROCHLORIDE|O18YUO0I83|
# Ketamine Hydrochloride Summary
Ketamine hydrochloride injection is indicated: Ketamine hydrochloride injection is indicated: • as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation.
KETALAR (ketamine hydrochloride) injection is indicated:
---
Ketoconazole|R9400W927I|
# Ketoconazole Summary
Ketoconazole Shampoo, 2% is indicated for the treatment of tinea (pityriasis) versicolor caused by or presumed to be caused by Pityrosporum orbiculare (also known as Malassezia furfur or M.
Limitations: Ketoconazole tablets are not indicated for treatment of onychomycosis, cutaneous dermatophyte infections, or Candida infections.
Ketoconazole tablets are indicated for the treatment of the following systemic fungal infections in patients who have failed or who are intolerant to other therapies: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.
Treatment of the infection may not immediately result in normalization of pigment to the affected sites.
Ketoconazole Cream, 2% is indicated for the topical treatment of tinea corporis, tinea cruris and tinea pedis caused by Trichophyton rubrum , T.
---
Ketoprofen|90Y4QC304K|
# Ketoprofen Summary
Ketoprofen capsules USP are indicated for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
Ketoprofen capsules USP are indicated for the management of pain.
Ketoprofen capsules USP are also indicated for treatment of primary dysmenorrhea.
---
Acular,Ketorolac Tromethamine|4EVE5946BQ|
# Ketorolac Tromethamine Summary
Ketorolac Tromethamine Tablets USP are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis.
Ketorolac tromethamine ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Ketorolac tromethamine ophthalmic solution 0.5% is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
ACULAR is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
---
Kisunla,donanemab|1ADB65P1KK|
# Donanemab Summary
KISUNLA TM is indicated for the treatment of Alzheimer's disease.
---
Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept),Lymphoseek,technetium tc-99m tilmanocept|8IHI69PQTC|
# Technetium Tc-99M Tilmanocept Summary
Lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in adult and pediatric patients age one month and older with solid tumors for which this procedure is a component of intraoperative management. Guiding sentinel lymph node biopsy using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity, breast cancer or melanoma. Lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for:
---
Kit for the Preparation of Technetium Tc 99m Medronate,technetium tc-99m medronate|X89XV46R07|
# Technetium Tc-99M Medronate Summary
Technetium Tc 99m medronate may be used as a bone imaging agent to delineate areas of altered osteogenesis.
---
Kit for the Preparation of Technetium Tc99m Sestamibi,technetium tc-99m sestamibi|971Z4W1S09|
# Technetium Tc-99M Sestamibi Summary
Myocardial Imaging: Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions.
Breast Imaging: Technetium Tc 99m Sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass.
Limitations: Technetium Tc 99m Sestamibi is not indicated for breast cancer screening, to confirm the presence or absence of malignancy, and it is not an alternative to biopsy.
---
KOMBIGLYZEXR,saxagliptin hydrochloride|Z8J84YIX6L|
# Saxagliptin Hydrochloride Summary
KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies (14) ].
KOMBIGLYZE XR is not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
---
Korsuva,difelikefalin acetate|0P70AR5BYB|
# Difelikefalin Acetate Summary
KORSUVA is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD).
---
KOSELUGO,selumetinib|6UH91I579U|
# Selumetinib Summary
KOSELUGO is indicated for the treatment of pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2) ].
KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2) ].
---
Krystexxa,pegloticase|R581OT55EA|
# Pegloticase Summary
KRYSTEXXA ® (pegloticase) is indicated, for the treatment of chronic gout in adult patients refractory to conventional therapy.
Gout refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
---
Labetalol Hydrochloride|1GEV3BAW9J|
# Labetalol Hydrochloride Summary
Labetalol HCl tablets are indicated in the management of hypertension.
Labetalol hydrochloride tablets USP are indicated in the management of hypertension.
Labetalol HCl injection is indicated for control of blood pressure in severe hypertension.
---
Labetalol Hydrochloride,labetalol|R5H8897N95|
# Labetalol Summary
Labetalol hydrochloride tablets, USP are indicated in the management of hypertension.
---
DELFLEX,EXTRANEAL,LACTATED RINGER,Lactated Ringers,Lactated Ringers and Dextrose,Potassium Chloride in Lactated Ringers and Dextrose,sodium lactate|TU7HW0W0QT|
# Sodium Lactate Summary
Lactated Ringer’s Injection is indicated for use as a source of water and electrolytes or as an alkalinizing agent in adults and pediatric patients.
EXTRANEAL (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of kidney failure in patients requiring long-term kidney replacement therapy.
DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis.
DELFLEX® is indicated in the treatment of chronic kidney failure patients being maintained on peritoneal dialysis Regulating body fluids, electrolytes and acid-base balance regulating drugs.
---
Lactulose,LACTULOSE Crystalline|9U7D5QH5AE|
# Lactulose Summary
Lactulose for Oral Solution is indicated for the treatment of constipation.
For the treatment of constipation.
---
Lamotrigine|U3H27498KS|
# Lamotrigine Summary
Limitations: Limitations of Use Treatment of acute manic or mixed episodes is not recommended.
Adjunctive Therapy Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: partial-onset seizures.
Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy [see Clinical Studies (14.2 )] .
Effectiveness of lamotrigine tablets in the acute treatment of mood episodes has not been established.
---
FEMLYV,Gallifrey,Larin Fe 1.5/30,Larin Fe 1/20,Norethindrone Acetate,Norethindrone Acetate and Ethinyl Estradiol,Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate|9S44LIC7OJ|
# Norethindrone Acetate Summary
LARIN TM Fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Gallifrey (Norethindrone Acetate Tablets, USP), 5 mg Microgestin Fe 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Blisovi Fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Limitations of Use ***N/A--Data not available Gallifrey is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.
---
LASTACAFT,alcaftadine|7Z8O94ECSX|
# Alcaftadine Summary
LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.
---
Latanoprost|6Z5B6HVF6O|
# Latanoprost Summary
Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
---
LAZCLUZE,lazertinib|4A2Y23XK11|
# Lazertinib Summary
LAZCLUZE, in combination with amivantamab, is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations, as detected by an FDA-approved test [see Dosage and Administration (2.1) ] .
---
leflunomide|G162GK9U4W|
# Leflunomide Summary
Leflunomide tablets is indicated for the treatment of adults with active rheumatoid arthritis (RA).
Leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (RA).
---
LECANEMAB AUTOINJECTOR,LEQEMBI,lecanemab|12PYH0FTU9|
# Lecanemab Summary
LEQEMBI is indicated for the treatment of Alzheimer’s disease.
---
LEQVIO,inclisiran sodium|UPC6BTX7PY|
# Inclisiran Sodium Summary
LEQVIO ® is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).
---
leucovorin calcium|RPR1R4C0P4|
# Leucovorin Calcium Summary
Leucovorin Calcium for Injection rescue is indicated after high dose methotrexate therapy in osteosarcoma.
Leucovorin Calcium is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible.
Leucovorin Calcium for Injection is also indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
Leucovorin Calcium is also indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
Leucovorin Calcium for Injection is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible.
---
Levalbuterol,levalbuterol hydrochloride|WDQ1526QJM|
# Levalbuterol Hydrochloride Summary
Levalbuterol Inhalation Solution, USP is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.
---
Levetiracetam,LevetiracetamER,LevetiracetamExtended-Release|44YRR34555|
# Levetiracetam Summary
Levetiracetam Injection is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Levetiracetam extended-release tablets are indicated for the treatment of partial-onset seizures in patients 12 years of age and older.
Levetiracetam Injection is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Levetiracetam Injection is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy.
---
Levofloxacin|6GNT3Y5LMF|
# Levofloxacin Summary
Levofloxacin tablets are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section.
Levofloxacin Injection in 5% dextrose is indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section.
Levofloxacin Injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form).
---
LEVORPHANOL TARTRATE|04WQU6T9QI|
# Levorphanol Tartrate Summary
Limitations: Limitations of Use Levorphanol tartrate tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration [see WARNINGS ] , and persist over the course of therapy, reserve opioid analgesics, including levorphanol tartrate tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
---
LEVOTHYROXINE SODIUM,levothyroxine sodium anhydrous|054I36CPMN|
# Levothyroxine Sodium Anhydrous Summary
Levothyroxine sodium for injection is indicated for the treatment of myxedema coma.
Limitations: Important Limitations of Use: The relative bioavailability between levothyroxine sodium for injection and oral levothyroxine products has not been established.
---
ERMEZA,LEVOTHYROXINE SODIUM|9J765S329G|
# Levothyroxine Sodium Summary
Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
Limitations: Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
• Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
---
Halobetasol propionate,LEXETTE|91A0K1TY3Z|
# Halobetasol Propionate Summary
LEXETTE ® is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Halobetasol Propionate Topical Foam is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Halobetasol propionate ointment, 0.05% is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
---
Diclona,Lidocaine,Lidocaine 5%,LIDOCAINE AND PRILOCAINE,LIDOCAINE AND PRILOCAINELIDOCAINE AND PRILOCAINE,Trubrexa|98PI200987|
# Lidocaine Summary
Lidocaine and Prilocaine Cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: Lidocaine Ointment USP, 5% is indicated for production of anesthesia of accessible mucous membranes of the oropharynx.
LIDOCAINE PATCH 5% is indicated for relief of pain associated with post-herpetic neuralgia.
Trubrexa TM Transdermal Patch is indicated in adults over the age of 12 years old for the treatment of acute and chronic pain in muscles and joints associated with muscle soreness, strains, sprains, arthritis, simple backache, muscle stiffness, and more.
---
LIDOCAINE AND PRILOCAINE,LIDOCAINE AND PRILOCAINELIDOCAINE AND PRILOCAINE,prilocaine|046O35D44R|
# Prilocaine Summary
Lidocaine and Prilocaine Cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: • genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia.
Lidocaine and prilocaine cream, 2.5%/2.5% (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: Lidocaine and Prilocaine Cream is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies (see WARNINGS).
---
Diclolidol Kit,Lidocaine,Lidocaine 5% Gel,Lidocaine Hydrochloride,Lidocaine Hydrochloride and Epinephrine,Lidocaine Viscous,Lidotral 5 Percent Roll On Gel,Lignospan Forte,Lignospan Standard|V13007Z41A|
# Lidocaine Hydrochloride Summary
Lidocaine hydrochloride injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
---
Linezolid|ISQ9I6J12J|
# Linezolid Summary
Linezolid is indicated for the treatment of nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates) or Streptococcus pneumoniae [ see Clinical Studies ( 14 ) ].
Linezolid is indicated for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae , including cases with concurrent bacteremia, or Staphylococcus aureus (methicillin-susceptible isolates only) [ see Clinical Studies ( 14 ) ].
Linezolid is indicated for the treatment of vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia [ see Clinical Studies ( 14 ) ].
Linezolid is indicated for the treatment of complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus pyogenes , or Streptococcus agalactiae .
---
Liraglutide|839I73S42A|
# Liraglutide Summary
Limitations: Limitations of Use: Limitations of Use The safety and effectiveness of liraglutide injection in pediatric patients with type 2 diabetes have not been established.
Limitations: Limitations of Use: Liraglutide injection contains liraglutide.
Liraglutide injection is indicated: Liraglutide injection is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Liraglutide injection contains liraglutide.
---
DASH Chlorhexidine Gluconate 0.12% Oral Rinse,Lidocaine Hydrochloride,Liraglutide,WEGOVY,hydrochloric acid|QTT17582CB|
# Hydrochloric Acid Summary
Limitations: Limitations of Use: Liraglutide injection contains liraglutide.
Limitations: to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with obesity Limitations of Use Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing.
Liraglutide injection is indicated: for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults.
---
Lisdexamfetamine dimesylate,Vyvanse|SJT761GEGS|
# Lisdexamfetamine Dimesylate Summary
Limitations: Lisdexamfetamine dimesylate capsules are not indicated or recommended for weight loss.
Lisdexamfetamine Dimesylate Capsules are indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see Clinical Studies ( 14.1 )] The use of lisdexamfetamine dimesylate chewable tablets is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations ( 8.4 )] .
Limitations: Lisdexamfetamine dimesylate chewable tablets are not indicated or recommended for weight loss.
---
LISINOPRIL,Lisinopril and Hydrochlorothiazide,Lisinopril/HCTZ|E7199S1YWR|
# Lisinopril Summary
Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure.
Limitations: These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION ).
Limitations: 1.2 Heart Failure These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION).
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
(See WARNINGS.) Lisinopril is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure.
---
Lithium,lithium citrate|5Z6E9K79YV|
# Lithium Citrate Summary
Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 ) ] Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 )].
Lithium oral solution is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )].
---
Lithium Carbonate|2BMD2GNA4V|
# Lithium Carbonate Summary
• Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )] Lithium Carbonate Extended-Release Tablets are indicated in the treatment of manic episodes of manic-depressive illness.
Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )] Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 )] • Maintenance treatment in patients 7 years and older [see Clinical Studies (14)] Lithium Carbonate Extended-Release Tablets is indicated in the treatment of manic episodes of manic-depressive illness.
Lithium carbonate extended-release tablets are indicated in the treatment of manic episodes of Bipolar Disorder.
---
LOCAMETZ,gozetotide|9AG41L3AOQ|
# Gozetotide Summary
for selection of patients who are indicated for PSMA-directed therapy as described in the prescribing information of the therapeutic products.
LOCAMETZ, after radiolabeling with gallium-68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer:
---
LOPERAMIDE HYDROCHLORIDE|77TI35393C|
# Loperamide Hydrochloride Summary
Loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease.
Loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from ileostomies.
Loperamide hydrochloride is indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease.
---
Ativan,Lorazepam|O26FZP769L|
# Lorazepam Summary
Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.
Lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.
Ativan (lorazepam) is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.
---
Benazepril Hydrochloride,Benazepril Hydrochloride and Hydrochlorothiazide,Lotensin,Lotensin HCT|N1SN99T69T|
# Benazepril Hydrochloride Summary
Limitations: This fixed combination drug is not indicated for the initial therapy of hypertension ( see DOSAGE AND ADMINISTRATION ).
Benazepril HCl tablets are indicated for the treatment of hypertension, to lower blood pressure.
Lotensin ® is indicated for the treatment of hypertension, to lower blood pressure.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure.
---
LOTEPREDNOL ETABONATE|YEH1EZ96K6|
# Loteprednol Etabonate Summary
Loteprednol etabonate ophthalmic suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Loteprednol etabonate ophthalmic suspension is also indicated for the treatment of post-operative inflammation following ocular surgery.
Loteprednol etabonate ophthalmic suspension is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.
---
Lovastatin|9LHU78OQFD|
# Lovastatin Summary
Lovastatin tablets USP are indicated as an adjunct to diet for the reduction of elevated total-C and LDL-C levels in patients with primary hypercholesterolemia (Types IIa and IIb 2 ), when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate.
Limitations: In such cases, lovastatin tablets USP are not indicated.
---
Elinest,Low-Ogestrel,norgestrel|3J8Q1747Z2|
# Norgestrel Summary
Low-Ogestrel is indicated for use by females of reproductive potential to prevent pregnancy.
Turqoz is indicated for use by females of reproductive potential to prevent pregnancy.
ELINEST TM is indicated for use by females of reproductive potential to prevent pregnancy.
---
Loxapine,loxapine succinate|X59SG0MRYU|
# Loxapine Succinate Summary
Loxapine Capsules are indicated for the treatment of schizophrenia.
Loxapine Capsules, USP are indicated for the treatment of schizophrenia.
---
Byooviz,CIMERLI,LUCENTIS,ranibizumab|ZL1R02VT79|
# Ranibizumab Summary
LUCENTIS is indicated for the treatment of patients with: CIMERLI is indicated for the treatment of patients with: BYOOVIZ is indicated for the treatment of patients with:
---
LULICONAZOLE,Luzu|RE91AN4S8G|
# Luliconazole Summary
Luliconazole Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum .
LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum .
---
LumaSon,sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)|841B886EJ7|
# Sodium 1,2-Dipalmitoyl-Sn-Glycero-3-Phospho-(1'-Rac-Glycerol) Summary
Ultrasonography of the Urinary Tract Lumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux.
Lumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.
Ultrasonography of the Liver Lumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
---
LumaSon,distearoylphosphatidylcholine, dl-|EAG959U971|
# Distearoylphosphatidylcholine, Dl- Summary
Ultrasonography of the Liver Lumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
Lumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.
Echocardiography Ultrasonography of the Urinary Tract Lumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux.
---
LumaSon,sulfur hexafluoride|WS7LR3I1D6|
# Sulfur Hexafluoride Summary
Ultrasonography of the Liver Lumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.
Ultrasonography of the Urinary Tract Lumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux.
Lumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
---
Lumryz,Sodium Oxybate|7G33012534|
# Sodium Oxybate Summary
LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Sodium oxybate oral solution is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy.
---
lurasidone hydrochloride|O0P4I5851I|
# Lurasidone Hydrochloride Summary
Lurasidone hydrochloride tablets are indicated for: Lurasidone hydrochloride tablets are indicated for: • Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies ( 14.2 )].
Lurasidone hydrochloride tablet is indicated for: Lurasidone hydrochloride tablets are indicated for: • Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [ see Clinical Studies (14.1) ].
Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2) ] .
---
LURBIRO,flurbiprofen|5GRO578KLP|
# Flurbiprofen Summary
Flurbiprofen tablets are indicated: For relief of the signs and symptoms of osteoarthritis.
---
LYBALVI,samidorphan l-malate|0AJQ5N56E0|
# Samidorphan L-Malate Summary
LYBALVI is indicated for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate Maintenance monotherapy treatment
---
LYBALVI,olanzapine|N7U69T4SZR|
# Olanzapine Summary
Schizophrenia in adults LYBALVI is indicated for the treatment of: Bipolar I disorder in adults Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate Maintenance monotherapy treatment
---
Lysodren,mitotane|78E4J5IB5J|
# Mitotane Summary
LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).
---
LYTGOBI,futibatinib|4B93MGE4AL|
# Futibatinib Summary
LYTGOBI is indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements [see Dosage and Administration (2.1) ] .
---
Manganese,manganese chloride|QQE170PANO|
# Manganese Chloride Summary
Manganese chloride injection, USP is indicated for use in adult patients as a supplement to intravenous solutions given for TPN.
---
MAYZENT,siponimod|RR6P8L282I|
# Siponimod Summary
MAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Meclizine Hydrochloride|HDP7W44CIO|
# Meclizine Hydrochloride Summary
Meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.
---
medroxyprogesterone acetate|C2QI4IOI2G|
# Medroxyprogesterone Acetate Summary
Limitations: Limitations of Use: Medroxyprogesterone acetate tablets, USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer.
They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.
Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy.
---
Megestrol Acetate|TJ2M0FR8ES|
# Megestrol Acetate Summary
Megestrol acetate tablets are indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (ie, recurrent, inoperable, or metastatic disease).
Megestrol acetate oral suspension, USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).
Limitations: Limitations of Use Megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).
Megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).
---
Memantine Hydrochloride|JY0WD0UA60|
# Memantine Hydrochloride Summary
Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine Hydrochloride Extended-Release Capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
---
MEMBRANEBLUE,trypan blue|I2ZWO3LS3M|
# Trypan Blue Summary
MembraneBlue™ 0.15% is indicated for use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue in adults and pediatric patients.
---
Meperidine Hydrochloride|N8E7F7Q170|
# Meperidine Hydrochloride Summary
Meperidine Hydrochloride Tablets and Oral Solution are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations: Limitations of Use Meperidine Hydrochloride Tablets or Oral Solution should not be used for the treatment of chronic pain.
Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions ( 5.2 )], reserve opioid analgesics, including Meperidine Hydrochloride Tablets and Oral Solution, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
---
MEPSEVII,vestronidase alfa|7XZ4062R17|
# Vestronidase Alfa Summary
Limitations: Limitations of Use MEPSEVII is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome).
---
KIRSTY,MERILOG,insulin aspart|D933668QVX|
# Insulin Aspart Summary
MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
KIRSTY is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
---
Meropenem,meropenem anhydrous|YOP6PX0BAO|
# Meropenem Anhydrous Summary
1.1 Bacterial Meningitis (Pediatric Patients 3 Months of Age and Older Only) Meropenem for Injection is indicated for the treatment of bacterial meningitis caused by Haemophilus influenzae, Neisseria meningitidis and penicillin-susceptible isolates of Streptococcus pneumoniae , in pediatric patients 3 months of age and older.
---
mesalamine,Rowasa,sfRowasaSulfite-Free Formulation|4Q81I59GXC|
# Mesalamine Summary
Mesalamine delayed-release tablets are indicated for the: treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
Mesalamine suppositories are indicated in adults for the treatment of mildly to moderately active ulcerative proctitis.
Mesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
ROWASA is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis in adults.
sfROWASA is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis in adults.
---
MESNEX,mesna|NR7O1405Q9|
# Mesna Summary
MESNEX is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.
Limitations: Limitation of Use: MESNEX is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia.
---
Metaxalone|1NMA9J598Y|
# Metaxalone Summary
Metaxalone tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults and pediatric patients 13 years of age and older.
Metaxalone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.
Metaxalone tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.
---
Glipizide and Metformin HCl,Glumetza,glyburide-metformin hydrochloride,KOMBIGLYZEXR,Metformin,Metformin ER  500 mg,Metformin ER 750 mg,Metformin HCL,Metformin Hydrochloride,Metformin Hydrochloride Oral Solution,Metformin hydrochlorideER,Pioglitazone and metformin hydrochloride|786Z46389E|
# Metformin Hydrochloride Summary
Metformin hydrochloride tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
KOMBIGLYZE XR is not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
---
Methadone Hydrochloride|229809935B|
# Methadone Hydrochloride Summary
Limitations: Methadone Hydrochloride Tablets are indicated for the: Limitations of Use Detoxification treatment of opioid addiction (heroin or other morphine-like drugs).
Methadone Hydrochloride Injection is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate.
Methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 CFR 8.12 [see Dosage and Administration ( 2.1 )] .
Maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services.
---
Methamphetamine Hydrochloride|997F43Z9CV|
# Methamphetamine Hydrochloride Summary
Methamphetamine hydrochloride tablets, USP is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older.
---
Methazolamide|W733B0S9SD|
# Methazolamide Summary
Methazolamide Tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.
---
Methimazole|554Z48XN5E|
# Methimazole Summary
In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option Methimazole tablets are indicated: Methimazole is indicated:
---
Methocarbamol,Methocarbamol Tablets, USP, 500 mg,Methocarbamol Tablets, USP, 750 mg|125OD7737X|
# Methocarbamol Summary
Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Methocarbamol Tablets USP, 500 mg and 750 mg are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
---
METHSCOPOLAMINE BROMIDE|RTN51LK7WL|
# Methscopolamine Bromide Summary
Adjunctive therapy for the treatment of peptic ulcer.
---
METHYLERGONOVINE MALEATE|IR84JPZ1RK|
# Methylergonovine Maleate Summary
Following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder. Following delivery of placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder.
---
APTENSIO XR,CONCERTA,METADATE CD,Methylphenidate,METHYLPHENIDATE HYDROCHLORIDE,Methylphenidate Hydrochloride (LA),Methylphenidate HydrochlorideExtended-Release,QuilliChew ER,QuillivantXR,RELEXXII,RitalinLA|4B3SC438HI|
# Methylphenidate Hydrochloride Summary
Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD ) in patients 6 years and older [see Clinical Studies (14) ].
Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies ( 14 )] .
Limitations: Narcolepsy Limitations of Use Methylphenidate hydrochloride tablets are indicated for the treatment of: Ritalin LA ® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), in pediatric patients 6 to 12 years of age [see Clinical Studies ( 14 )] .
---
Cotempla XR-ODT,Methylphenidate Transdermal System,methylphenidate|207ZZ9QZ49|
# Methylphenidate Summary
DAYTRANA (methylphenidate transdermal system) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age.
Methylphenidate Transdermal System (methylphenidate transdermal system) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age.
Limitations: Limitations of Use COTEMPLA XR-ODT is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age [see Clinical Studies (14) ].
---
Medrol,Methylpred DP,METHYLPREDNISOLONE|X4W7ZR7023|
# Methylprednisolone Summary
Rheumatic Disorders Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Acute gouty arthritis Methylprednisolone Tablets are indicated in the following conditions: Severe erythema multiforme (Stevens-Johnson syndrome) Systemic dermatomyositis (polymyositis) Post-traumatic osteoarthritis Epicondylitis 11.Gastrointestinal Diseases Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Symptomatic sarcoidosis 6.Ophthalmic Diseases Pemphigus Bullous dermatitis herpetiformis Acute rheumatic carditis Aspiration pneumonitis To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.
---
Methylprednisolone acetate|43502P7F0P|
# Methylprednisolone Acetate Summary
When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension is indicated as follows: Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy).
For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.
---
Metoclopramide,metoclopramide hydrochloride|W1792A2RVD|
# Metoclopramide Hydrochloride Summary
Metoclopramide is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis.
Small Bowel Intubation Metoclopramide Injection, USP is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.
Limitations: Limitations of Use : Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [ see Use in Specific Populations ( ) ].
---
Metolazone|TZ7V40X7VX|
# Metolazone Summary
Metolazone is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.
Metolazone tablets, USP, are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.
Metolazone tablets, USP, are indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (see PRECAUTIONS ).
Mykrox ® tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension.
---
Metopirone,metyrapone|ZS9KD92H6V|
# Metyrapone Summary
Metopirone is indicated, in combination with other diagnostic tests, for the diagnosis of adrenal insufficiency in adult and pediatric patients.
---
Metoprolol Succinate ER,metoprolol succinate|TH25PD4CCB|
# Metoprolol Succinate Summary
Metoprolol succinate extended-release tablets are indicated to reduce the risk of cardiovascular mortality and heart-failure hospitalization in patients with heart failure.
Metoprolol succinate extended-release tablets are indicated in the long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance.
1.1 Hypertension 1.3 Heart Failure Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
Metoprolol Tartrate|W5S57Y3A5L|
# Metoprolol Tartrate Summary
Myocardial Infarction Metoprolol tartrate tablets are indicated for the treatment of hypertension.
Hypertension Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.
Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris.
Metoprolol tartrate is indicated for the treatment of hypertension in adult patients, to lower blood pressure.
Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.
---
Flagyl,METRONIDAZOLE,Metronidazole Vaginal Gel,Vandazole|140QMO216E|
# Metronidazole Summary
Metronidazole tablets are indicated for the treatment of T.
Metronidazole is indicated in the treatment of asymptomatic T.
Metronidazole tablets are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to metronidazole tablets.
FLAGYL 375 capsules are indicated in the treatment of asymptomatic T.
---
Micafungin,micafungin sodium|IS1UP79R56|
# Micafungin Sodium Summary
Limitations: Limitations of Use Treatment of Esophageal Candidiasis in adult and pediatric patients 4 months of age and older [see Clinical Studies ( 14.2 )].
Micafungin for injection is indicated for: The safety and effectiveness of micafungin for injection have not been established for the treatment of candidemia with meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age as a higher dose may be needed [see Use in Specific Populations ( 8.4 )].
Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see Use in Specific Populations ( 8.4 )] .
---
Micafungin|R10H71BSWG|
# Micafungin Summary
Limitations: Limitations of Use Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see Use in Specific Populations (8.4) ].
Limitations: Limitations of Use Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see Use in Specific Populations ( 8.4 )] .
Micafungin for Injection is indicated for: The efficacy of Micafungin for Injection against infections caused by fungi other than Candida has not been established.
---
Midazolam,Midazolam Hydrochloride|W7TTW573JJ|
# Midazolam Hydrochloride Summary
Midazolam injection is indicated: intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants; Midazolam HCl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia.
Midazolam injection, USP is indicated:
intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; Midazolam HCl syrup is intended for use in monitored settings only and not for chronic or home use [see WARNINGS ].
---
MIDAZOLAM IN 0.8% SODIUM CHLORIDE,Midazolam in Sodium Chloride,midazolam|R60L0SM5BC|
# Midazolam Summary
Midazolam in Sodium Chloride Injection is indicated: Continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting.
Midazolam in 0.9% Sodium Chloride Injection is indicated:
---
Midodrine  Hydrochloride,Midodrine Hydrochloride|59JV96YTXV|
# Midodrine Hydrochloride Summary
Midodrine hydrochloride is indicated for the treatment of symptomatic orthostatic hypotension (OH).
Midodrine Hydrochloride Tablets, USP are indicated for the treatment of symptomatic orthostatic hypotension (OH).
Midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (OH).
---
Korlym,Mifepristone|320T6RNW1F|
# Mifepristone Summary
Limitations: LIMITATIONS OF USE: KORLYM should not be used in the treatment of patients with type 2 diabetes unless it is secondary to Cushing's syndrome.
Mifepristone should not be used in the treatment of patients with type 2 diabetes unless it is secondary to Cushing's syndrome.
---
MILRINONE LACTATE,Milrinone Lactate in 5% Dextrose|9K8XR81MO8|
# Milrinone Lactate Summary
Milrinone lactate injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure.
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure.
The facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available.
---
Minocin,Minocycline Hydrochloride|0020414E5U|
# Minocycline Hydrochloride Summary
Limitations: Oral minocycline is not indicated for the treatment of meningococcal infection .
Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections.
Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum .
---
Minoxidil|5965120SH1|
# Minoxidil Summary
Because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs.
---
Miudella,copper|789U1901C5|
# Copper Summary
Miudella is indicated for prevention of pregnancy in females of reproductive potential for up to 3 years.
---
Modafinil,Provigil|R3UK8X3U3D|
# Modafinil Summary
Limitations: Limitations of Use Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).
In OSA, PROVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.
PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).
If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with PROVIGIL for excessive sleepiness.
---
MODEYSO,dordaviprone|9U35A31JAI|
# Dordaviprone Summary
MODEYSO is indicated for the treatment of adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy.
---
Moexipril Hydrochloride|Q1UMG3UH45|
# Moexipril Hydrochloride Summary
Moexipril hydrochloride tablets USP are indicated for treatment of patients with hypertension.
---
Mometasone Furoate|04201GDN4R|
# Mometasone Furoate Summary
Mometasone Furoate Ointment, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older.
Mometasone Furoate Cream USP, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older.
Mometasone furoate topical solution USP, 0.1% (lotion) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older.
---
Monoferric,ferric derisomaltose|AHU547PI9H|
# Ferric Derisomaltose Summary
who have intolerance to oral iron or have had unsatisfactory response to oral iron who have non-hemodialysis dependent chronic kidney disease (NDD-CKD) Monoferric is indicated for the treatment of iron deficiency anemia (IDA) in adult patients:
---
MITIGO,Morphine Sulfate|X3P646A2J0|
# Morphine Sulfate Summary
Morphine sulfate tablets are indicated for the management of: Morphine sulfate tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.
MITIGO ® is for use in continuous microinfusion devices and indicated only for intrathecal or epidural infusion in the management of intractable chronic pain severe enough to require an opioid analgesic and for which less invasive means of controlling pain are inadequate.
---
MOUNJARO,tirzepatide|OYN3CCI6QE|
# Tirzepatide Summary
MOUNJARO ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
Moxifloxacin,moxifloxacin hydrochloride monohydrate|B8956S8609|
# Moxifloxacin Hydrochloride Monohydrate Summary
Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis
---
Moxifloxacin Ophthalmic Solution,moxifloxacin hydrochloride|C53598599T|
# Moxifloxacin Hydrochloride Summary
Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species * Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenzae Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections.
---
Mozobil,Plerixafor|S915P5499N|
# Plerixafor Summary
Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM).
Mozobil is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).
Plerixafor is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).
---
Mulpleta,lusutrombopag|6LL5JFU42F|
# Lusutrombopag Summary
MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
---
Multaq,dronedarone|JQZ1L091Y2|
# Dronedarone Summary
MULTAQ ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF) [see Clinical Studies (14) ] .
---
Multivitamin with Fluoride,vitamin a|81G40H8B0T|
# Vitamin A Summary
Multivitamin with 1.0 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 6-16 years of age in areas where the water fluoride level is less than 0.3 ppm. Multivitamin with Fluoride Chewable Tablets supply significant amounts of vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain ten essential vitamins and the important mineral, fluoride. Supplementation of the diet with fluoride for caries prophylaxis. The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive...
---
Multivitamin with Fluoride,thiamine mononitrate|8K0I04919X|
# Thiamine Mononitrate Summary
Multivitamin with 1.0 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 6-16 years of age in areas where the water fluoride level is less than 0.3 ppm. Multivitamin with Fluoride Chewable tablets are prescription product for the clinical dietary management of metabolic processes of caries prophylaxis and provides supplementation of the diet with ten essential vitamins. Children using Multivitamin with Fluoride Chewable Tablets regularly should receive semiannual dental examinations. The regular brushing of teeth and attention to good oral hygiene practices are also essential. Supplementation of the diet with fluoride and ten essential vitamins. Multivitamin with 0.5 mg Fluoride Chewable Tablet s provide fluoride in tablet form for children 4-6 years of age where the water fluoride...
---
Multivitamin with Fluoride,PEG-3350, Electrolytes, and Ascorbate,Pouch B,sodium ascorbate|S033EH8359|
# Sodium Ascorbate Summary
Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
---
Multivitamin with Fluoride,riboflavin|TLM2976OFR|
# Riboflavin Summary
Multivitamin with Fluoride Chewable Tablets supply significant amounts of vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain ten essential vitamins and the important mineral, fluoride. Supplementation of the diet with fluoride for caries prophylaxis. The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. Multivitamin with 0.25 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 4-6 years of age where the drinking water contains 0.3 through 0.6 ppm...
---
Multivitamin with Fluoride,.alpha.-tocopherol acetate, dl-|WR1WPI7EW8|
# .Alpha.-Tocopherol Acetate, Dl- Summary
Multivitamin with 1.0 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 6-16 years of age in areas where the water fluoride level is less than 0.3 ppm. Multivitamin with 0.5 mg Fluoride Chewable Tablet s provide fluoride in tablet form for children 4-6 years of age where the water fluoride level is less than 0.3 ppm, and for children 6 years of age and above where the drinking water contains 0.3 through 0.6 ppm of fluoride. Multivitamin with 0.25 mg Fluoride Chewable Tablets provide fluoride in tablet form for children 4-6 years of age where the drinking water contains 0.3 through 0.6 ppm of fluoride. Multivitamin with Fluoride Chewable tablets are prescription product for the clinical dietary...
---
mupirocin|D0GX863OA5|
# Mupirocin Summary
Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus (S.
---
Mupirocin,mupirocin calcium|RG38I2P540|
# Mupirocin Calcium Summary
Mupirocin Cream USP, 2% is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S.
---
Mycapssa,octreotide|RWM8CCW8GP|
# Octreotide Summary
MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
---
CellCept,Mycophenolate Mofetil,MYHIBBIN|9242ECW6R0|
# Mycophenolate Mofetil Summary
Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies ( 14.1 )] , heart [see Clinical Studies ( 14.2 )] or liver transplants [see Clinical Studies ( 14.3 )] , in combination with other immunosuppressants.
Mycophenolate mofetil capsules are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ], in combination with other immunosuppressants.
---
Nabumetone,Nabumetone 1000 mg,Nabumetone 500 mg,Nabumetone 750 mg|LW0TIW155Z|
# Nabumetone Summary
Nabumetone tablets are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Nabumetone tablets, USP are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
---
Nafcillin,NAFCILLIN SODIUM|49G3001BCK|
# Nafcillin Sodium Summary
Nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
---
Naftifine Hydrochloride,Naftin|25UR9N9041|
# Naftifine Hydrochloride Summary
Naftifine Hydrochloride Cream is indicated for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton rubrum .
NAFTIN ® Gel is an allylamine antifungal indicated for the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum , Trichophyton mentagrophytes , and Epidermophyton floccosum .
---
Nalbuphine Hydrochloride|ZU4275277R|
# Nalbuphine Hydrochloride Summary
Nalbuphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations: Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration [see WARNINGS], reserve nalbuphine hydrochloride injection for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: Limitations of Use: Have not provided adequate analgesia or are not expected to provide adequate analgesia.
---
NALMEFENE HYDROCHLORIDE,Zurnai|K7K69QC05X|
# Nalmefene Hydrochloride Summary
Nalmefene hydrochloride injection is indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids.
Nalmefene hydrochloride injection is indicated in the management of known or suspected opioid overdose.
ZURNAI is indicated for the emergency treatment of known or suspected opioid overdose induced by natural or synthetic opioids in adults and pediatric patients aged 12 years and older, as manifested by respiratory and/or central nervous system depression.
---
Buprenorphine and Naloxone,NALOXONE HYDROCHLORIDE,Narcan,PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,ZIMHI|F850569PQR|
# Naloxone Hydrochloride Summary
Naloxone Hydrochloride Injection, USP is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine.
Naloxone Hydrochloride Injection, USP is also indicated for diagnosis of suspected or known acute opioid overdosage.
Naloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine.
---
Naltrexone Hydrochloride|Z6375YW9SF|
# Naltrexone Hydrochloride Summary
Naltrexone Hydrochloride Tablets USP are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids.
Naltrexone hydrochloride tablets are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids.
---
Naproxen,Naproxen and esomeprazole magnesium|57Y76R9ATQ|
# Naproxen Summary
Limitations: Naproxen delayed-release tablets are indicated for: • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea Naproxen tablets are indicated for: polyarticular juvenile idiopathic arthritis Limitations of Use: juvenile idiopathic arthritis (JIA) in adolescent patients.
Naproxen tablets are also indicated for: the relief of signs and symptoms of: rheumatoid arthritis The relief of the signs and symptoms of: The management of: bursitis Do not substitute naproxen and esomeprazole magnesium delayed-release tablets with the single-ingredient products of naproxen and esomeprazole magnesium.
The esomeprazole magnesium component of naproxen and esomeprazole magnesium delayed-release tablet is indicated to decrease the risk of developing naproxen-associated gastric ulcers.
---
Naproxen and esomeprazole magnesium,esomeprazole magnesium trihydrate|R6DXU4WAY9|
# Esomeprazole Magnesium Trihydrate Summary
Limitations: Limitations of Use: juvenile idiopathic arthritis (JIA) in adolescent patients.
Naproxen and esomeprazole magnesium delayed-release tablets, a combination of naproxen and esomeprazole magnesium, is indicated in adult and adolescent patients 12 years of age and older weighing at least 38 kg, requiring naproxen for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk for developing naproxen-associated gastric ulcers.
The esomeprazole magnesium component of naproxen and esomeprazole magnesium delayed-release tablet is indicated to decrease the risk of developing naproxen-associated gastric ulcers.
Naproxen and esomeprazole magnesium delayed-release tablets are not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.
---
Naprelan,Naproxen,Naproxen Sodium,Sumatriptan and Naproxen Sodium|9TN87S3A3C|
# Naproxen Sodium Summary
bursitis Naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: acute gout the management of: rheumatoid arthritis (RA) Naproxen sodium tablets are indicated for: pain ankylosing spondylitis osteoarthritis tendinitis, bursitis Naproxen Sodium Controlled-Release Tablets are indicated for the treatment of: Naproxen sodium tablets are also indicated for: Naproxen tablets is also indicated for: the relief of signs and symptoms of: Polyarticular Juvenile Idiopathic Arthritis ankylosing spondylitis (AS) primary dysmenorrhea Use only if a clear diagnosis of migraine headache has been established.
rheumatoid arthritis NAPRELAN Tablets are indicated for the treatment of: [see Warnings and Precautions ( 5 )] .
---
Nateglinide|41X3PWK4O2|
# Nateglinide Summary
Nateglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations: Limitations of Use : Nateglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
---
Nefazodone Hydrochloride|27X63J94GR|
# Nefazodone Hydrochloride Summary
Nefazodone hydrochloride tablets are indicated for the treatment of depression.
The efficacy of nefazodone in the treatment of depression was established in 6 to 8 week controlled trials of outpatients and in a 6 week controlled trial of depressed inpatients whose diagnoses corresponded most closely to the DSM-III or DSM-IIIR category of major depressive disorder (see CLINICAL PHARMACOLOGY ).
---
Arranon,NELARABINE|60158CV180|
# Nelarabine Summary
Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
ARRANON is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
---
MAXITROL,Neomycin and Polymyxin B Sulfates,Neomycin and Polymyxin B Sulfates and Dexamethasone,Neomycin and Polymyxin B Sulfates and Hydrocortisone,Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension,Neomycin Polymyxin B Sulfates and Dexamethasone,neomycin sulfate, polymyxin b sulfate and dexamethasone,Polymyxin B,Polymyxin B Sulfate and Trimethoprim,polymyxin b sulfate|19371312D4|
# Polymyxin B Sulfate Summary
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.
Acute Infections Caused by Susceptible Strains of Pseudomonas aeruginosa Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation.
---
Cortisporin TC,MAXITROL,Neomycin and Polymyxin B Sulfates,Neomycin and Polymyxin B Sulfates and Dexamethasone,Neomycin and Polymyxin B Sulfates and Hydrocortisone,Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension,Neomycin Polymyxin B Sulfates and Dexamethasone,Neomycin Sulfate,neomycin sulfate, polymyxin b sulfate and dexamethasone|057Y626693|
# Neomycin Sulfate Summary
A three-way closed catheter system with constant neomycin-polymyxin B bladder rinse is indicated to prevent the development of infection while using indwelling catheters.
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation.
---
NESACAINE,chloroprocaine hydrochloride|LT7Z1YW11H|
# Chloroprocaine Hydrochloride Summary
Nesacaine 1% and 2% Injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block.
Nesacaine-MPF 2% and 3% Injections, in single dose vials without preservative and without EDTA, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks.
---
nevirapine|99DK7FVK1H|
# Nevirapine Summary
Nevirapine tablet is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 15 days and older [see Clinical Studies (14.1 , 14.2) ] .
Limitations: Limitations of Use:
---
Nexletol,Nexlizet,bempedoic acid|1EJ6Z6Q368|
# Bempedoic Acid Summary
Bempedoic acid, a component of NEXLIZET, is indicated: NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated: to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or coronary revascularization) in adults at increased risk for these events who are unable to take recommended statin therapy (including those not taking a statin).
NEXLETOL is indicated: as an adjunct to diet and exercise, in combination with other low-density lipoprotein cholesterol (LDL-C) lowering therapies or alone when concomitant LDL-C lowering therapy is not possible, to reduce LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).
---
NEXOBRID,anacaulase-bcdb|JD24M53P9U|
# Anacaulase-Bcdb Summary
Limitations: Circumferential burns NEXOBRID is not recommended for: Limitations of Use Burns on the feet of patients with diabetes mellitus or on the feet of patients with occlusive vascular disease Burns on the face, perineum, or genitalia Burns in patients with significant cardiopulmonary disease, including inhalation injury NEXOBRID is indicated for eschar removal in adults and pediatric patients with deep partial thickness (DPT) and/or full thickness (FT) thermal burns.
Chemical or electrical burns Treatment of burn wounds where medical devices (e.g., implants, pacemakers, shunts) or vital structures (e.g., large vessels) could become exposed during eschar removal.
The safety and effectiveness of NEXOBRID have not been established for treatment of:
---
Ngenla,somatrogon|6D848RA61B|
# Somatrogon Summary
NGENLA is indicated for the treatment of pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of endogenous growth hormone.
---
NIACIN|2679MF687A|
# Niacin Summary
Niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.
Niacin extended-release tablets are indicated to reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia.
In patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction.
Niacin is also indicated as adjunctive therapy for treatment of adult patients with severe hypertriglyceridemia who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them.
---
NICARDIPINE HYDROCHLORIDE|K5BC5011K3|
# Nicardipine Hydrochloride Summary
Nicardipine hydrochloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.
---
Nifedipine|I9ZF7L6G2L|
# Nifedipine Summary
Nifedipine extended-release tablets are indicated for the treatment of hypertension.
Nifedipine extended-release tablets, USP are indicated for the treatment of hypertension.
Nifedipine extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
NIKTIMVO,axatilimab|R96Z451BMC|
# Axatilimab Summary
NIKTIMVO is indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg.
---
Nilutamide|51G6I8B902|
# Nilutamide Summary
Metastatic Prostate Cancer Nilutamide tablets are indicated for use in combination with surgical castration for the treatment of metastatic prostate cancer (Stage D 2 ).
---
Nimodipine|57WA9QZ5WH|
# Nimodipine Summary
Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).
---
NINLARO,ixazomib citrate|46CWK97Z3K|
# Ixazomib Citrate Summary
NINLARO is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
---
Nipent,pentostatin|395575MZO7|
# Pentostatin Summary
NIPENT is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.
---
Nisoldipine|4I8HAB65SZ|
# Nisoldipine Summary
Nisoldipine extended-release tablets are indicated for the treatment of hypertension.
---
Nitisinone|K5BN214699|
# Nitisinone Summary
Nitisinone capsules are indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
---
Macrobid,NITROFURANTOIN,Nitrofurantoin (monohydrate/macrocrystals),nitrofurantoin macrocrystals,Nitrofurantoin Oral Suspension|927AH8112L|
# Nitrofurantoin Summary
Nitrofurantoin capsules (monohydrate/macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus.
Nitrofurantoin capsules (macrocrystals) are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli , enterococci, Staphylococcus aureus , and certain susceptible strains of Klebsiella and Enterobacter species.
Limitations: Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
Nitrofurantoin oral suspension is indicated in adults and pediatric patients 1 month of age and older for the treatment of urinary tract infections due to susceptible strains of Escherichia coli, Enterococcus species, Staphylococcus aureus, Klebsiella species and Enterobacter species .
---
Macrobid,Nitrofurantoin,Nitrofurantoin (monohydrate/macrocrystals),nitrofurantoin monohydrate|E1QI2CQQ1I|
# Nitrofurantoin Monohydrate Summary
Limitations: Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
Nitrofurantoin Capsules, USP (monohydrate/macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus .
Nitrofurantoin capsules (monohydrate/macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus .
Nitrofurantoin (monohydrate/macrocrystals) is indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus.
---
NITRO-BID,NITRO-TIME,NITROGLYCERIN|G59M7S0WS3|
# Nitroglycerin Summary
Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.
Nitroglycerin ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
INDICATIONS AND USAGE: Nitroglycerin Extended-Release Capsules are indicated for the prevention of angina pectoris due to coronary artery disease.
Nitroglycerin Injection is indicated for treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and β -blockers; and for induction of intraoperative hypotension.
---
Ampicillin,Calcium Gluconate in Sodium Chloride,Midazolam in Sodium Chloride,Norepinephrine,natural latex rubber|2LQ0UUW8IN|
# Natural Latex Rubber Summary
Norepinephrine in Sodium Chloride Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension.
Limitations: Limitations of Use The safety of Calcium Gluconate in Sodium Chloride Injection for long term use has not been established.
Midazolam in 0.9% Sodium Chloride Injection is indicated: Calcium Gluconate in Sodium Chloride Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
Ampicillin for Injection, USP is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: Respiratory Tract Infections caused by S.
---
Norepinephrine,NOREPINEPHRINE BITARTRATE|IFY5PE3ZRW|
# Norepinephrine Bitartrate Summary
Norepinephrine Bitartrate Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension.
Norepinephrine in Sodium Chloride Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension.
---
DISOPYRAMIDE PHOSPHATE,Norpace,Norpace CR|N6BOM1935W|
# Disopyramide Phosphate Summary
Disopyramide phosphate capsules are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Norpace and Norpace CR are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Treatment of patients with asymptomatic ventricular premature contractions should be avoided.
---
Nortriptyline HCL,Nortriptyline Hydrochloride,PAMELOR|00FN6IH15D|
# Nortriptyline Hydrochloride Summary
Nortriptyline hydrochloride capsules are indicated for the relief of symptoms of depression.
Nortriptyline hydrochloride, USP is indicated for the relief of symptoms of depression.
Pamelor™ (nortriptyline HCl) is indicated for the relief of symptoms of depression.
---
Norvir,Ritonavir|O3J8G9O825|
# Ritonavir Summary
NORVIR tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
NORVIR oral powder is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection.
---
Novarel,chorionic gonadotropin|20ED16GHEB|
# Chorionic Gonadotropin Summary
HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY.
---
GENOSYL,INOMAX,Noxivent 102,nitric oxide|31C4KY9ESH|
# Nitric Oxide Summary
Noxivent™ is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (&gt;34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
GENOSYL ® is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (&gt;34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
---
NP Thyroid 120,NP Thyroid 15,NP Thyroid 30,NP Thyroid 60,NP Thyroid 90,liothyronine|06LU7C9H1V|
# Liothyronine Summary
NP Thyroid ® tablets (thyroid tablets, USP) are indicated: 2.
NP Thyroid® tablets (thyroid tablets, USP) are indicated:
---
NP Thyroid 120,NP Thyroid 15,NP Thyroid 30,NP Thyroid 60,NP Thyroid 90,levothyroxine|Q51BO43MG4|
# Levothyroxine Summary
NP Thyroid ® tablets (thyroid tablets, USP) are indicated: NP Thyroid® tablets (thyroid tablets, USP) are indicated:
---
Hyoscyamine Sulfate,Hyoscyamine Sulfate ODT,Hyoscyamine Sulfate SL,Hyoscyamine Sulfate TAB,HyoscyamineER,Levbid,Levsin,LevsinSL,NuLev,Phenohytro,URELLE,UROGESIC BLUE|F2R8V82B84|
# Hyoscyamine Sulfate Summary
NuLev ® is indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis.
Hyoscyamine Sulfate Tablets USP are indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis.
NuLev ® is effective as adjunctive therapy in the treatment of peptic ulcer.
---
Etonogestrel and Ethinyl Estradiol,NUVARING,etonogestrel|304GTH6RNH|
# Etonogestrel Summary
NuvaRing ® is indicated for use by females of reproductive age to prevent pregnancy.
FOR VAGINAL USE ONLY Etonogestrel and ethinyl estradiol vaginal ring is indicated for use by females of reproductive age to prevent pregnancy.
---
Nystatin,Nystatin and Triamcinolone Acetonide,Nystop|BDF1O1C72E|
# Nystatin Summary
Nystatin cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
Limitations: This cream is not indicated for systemic, oral, intravaginal or ophthalmic use.
Nystatin Oral Suspension is indicated for the treatment of candidiasis in the oral cavity.
Nystatin and Triamcinolone Acetonide Cream and Ointment are indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.
Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
---
Juluca,ODEFSEY,rilpivirine hydrochloride|212WAX8KDD|
# Rilpivirine Hydrochloride Summary
ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 25 kg: to replace a stable antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies/mL) for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of ODEFSEY [see Microbiology (12.4) and Clinical Studies (14) ].
---
Biktarvy,ODEFSEY,tenofovir alafenamide fumarate|FWF6Q91TZO|
# Tenofovir Alafenamide Fumarate Summary
ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 25 kg: to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir [see Dosage and Administration (2.4) , and Use in Specific Populations (8.1) ].
---
Biktarvy,Efavirenz, emtricitabine and tenofovir disoproxil fumarate,emtricitabine,ODEFSEY|G70B4ETF4S|
# Emtricitabine Summary
with an antiretroviral treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir, or BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: Emtricitabine is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
---
ofloxacin,Ofloxacin Otic|A4P49JAZ9H|
# Ofloxacin Summary
Ofloxacin Otic Solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: Chronic Suppurative Otitis Media in patients 12 years and older with perforated tympanic membranes due to Proteus mirabilis , Pseudomonas aeruginosa, and Staphylococcus aureus .
Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: Otitis Externa in adults and pediatric patients, 6 months and older, due to Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.
---
Ohtuvayre,ensifentrine|3E3D8T1GIX|
# Ensifentrine Summary
OHTUVAYRE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
---
OJEMDA,tovorafenib|ZN90E4027M|
# Tovorafenib Summary
OJEMDA is indicated for the treatment of patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutation.
---
Benicar,Olmesartan Medoxomil,Olmesartan medoxomil Amlodipine and Hydrochlorothiazide,OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE|6M97XTV3HD|
# Olmesartan Medoxomil Summary
Limitations: Olmesartan medoxomil and hydrochlorothiazide tablet is not indicated for the initial therapy of hypertension.
Olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure [see Dosage and Administration ( 2 )] .
Limitations: Olmesartan medoxomil and hydrochlorothiazide tablets is not indicated for the initial therapy of hypertension.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
OMEGA-3-ACID ETHYL ESTERS|D87YGH4Z0Q|
# Omega-3-Acid Ethyl Esters Summary
Limitations: Limitations of Use: Omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (greater than or equal to 500 mg/dL) hypertriglyceridemia.
---
Omegaven,Smoflipid,fish oil|XGF7L72M0F|
# Fish Oil Summary
Omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC).
Limitations: Limitations of Use: Omegaven is not indicated for the prevention of PNAC.
SMOFlipid is indicated in adult and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
GaviLyte - CTM,Omeprazole and Sodium Bicarbonate,Sodium Bicarbonate|8MDF5V39QO|
# Sodium Bicarbonate Summary
Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis.
Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate.
But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself.
---
Omeprazole and Sodium Bicarbonate,omeprazole|KG60484QX9|
# Omeprazole Summary
Omeprazole and Sodium Bicarbonate capsules are indicated in adults for the : short-term treatment of active duodenal ulcer.
treatment of heartburn and other symptoms associated with GERD for up to 4 weeks.
---
ONAPGO,apomorphine hydrochloride|F39049Y068|
# Apomorphine Hydrochloride Summary
ONAPGO is indicated for the treatment of motor fluctuations in adults with advanced Parkinson's disease.
---
Ondansetron|4AF302ESOS|
# Ondansetron Summary
radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy Ondansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: Ondansetron orally disintegrating tablets also indicated for the prevention of postoperative nausea and/or vomiting.
Ondansetron is also indicated for the prevention of postoperative nausea and/or vomiting.
---
ondansetron,Ondansetron Hydrochloride|NMH84OZK2B|
# Ondansetron Hydrochloride Summary
radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting.
Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 .
Ondansetron oral solution is also indicated for the prevention of postoperative nausea and/or vomiting.
---
Onpattro,patisiran sodium|WO0YM16LKG|
# Patisiran Sodium Summary
ONPATTRO is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
---
Opium Tincture Deodorized,morphine|76I7G6D29C|
# Morphine Summary
Opium tincture is useful for the treatment of diarrhea.
---
ORKAMBI,ivacaftor|1Y740ILL1Z|
# Ivacaftor Summary
ORKAMBI is indicated for the treatment of cystic fibrosis (CF) in patients aged 1 year and older who are homozygous for the F508del mutation in the CFTR gene.
---
ORKAMBI,lumacaftor|EGP8L81APK|
# Lumacaftor Summary
ORKAMBI is indicated for the treatment of cystic fibrosis (CF) in patients aged 1 year and older who are homozygous for the F508del mutation in the CFTR gene.
---
Orladeyo,berotralstat hydrochloride|88SH1NBL2B|
# Berotralstat Hydrochloride Summary
ORLADEYO ® is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 2 years of age and older.
---
Dichlorphenamide,ORMALVI|VVJ6673MHY|
# Dichlorphenamide Summary
ORMALVI is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
---
Orphenadrine Citrate|X0A40N8I4S|
# Orphenadrine Citrate Summary
Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.
---
Osmitrol,mannitol|3OWL53L36A|
# Mannitol Summary
OSMITROL is indicated for: The reduction of intracranial pressure and treatment of cerebral edema; The reduction of elevated intraocular pressure.
---
Oxacillin,oxacillin sodium|G0V6C994Q5|
# Oxacillin Sodium Summary
Oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.
---
oxaliplatin|04ZR38536J|
# Oxaliplatin Summary
Oxaliplatin Injection, in combination with infusional fluorouracil and leucovorin, is indicated for: Oxaliplatin Injection USP, in combination with infusional fluorouracil and leucovorin, is indicated for: Oxaliplatin injection, in combination with infusional fluorouracil and leucovorin, is indicated for: • adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
treatment of advanced colorectal cancer.
adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
---
Oxaprozin|MHJ80W9LRB|
# Oxaprozin Summary
OXAPROZIN is indicated: For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis
---
Oxcarbazepine,OXTELLAR XR|VZI5B1W380|
# Oxcarbazepine Summary
Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.
Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.
---
Oxiconazole Nitrate,Oxistat|RQ8UL4C17S|
# Oxiconazole Nitrate Summary
Oxiconazole nitrate cream is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.
Oxiconazole nitrate cream is indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES ).
OXISTAT Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES ).
---
OXLUMO,lumasiran sodium|67P6XH37HD|
# Lumasiran Sodium Summary
OXLUMO is indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels in pediatric and adult patients [see Clinical Pharmacology (12.1) , Clinical Studies (14.1 , 14.2 , 14.3) ] .
---
OXYBUTYNIN CHLORIDE,Oxybutynin ChlorideExtended Release|L9F3D9RENQ|
# Oxybutynin Chloride Summary
Oxybutynin Chloride is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).
Oxybutynin chloride tablets, USP are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).
Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
---
ENDOCET,OXAYDO,OXYCODONE AND ACETAMINOPHEN,oxycodone hydrochloride,oxycodone hydrochloride and acetaminophen,Prolate|C1ENJ2TE6C|
# Oxycodone Hydrochloride Summary
Oxycodone Hydrochloride Oral Solution is indicated in adults for the management of pain severe enough to require an opioid-analgesic and for which alternative treatments are inadequate.
Oxycodone hydrochloride is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations of Use: Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration [see WARNINGS ] , reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): Oxycodone Hydrochloride Oral Solution is indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
---
OXYMORPHONE HYDROCHLORIDE|5Y2EI94NBC|
# Oxymorphone Hydrochloride Summary
Limitations: Limitations of Use: Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration [see Warnings and Precautions (5.1)] , and persist over the course of therapy, reserve opioid analgesics, including oxymorphone hydrochloride tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
Oxymorphone hydrochloride tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
---
Oxytocin|1JQS135EYN|
# Oxytocin Summary
Oxytocin injection (synthetic) is indicated to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage.
Oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons.
---
PADCEVEJFV,enfortumab vedotin|DLE8519RWM|
# Enfortumab Vedotin Summary
PADCEV ® , in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph, as neoadjuvant treatment and then continued after cystectomy as adjuvant treatment, is indicated for the treatment of adult patients with muscle invasive bladder cancer (MIBC) who are ineligible for cisplatin-containing chemotherapy.
have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or PADCEV ® , in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph, is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC).
PADCEV, as a single agent, is indicated for the treatment of adult patients with locally advanced or mUC who:
---
Paliperidone|838F01T721|
# Paliperidone Summary
Paliperidone extended-release tablets are indicated for the treatment of schizophrenia [see Clinical Studies (14.1) ].
Paliperidone extended-release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and/or antidepressant therapy [see Clinical Studies (14.2) ] .
---
Palonosetron Hydrochloride|23310D4I19|
# Palonosetron Hydrochloride Summary
Palonosetron hydrochloride injection is indicated in pediatric patients 1 month to less than 17 years of age for prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
Palonosetron hydrochloride injection is indicated in pediatric patients 1 month to less than 17 years of age for prevention of: acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy.
Palonosetron hydrochloride injection is indicated in adults for prevention of:
---
PALSONIFY,paltusotine hydrochloride|FZT5Z83JNS|
# Paltusotine Hydrochloride Summary
PALSONIFY is indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.
---
Palynziq,pegvaliase|N6UAH27EUV|
# Pegvaliase Summary
Palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management.
---
Panhematin,hemin|743LRP9S7N|
# Hemin Summary
Limitations: Limitations of Use PANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate.
---
PANRETIN,alitretinoin|1UA8E65KDZ|
# Alitretinoin Summary
Limitations: 1.1 Kaposi’s Sarcoma Limitations of Use: PANRETIN GEL is not indicated when systemic anti-KS therapy is required (including more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement) [see Clinical Studies ( 14.1 )] .
PANRETIN GEL is indicated for topical treatment of cutaneous lesions in adults with AIDS related Kaposi’s sarcoma (KS).
---
Paroxetine,PAROXETINE HYDROCHLORIDE,PAXIL,PAXIL CR|X2ELS050D8|
# Paroxetine Hydrochloride Summary
Generalized anxiety disorder (GAD) Major depressive disorder (MDD) Paroxetine HCL CR is indicated in adults for the treatment of: Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Obsessive compulsive disorder (OCD) PAXIL is indicated in adults for the treatment of: Panic disorder (PD) Paroxetine tablets are indicated in adults for the treatment of: PAXIL CR is indicated in adults for the treatment of: Premenstrual dysphoric disorder (PMDD)
---
PAROXETINE,paroxetine hydrochloride anhydrous|3I3T11UD2S|
# Paroxetine Hydrochloride Anhydrous Summary
Generalized anxiety disorder (GAD) Obsessive compulsive disorder (OCD) Social anxiety disorder (SAD) Paroxetine tablets are indicated in adults for the treatment of: Major depressive disorder (MDD) Posttraumatic stress disorder (PTSD) Panic disorder (PD)
---
PaxLyte,magnesium ascorbate|0N1G678593|
# Magnesium Ascorbate Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,sodium citrate, unspecified form|1Q73Q2JULR|
# Sodium Citrate, Unspecified Form Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
Biopar delta-FORTE,PaxLyte,levomefolate magnesium|1VZZ62R081|
# Levomefolate Magnesium Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,magnesium l-threonate|1Y26ZZ0OTM|
# Magnesium L-Threonate Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,phosphatidyl serine|394XK0IH40|
# Phosphatidyl Serine Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,betaine|3SCV180C9W|
# Betaine Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,nadh|4J24DQ0916|
# Nadh Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium|6WJM73T46K|
# 1,2-Docosahexanoyl-Sn-Glycero-3-Phosphoserine Calcium Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,ferrous cysteine glycinate|8B4OP7RK5N|
# Ferrous Cysteine Glycinate Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium|9ABD9DRK7B|
# 1,2-Icosapentoyl-Sn-Glycero-3-Phosphoserine Calcium Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,zinc ascorbate|9TI35313XW|
# Zinc Ascorbate Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
Biopar delta-FORTE,PaxLyte,cobamamide|F0R1QK73KB|
# Cobamamide Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,leucovorin|Q573I9DVLP|
# Leucovorin Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,cocarboxylase|Q57971654Y|
# Cocarboxylase Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
PaxLyte,flavin adenine dinucleotide|ZC44YTI8KK|
# Flavin Adenine Dinucleotide Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,.alpha.-tocopherol acetate|9E8X80D2L0|
# .Alpha.-Tocopherol Acetate Summary
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
---
PEG-3350, Electrolytes, and Ascorbate,Pouch A,sodium sulfate|0YPR65R21J|
# Sodium Sulfate Summary
Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
---
Adult Infuvite Multiple Vitamins,Ascor,Embriva,Multivitamin with Fluoride,Pediatric Infuvite Multiple Vitamins,PEG-3350, Electrolytes, and Ascorbate,Pouch B,Virexa,ascorbic acid|PQ6CK8PD0R|
# Ascorbic Acid Summary
Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
Limitations: ASCOR is not indicated for treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy.
Prenatal and Postnatal prescriptive Folic Acid INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
ASCOR is vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administration is not possible, insufficient or contraindicated.
---
pemgarda,pemivibart|557S3L3FAP|
# Pemivibart Summary
Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product PEMGARDA (pemivibart) for the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents (12 years of age and older weighing at least 40 kg): Declared that circumstances exist justifying the authorization of emergency use of drugs and biological products for the prevention or treatment of COVID-19 .
---
Penciclovir|359HUE8FJC|
# Penciclovir Summary
Penciclovir cream, 1% is a deoxynucleoside analog HSV DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age or older.
---
Penicillin V Potassium|146T0TU1JB|
# Penicillin V Potassium Summary
Penicillin V potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin G-sensitive microorganisms.
Medical conditions in which oral penicillin therapy is indicated as prophylaxis: For the prevention of recurrence following rheumatic fever and/or chorea: Prophylaxis with oral penicillin on a continuing basis has proven effective in preventing recurrence of these conditions.
Penicillin V potassium tablets and penicillin V potassium for oral solution are indicated in the treatment of mild to moderately severe infections due to penicillin G-sensitive microorganisms.
---
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,pentazocine hydrochloride|A36BXO4PPX|
# Pentazocine Hydrochloride Summary
Pentazocine and Naloxone Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Limitations: Limitations of Use
Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy, reserve opioid analgesics, including Pentazocine and Naloxone Tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
---
PENTOXIFYLLINE|SD6QCT3TSU|
# Pentoxifylline Summary
Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs.
---
Kabiven,Perikabiven,tyrosine|42HK56048U|
# Tyrosine Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
Kabiven,Perikabiven,methionine|AE28F7PNPL|
# Methionine Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
Kabiven,Perikabiven,lysine hydrochloride|JNJ23Q2COM|
# Lysine Hydrochloride Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Magnesium Sulfate,Magnesium Sulfate in Water,Perikabiven,magnesium sulfate heptahydrate|SK47B8698T|
# Magnesium Sulfate Heptahydrate Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively.
Limitations: Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Kabiven,Perikabiven,glycine|TE7660XO1C|
# Glycine Summary
PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Limitations: Limitations of Use:
KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] .
---
Permethrin|509F88P9SZ|
# Permethrin Summary
Permethrin Cream 5% w/w is indicated for the treatment of infestation with Sarcoptesscabiei (scabies).
Permethrin Cream, 5% is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).
Permethrin cream is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).
---
Perphenazine,Perphenazine and Amitriptyline Hydrochloride|FTA7XXY4EZ|
# Perphenazine Summary
Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults.
Perphenazine and amitriptyline hydrochloride tablets are recommended for treatment of (1) patients with moderate to severe anxiety and/or agitation and depressed mood, (2) patients with depression in whom anxiety and/or agitation are severe, and (3) patients with depression and anxiety in association with chronic physical disease.
---
PHEBURANE,sodium phenylbutyrate|NT6K61736T|
# Sodium Phenylbutyrate Summary
Limitations: PHEBURANE is not indicated for the treatment of acute hyperammonemia, which can be a life-threatening medical emergency that requires rapid acting interventions to reduce plasma ammonia levels.
Limitations: Limitations of Use PHEBURANE is indicated as adjunctive therapy to standard of care, which includes dietary management, for the chronic management of adult and pediatric patients with urea cycle disorders (UCDs), involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC) or argininosuccinic acid synthetase (AS).
---
Phenazopyridine Hydrochloride|0EWG668W17|
# Phenazopyridine Hydrochloride Summary
Phenazopyridine Hydrochloride is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
Phenazopyridine HCl is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
---
Phendimetrazine Tartrate|6985IP0T80|
# Phendimetrazine Tartrate Summary
Phendimetrazine tartrate is indicated for use as monotherapy only.
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
---
Phenobarbital,Phenobarbital Oral Solution,Phenohytro|YQE403BP4D|
# Phenobarbital Summary
Phenobarbital Tablets, USP are indicated for use as a sedative or anticonvulsant.
Anticonvulsant – For the treatment of generalized and partial seizures.
Anticonvulsant - For the treatment of generalized and partial seizures.
---
Phenobarbital Sodium|SW9M9BB5K3|
# Phenobarbital Sodium Summary
Phenobarbital is indicated in pediatric patients as an anticonvulsant and as a sedative, including its preoperative and postoperative use.
Hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see CLINICAL PHARMACOLOGY ).
Phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract.
---
Phenohytro,scopolamine hydrobromide|451IFR0GXB|
# Scopolamine Hydrobromide Summary
Based on the National Academy of Sciences-National Research Council's review of this drug and/or other information, FDA has classified the following indications as "possibly" effective: For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
May also be useful as adjunctive therapy in the treatment of duodenal ulcer.
---
LOMAIRA,Phentermine Hydrochloride,Qsymia|0K2I505OTV|
# Phentermine Hydrochloride Summary
Phentermine hydrochloride tablets, USP is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥30 kg/m 2 , or ≥27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia).
---
PHENYLEPHRINE HYDROCHLORIDE|04JA59TNSJ|
# Phenylephrine Hydrochloride Summary
Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%, is indicated to dilate the pupil.
Phenylephrine hydrochloride Injection, 10 mg/mL is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
Phenylephrine Hydrochloride Ophthalmic Solution 2.5% and 10%, is indicated to dilate the pupil.
---
Phenytoin,Phenytoin Infatabs|6158TKW0C5|
# Phenytoin Summary
Phenytoin oral suspension is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures.
Phenytoin chewable tablets are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
Phenytoin Infatabs are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
---
DILANTIN,Extended Phenytoin Sodium,Phenytoin Sodium|4182431BJH|
# Phenytoin Sodium Summary
Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
DILANTIN is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and prevention and treatment of seizures occurring during neurosurgery.
---
Photrexa,Photrexa Cross-linking Kit,Photrexa Viscous,riboflavin 5'-phosphate sodium anhydrous|957E53WV42|
# Riboflavin 5'-Phosphate Sodium Anhydrous Summary
PHOTREXA ® VISCOUS and PHOTREXA ® are indicated for use in corneal collagen cross-linking in combination with the KXL ® System for the treatment of
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,Phytonadione|A034SE7857|
# Phytonadione Summary
hypoprothrombinemia secondary to antibacterial therapy; prophylaxis and therapy of hemorrhagic disease of the newborn; Phytonadione tablets are indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.
Phytonadione Injectable Emulsion is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.
---
Piasky,crovalimab|H9KH1GP3UU|
# Crovalimab Summary
PIASKY is indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.
---
PIFELTRO,doravirine|913P6LK81M|
# Doravirine Summary
PIFELTRO ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:
---
Pilocarpine Hydrochloride,Pilocarpine Hydrochloride Ophthalmic|0WW6D218XJ|
# Pilocarpine Hydrochloride Summary
Pilocarpine hydrochloride ophthalmic solution, is indicated for the: Pilocarpine hydrochloride ophthalmic solution is indicated for the treatment of presbyopia in adults.
---
Pimecrolimus|7KYV510875|
# Pimecrolimus Summary
Limitations: Pimecrolimus Cream, 1% is not indicated for use in children less than 2 years of age [see Warnings and Precautions (5.1) , Use in Specific Populations (8.4) ] .
Pimecrolimus Cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable.
---
PIMTREA,desogestrel|81K9V7M3A3|
# Desogestrel Summary
PIMTREA TM (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
---
Pindolol|BJ4HF6IU1D|
# Pindolol Summary
Pindolol tablets are indicated in the management of hypertension.
---
Alogliptin and Pioglitazone,Pioglitazone,pioglitazone and glimepiride,Pioglitazone and metformin hydrochloride,PIOGLITAZONE HYDROCHLORIDE|JQT35NPK6C|
# Pioglitazone Hydrochloride Summary
Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] .
Limitations: Important Limitations of Use Pioglitazone tablets exert its antihyperglycemic effect only in the presence of endogenous insulin.
Limitations: Limitations of Use Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] .
---
Pirfenidone|D7NLD2JX7U|
# Pirfenidone Summary
Pirfenidone tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
Pirfenidone capsules are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
---
pitavastatin calcium|IYD54XEG3W|
# Pitavastatin Calcium Summary
Pitavastatin tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: • Adults with primary hyperlipidemia.
---
Plegridy,peginterferon beta-1a|I8309403R0|
# Peginterferon Beta-1A Summary
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
PLUVICTO,lutetium lu-177 vipivotide tetraxetan|G6UF363ECX|
# Lutetium Lu-177 Vipivotide Tetraxetan Summary
PLUVICTO is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy, and have received prior taxane-based chemotherapy.
---
Polymyxin B Sulfate and Trimethoprim,trimethoprim sulfate|E377MF8EQ8|
# Trimethoprim Sulfate Summary
Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Haemophilus influenzae and Pseudomonas aeruginosa.
---
PONVORY,ponesimod|5G7AKV2MKP|
# Ponesimod Summary
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
Positive Skin Test Control - Histamine,histamine|820484N8I3|
# Histamine Summary
Positive Skin Test Control - Histamine is indicated as an adjunct in allergy skin test for diagnosis, as a positive control to test wheal-flare response of skin for evaluation of skin test response to allergenic extracts.
---
POSLUMA,flotufolastat f-18|811W19E3OL|
# Flotufolastat F-18 Summary
POSLUMA is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer
---
GaviLyte - CTM,Kabiven,KLOR-CON,LACTATED RINGER,Lactated Ringers,Lactated Ringers and Dextrose,PEG-3350, Electrolytes, and Ascorbate,Perikabiven,Potassium Chloride,Potassium Chloride ER,POTASSIUM CHLORIDE EXTENDED RELEASE,Potassium Chloride Extended-Release,Potassium Chloride for Oral Solution,Potassium Chloride in Lactated Ringers and Dextrose,Potassium ChlorideExtended-Release,Pouch A,Ringers|660YQ98I10|
# Potassium Chloride Summary
Potassium chloride oral solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.
Potassium Chloride in Lactated Ringer’s and Dextrose (5%) Injection is indicated for use as a source of water, electrolytes, and calories or as an alkalinizing agent in adults and pediatric patients.
Potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.
---
Potassium Phosphates,potassium phosphate, dibasic|CI71S98N1Z|
# Potassium Phosphate, Dibasic Summary
Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated.
Potassium Phosphates Injection is indicated as a source of phosphorus:
in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated.
for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated.
---
POTASSIUM PHOSPHATES,potassium phosphate, monobasic|4J9FJ0HL51|
# Potassium Phosphate, Monobasic Summary
Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated.
Potassium Phosphates Injection is indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated.
for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated.
---
Praluent,alirocumab|PP0SHH6V16|
# Alirocumab Summary
PRALUENT ® is indicated: As an adjunct to other LDL-C-lowering therapies in adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
---
PRAVASTATIN SODIUM|3M8608UQ61|
# Pravastatin Sodium Summary
Pravastatin sodium tablets are indicated: To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD.
As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia.
---
Prazosin Hydrochloride|X0Z7454B90|
# Prazosin Hydrochloride Summary
Prazosin Hydrochloride Capsules, USP is indicated for the treatment of hypertension, to lower blood pressure.
Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure.
Prazosin hydrochloride capsules is indicated for the treatment of hypertension, to lower blood pressure.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
Prednisolone|9PHQ9Y1OLM|
# Prednisolone Summary
Edematous States During an exacerbation or as maintenance therapy in selected cases of: In addition to the above indications prednisolone oral solution is indicated for systemic dermatomyositis (polymyositis).
Miscellaneous Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer Prednisolone Oral Solution, USP is indicated in the following conditions: 4.
---
PRED MILD,PREDNISOLONE ACETATE|8B2807733D|
# Prednisolone Acetate Summary
Prednisolone acetate ophthalmic suspension is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
PRED MILD ® is indicated for the treatment of mild to moderate noninfectious allergic and inflammatory disorders of the lid, conjunctiva, cornea, and sclera (including chemical and thermal burns).
---
Prednisolone Sodium Phosphate,Prednisolone Sodium Phosphate Oral Solution,prednisolone sodium phosphateODT|IV021NXA9J|
# Prednisolone Sodium Phosphate Summary
Prednisolone Sodium Phosphate Oral Solution (15 mg Prednisolone per 5 mL) are indicated in the following conditions: To tide the patient over a critical period of the disease in: ulcerative colitis; regional enteritis.
Allergic States Prednisolone sodium phosphate oral solution is indicated in the following conditions: Symptomatic sarcoidosis; idiopathic eosinophilic pneumonias; fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy; asthma (as distinct from allergic asthma listed above under “Allergic States”), hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, acute exacerbations of chronic obstructive pulmonary disease (COPD), and Pneumocystis carinii pneumonia (PCP) associated with hypoxemia occurring in an HIV (+) individual who is also under treatment with appropriate anti-PCP antibiotics.
---
Prednisone,Prednisone delayed release,PredniSONE Tablets, USP, 10 mg,PredniSONE Tablets, USP, 20 mg,PredniSONE Tablets, USP, 5 mg|VB0R961HZT|
# Prednisone Summary
Respiratory Diseases During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus Systemic dermatomyositis (polymyositis) Acute rheumatic carditis Rheumatic Disorders Keratitis Prednisone tablets are indicated in the following conditions: Ankylosing spondylitis Trichinosis with neurologic or myocardial involvement 11.
Allergic conjunctivitis Acute and subacute bursitis Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional Prednisone Tablets, USP are indicated in the following conditions: Chorioretinitis Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: allergic corneal marginal ulcers, herpes zoster ophthalmicus, anterior segment inflammation, diffuse posterior uveitis and choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, chorioretinitis, optic neuritis, iritis and iridocyclitis.
---
Lyrica,Lyrica CR,Pregabalin|55JG375S6M|
# Pregabalin Summary
Adjunctive therapy for the treatment of partial-onset seizures in patients 1month of age and older Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Pregabalin capsules are indicated for: Management of neuropathic pain associated with spinal cord injury Management of postherpetic neuralgia Pregabalin capsules are indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia • Management of...
---
Pregnyl,choriogonadotropin alfa|6413W06WR3|
# Choriogonadotropin Alfa Summary
HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY.
---
PREZCOBIX,PREZISTA,darunavir ethanolate|33O78XF0BW|
# Darunavir Ethanolate Summary
PREZCOBIX is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) in treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 25 kg with no darunavir resistance-associated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V).
PREZISTA, co-administered with ritonavir (PREZISTA/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adult and pediatric patients 3 years of age and older [see Use in Specific Populations (8.4) and Clinical Studies (14) ] .
---
PREZCOBIX,cobicistat|LW2E03M5PG|
# Cobicistat Summary
PREZCOBIX is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) in treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 25 kg with no darunavir resistance-associated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V).
---
Primaquine Phosphate|H0982HF78B|
# Primaquine Phosphate Summary
Primaquine phosphate Tablets are indicated for the radical cure (prevention of relapse) of vivax malaria.
Primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria.
---
Primidone|13AFD7670Q|
# Primidone Summary
Primidone tablets used alone or concomitantly with other anticonvulsants, are indicated in the control of grand mal, psychomotor, and focal epileptic seizures.
Primidone, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures.
---
Probenecid|PO572Z7917|
# Probenecid Summary
Probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis.
---
Procainamide Hydrochloride|SI4064O0LX|
# Procainamide Hydrochloride Summary
(see WARNINGS and Boxed Warning.) Procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening.
Treatment of patients with asymptomatic ventricular premature contractions should be avoided.
---
PROCHLORPERAZINE MALEATE|I1T8O1JTL6|
# Prochlorperazine Maleate Summary
When used in the treatment of non-psychotic anxiety, prochlorperazine maleate tablets should not be administered at doses of more than 20 mg per day or for longer than 12 weeks because the use of prochlorperazine maleate tablets at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see WARNINGS ).
For the treatment of schizophrenia.
---
PROGESTERONE,Progesterone vaginal insert|4G7DS2Q64Y|
# Progesterone Summary
Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.
They are also indicated for use in secondary amenorrhea.
Progesterone vaginal insert is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.
---
Promethazine Hydrochloride,Promethazine Hydrochloride and Dextromethorphan Hydrobromide,Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution|R61ZEH7I1I|
# Promethazine Hydrochloride Summary
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.
Promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.
Promethazine hydrochloride injection is indicated for the following conditions: Intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia.
Active and prophylactic treatment of motion sickness.
Active treatment of motion sickness.
---
AUVELITY,Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide,Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide,Promethazine Hydrochloride and Dextromethorphan Hydrobromide,Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,dextromethorphan hydrobromide|9D2RTI9KYH|
# Dextromethorphan Hydrobromide Summary
Promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.
AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.
---
Propafenone Hydrochloride|33XCH0HOCD|
# Propafenone Hydrochloride Summary
Propafenone Hydrochloride Tablets are indicated to: Some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate.
Propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.
---
Proparacaine Hydrochloride|U96OL57GOY|
# Proparacaine Hydrochloride Summary
Proparacaine Hydrochloride Ophthalmic Solution is indicated for topical anesthesia in ophthalmic practice.
Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction.
Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g.
---
Diprivan,Propofol|YI7VU623SF|
# Propofol Summary
Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age Propofol Injectable Emulsion is an intravenous general anesthetic and sedation drug indicated for: Sedation for Adult Patients in Combination with Regional Anesthesia Intensive Care Unit (ICU) Sedation of Intubated, Mechanically Ventilated Adult Patients Safety, effectiveness and dosing guidelines for propofol injectable emulsion have not been established for MAC sedation in the pediatric population; therefore, it is not recommended for this use [see Pediatric Use (8.4) ] .
Limitations: Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation in Adult Patients DIPRIVAN is not indicated for use in Pediatric ICU sedation since the safety of this regimen has not been established [see Pediatric Use ( 8.4 )].
---
Propranolol,Propranolol Hydrochloride|F8A3652H1V|
# Propranolol Hydrochloride Summary
Hypertension Myocardial Infarction Migraine Propranolol hydrochloride tablets are indicated in the management of hypertension.
Limitations: Propranolol hydrochloride is not indicated in the management of hypertensive emergencies.
Angina Pectoris Due to Coronary Atherosclerosis Essential Tremor Intravenous propranolol is indicated for the short-term treatment of supraventricular tachycardia, including Wolff-Parkinson-White syndrome and thyrotoxicosis, to decrease ventricular rate.
The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use.
Propranolol is not indicated for the treatment of tremor associated with Parkinsonism.
---
Pantoprazole,Pantoprazole Sodium,Pantoprazole sodium delayed-release,ProtonixI.V.|6871619Q5X|
# Pantoprazole Sodium Summary
Pantoprazole sodium delayed-release tablets are indicated for: pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults.
Pantoprazole sodium for injection is indicated for treatment of: PROTONIX I.V.
Limitations: is indicated for treatment of: Limitations of Use Pantoprazole Sodium Delayed-Release Tablets, USP are indicated for: The safety and effectiveness of pantoprazole sodium for injection for the treatment of upper gastrointestinal bleeding have not been established in adult or pediatric patients.
for the treatment of upper gastrointestinal bleeding have not been established in adult or pediatric patients.
---
Prucalopride|0A09IUW5TP|
# Prucalopride Summary
Prucalopride tablet is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
---
Prucalopride,Prucalopride succinate|4V2G75E1CK|
# Prucalopride Succinate Summary
Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
Prucalopride tablet is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
---
Purified Cortrophin Gel,corticotropin|K0U68Q2TXA|
# Corticotropin Summary
Purified Cortrophin Gel is indicated in the following disorders: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic conjunctivitis.
---
Pyrazinamide|2KNI5N06TI|
# Pyrazinamide Summary
It is possible these patients may require a longer course of treatment.) Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
(The current recommendation of the CDC for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.
---
Pyridostigmine Bromide|KVI301NA53|
# Pyridostigmine Bromide Summary
Pyridostigmine bromide is useful in the treatment of myasthenia gravis.
Pyridostigmine Bromide Tablets USP are useful in the treatment of myasthenia gravis.
---
QELBREE,viloxazine hydrochloride|OQW30I1332|
# Viloxazine Hydrochloride Summary
Qelbree is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
---
Qfitlia,fitusiran|SV9W47ZLE1|
# Fitusiran Summary
QFITLIA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without factor VIII or IX inhibitors.
---
QIVIGY kthm,human immunoglobulin g|66Y330CJHS|
# Human Immunoglobulin G Summary
QIVIGY (immune globulin intravenous, human-kthm) 10% solution is indicated for the treatment of adults with Primary Humoral Immunodeficiency (PI).
---
Qsymia,Topiramate|0H73WJJ391|
# Topiramate Summary
Adults and pediatric patients aged 12 years and older with obesity 1.1 Monotherapy Epilepsy Topiramate extended-release capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older.
Topiramate extended-release capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older.
---
Quetiapine Fumarate ER,quetiapine fumarate|2S3PL1B6UJ|
# Quetiapine Fumarate Summary
Quetiapine extended-release tablets are indicated for the acute treatment of depressive episodes associated with bipolar disorder.
Medication treatment for both pediatric schizophrenia and bipolar I disorder is indicated as part of a total treatment program that often includes psychological, educational and social interventions.
Quetiapine extended-release tablets are indicated for use as adjunctive therapy to antidepressants for the treatment of MDD.
1.4 Special Considerations in Treating Pediatric Schizophrenia and Bipolar I Disorder Quetiapine extended-release tablets are indicated for the maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex.
The effectiveness of monotherapy for the maintenance treatment of bipolar I disorder has not been systematically evaluated in controlled clinical trials [see Clinical Studies (14.2) ].
---
Quinine Sulfate|KF7Z0E0Q2B|
# Quinine Sulfate Summary
Limitations: Limitations of Use: Quinine sulfate capsules are not approved for:
Quinine sulfate capsules are an antimalarial drug indicated only for treatment of uncomplicated Plasmodium falciparum malaria.
Treatment of severe or complicated P.
---
QVAR REDIHALER,beclomethasone dipropionate|5B307S63B2|
# Beclomethasone Dipropionate Summary
Limitations: Limitations of Use: QVAR REDIHALER is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older.
Limitations: QVAR REDIHALER is not indicated for the relief of acute bronchospasm.
---
Ramelteon|901AS54I69|
# Ramelteon Summary
Ramelteon Tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset.
---
RANITIDINE,ranitidine hydrochloride|BK76465IHM|
# Ranitidine Hydrochloride Summary
Ranitidine Tablets are indicated in:
Treatment of GERD.
Treatment of endoscopically diagnosed erosive esophagitis.
---
RANOLAZINE|A6IEZ5M406|
# Ranolazine Summary
Ranolazine extended-release tablets are indicated for the treatment of chronic angina.
---
Azilect,Rasagiline,rasagiline mesylate|LH8C2JI290|
# Rasagiline Mesylate Summary
Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD).
AZILECT (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).
Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD).
---
Ravicti,glycerol phenylbutyrate|ZH6F1VCV7B|
# Glycerol Phenylbutyrate Summary
RAVICTI is indicated for use as a nitrogen-binding agent for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.
Limitations: RAVICTI is not indicated for the treatment of acute hyperammonemia in patients with UCDs because more rapidly acting interventions are essential to reduce plasma ammonia levels.
Limitations: Limitations of Use: The safety and efficacy of RAVICTI for the treatment of N- acetylglutamate synthase (NAGS) deficiency has not been established.
---
RayaSal,salicylic acid|O414PZ4LPZ|
# Salicylic Acid Summary
For dermatologic Use For Podiatric Use RAYASAL is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae and the various ichthyoses, keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis. RAYASAL is a topical aid in removing excessive keratin on dorsal and plantar hyperkeratotic lesions.
---
AVONEX,Avonex Pen,Rebif,REBIF REBIDOSE,interferon beta-1a|XRO4566Q4R|
# Interferon Beta-1A Summary
REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
REDEMPLO,plozasiran|XG9ARL6P25|
# Plozasiran Summary
REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
---
Regadenoson|2XLN4Y044H|
# Regadenoson Summary
Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
---
Regadenoson,regadenoson anhydrous|7AXV542LZ4|
# Regadenoson Anhydrous Summary
Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
---
Regranex Gel 0.01%,becaplermin|1B56C968OA|
# Becaplermin Summary
Limitations: Limitations of Use: REGRANEX is not intended to be used in wounds that close by primary intention.
REGRANEX is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, when used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control.
---
Mirtazapine,REMERON,REMERONSOLTAB|A051Q2099Q|
# Mirtazapine Summary
REMERON/REMERONSolTab are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] .
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ].
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] .
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] .
Mirtazapine orally disintegrating tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ].
---
Repaglinide|668Z8C33LU|
# Repaglinide Summary
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
---
REPATHA,evolocumab|LKC0U3A8NJ|
# Evolocumab Summary
REPATHA is indicated:
---
RHAPSIDO,remibrutinib|I7MVZ8HDNU|
# Remibrutinib Summary
Limitations: RHAPSIDO is not indicated for other forms of urticaria.
RHAPSIDO ® is indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamine treatment.
Limitations: Limitations of Use:
---
Rhopressa,netarsudil mesylate|VL756B1K0U|
# Netarsudil Mesylate Summary
RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
---
Rifabutin|1W306TDA6S|
# Rifabutin Summary
Rifabutin capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
---
Rifampin|VJT6J7R4TR|
# Rifampin Summary
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type.
---
MAXALT,MAXALT-MLT,Rizatriptan,Rizatriptan Benzoate,SYMBRAVO|WR978S7QHH|
# Rizatriptan Benzoate Summary
Rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old.
Limitations: Limitations of Use Rizatriptan benzoate orally disintegrating tablets are not indicated for the prevention of migraine attacks.
Limitations: Rizatriptan benzoate orally disintegrating tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ] .
SYMBRAVO is not indicated for the treatment of cluster headache.
MAXALT is not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ] .
---
Rocuronium,ROCURONIUM BROMIDE|I65MW4OFHZ|
# Rocuronium Bromide Summary
Rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Rocuronium Bromide Injection is indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
---
ROFLUMILAST|0P6C6ZOP5U|
# Roflumilast Summary
Limitations: Limitations of Use Roflumilast Tablets are not a bronchodilator and is not indicated for the relief of acute bronchospasm.
Roflumilast Tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
Limitations: Roflumilast tablet is not a bronchodilator and is not indicated for the relief of acute bronchospasm.
---
Rolvedon,eflapegrastim|UT99UG9QJX|
# Eflapegrastim Summary
Limitations: Rolvedon is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Limitations: Limitations of Use Rolvedon is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia.
---
Ropinirole,ropinirole hydrochloride|D7ZD41RZI9|
# Ropinirole Hydrochloride Summary
Ropinirole extended-release tablets are indicated for the treatment of Parkinson's disease.
Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease.
---
ROPINIROLE|030PYR8953|
# Ropinirole Summary
Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease.
---
ROPIVACAINE HYDROCHLORIDE|V910P86109|
# Ropivacaine Hydrochloride Summary
Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Ropivacaine Hydrochloride is indicated for the production of local or regional anesthesia for surgery and for acute pain management.
Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management.
---
Rosuvastatin|413KH5ZJ73|
# Rosuvastatin Summary
Rosuvastatin tablets are indicated:
As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia.
---
Rosuvastatin,Rosuvastatin Calcium,rosuvstatin|83MVU38M7Q|
# Rosuvastatin Calcium Summary
Rosuvastatin tablets is indicated: Rosuvastatin tablets are indicated: Primary dysbetalipoproteinemia.
Rosuvastatin tablets are indicated: • To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease based on age, high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, and at least one additional CV risk factor.
Rosuvastatin tablet is indicated: Reduce low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia.
• As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia.
• As an adjunct to diet for the treatment of adults with: º Primary dysbetalipoproteinemia.
---
Rufinamide|WFW942PR79|
# Rufinamide Summary
Rufinamide is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.
Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.
---
RYONCIL,allogenic bone-marrow-derived mesenchymal stem cells|OEN4982XNW|
# Allogenic Bone-Marrow-Derived Mesenchymal Stem Cells Summary
RYONCIL is indicated for the treatment of steroid refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.
---
RYZNEUTA,efbemalenograstim alfa|5UPW5HJW3O|
# Efbemalenograstim Alfa Summary
Limitations: RYZNEUTA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Limitations: Limitations of Use RYZNEUTA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
---
SAPHRIS,asenapine maleate|CU9463U2E2|
# Asenapine Maleate Summary
Bipolar I disorder [see Clinical Studies ( 14.2 )] • Acute monotherapy of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age • Adjunctive treatment to lithium or valproate in adults • Maintenance monotherapy treatment in adults SAPHRIS is indicated for: Schizophrenia in adults [see Clinical Studies ( 14.1 )]
---
Kuvan,Sapropterin Dihydrochloride|RG277LF5B3|
# Sapropterin Dihydrochloride Summary
Sapropterin dihydrochloride powder for oral solution is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU).
KUVAN ® is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU).
---
Savella,milnacipran hydrochloride|RNZ43O5WW5|
# Milnacipran Hydrochloride Summary
SAVELLA is indicated for the management of fibromyalgia.
SAVELLA is not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )] .
---
SCEMBLIX,asciminib hydrochloride|C5U34S9XFV|
# Asciminib Hydrochloride Summary
SCEMBLIX is indicated for the treatment of adult patients with:
---
Scopolamine,Scopolamine Transdermal System|DL48G20X8X|
# Scopolamine Summary
Scopolamine transdermal system is indicated in adults for the prevention of: post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery.
---
Selegiline Hydrochloride|6W731X367Q|
# Selegiline Hydrochloride Summary
Selegiline Hydrochloride Tablets USP are indicated as an adjunct in the management of Parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.
Selegiline hydrochloride capsules, USP are indicated as an adjunct in the management of Parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.
Selegiline capsules, USP are indicated as an adjunct in the management of Parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.
---
Sephience,sepiapterin|CJQ26KO7HP|
# Sepiapterin Summary
SEPHIENCE is indicated for the treatment of hyperphenylalaninemia (HPA) in adult and pediatric patients 1 month of age and older with sepiapterin-responsive phenylketonuria (PKU).
---
Sertraline,Sertraline Hydrochloride|UTI8907Y6X|
# Sertraline Hydrochloride Summary
Social anxiety disorder (SAD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are indicated for the treatment of the following [ See Clinical Studies ( 14 ) ]: • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are indicated for the treatment of the following [ See Clinical Studies (14) ]: • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are indicated for...
---
Renvela,Sevelamer Carbonate|9YCX42I8IU|
# Sevelamer Carbonate Summary
Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
Sevelamer carbonate is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
Renvela ® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
---
Sevelamer Hydrochloride|GLS2PGI8QG|
# Sevelamer Hydrochloride Summary
Sevelamer hydrochloride is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
Sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
---
Sevenfact,coagulation factor viia recombinant human|AC71R787OV|
# Coagulation Factor Viia Recombinant Human Summary
Limitations: SEVENFACT is not indicated for the treatment of patients with congenital Factor VII deficiency.
SEVENFACT is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.
---
Sevoflurane,Sevoflurane, (Volatile for Inhalation),Sojourn|38LVP0K73A|
# Sevoflurane Summary
Sevoflurane, USP is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Sojourn ® (sevoflurane, USP) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
---
Sildenafil,Sildenafil Citrate,Viagra|BW9B0ZE037|
# Sildenafil Citrate Summary
Sildenafil tablets are indicated for the treatment of erectile dysfunction.
Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies ( 14 )] .
VIAGRA is indicated for the treatment of erectile dysfunction.
Sildenafil citrate is indicated for the treatment of erectile dysfunction.
Adults Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies (14) ] .
---
SILODOSIN|CUZ39LUY82|
# Silodosin Summary
Silodosin capsule, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see CLINICAL STUDIES (14) ].
Limitations: Silodosin capsule is not indicated for the treatment of hypertension.
Silodosin, a selective alpha‑1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see CLINICAL STUDIES (14) ] .
Silodosin capsules is not indicated for the treatment of hypertension.
Silodosin capsules, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14 )].
---
Silver Sulfadiazine,SSD Cream|W46JY43EJR|
# Silver Sulfadiazine Summary
Silver sulfadiazine cream, USP 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.
Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.
---
Simulect,basiliximab|9927MT646M|
# Basiliximab Summary
Simulect ® (basiliximab) is indicated for the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine, USP (MODIFIED), and corticosteroids.
---
Simvastatin,VYTORIN|AGG2FN16EV|
# Simvastatin Summary
Simvastatin tablets are indicated: As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia.
Simvastatin tablets USP are indicated: Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.
Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.
As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia.
• As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia.
---
SIRTURO,bedaquiline fumarate|P04QX2C1A5|
# Bedaquiline Fumarate Summary
SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (2 years and older and weighing at least 8 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid.
---
Skytrofa,lonapegsomatropin|OP35X9610Y|
# Lonapegsomatropin Summary
SKYTROFA (lonapegsomatropin-tcgd) is a human growth hormone indicated for the: Replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).
Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH).
---
Smoflipid,medium-chain triglycerides|C9H2L21V7U|
# Medium-Chain Triglycerides Summary
SMOFlipid is indicated in adult and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
---
SODIUM ACETATE,sodium acetate anhydrous|NVG71ZZ7P0|
# Sodium Acetate Anhydrous Summary
Sodium acetate injection, 2 mEq/mL is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake.
---
DELFLEX,Dextrose and Sodium Chloride,EXTRANEAL,GaviLyte - CTM,LACTATED RINGER,Lactated Ringers,Lactated Ringers and Dextrose,PEG-3350, Electrolytes, and Ascorbate,Potassium Chloride in Lactated Ringers and Dextrose,Pouch A,Ringers,Sodium Chloride,Sodium Chloride Injection, solution|451W47IQ8X|
# Sodium Chloride Summary
Lactated Ringer’s and Dextrose (5%) Injection is indicated for use as a source of water, electrolytes, and calories or as an alkalinizing agent in adults and pediatric patients.
0.9% Sodium Chloride Injection, USP is indicated as a source of water and electrolytes and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 mL) drug product packaged in a vial with a 20 mm closure.
Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults.
DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis.
---
Multivitamin with Fluoride,Sodium Fluoride 1.1%,Sodium Fluoride Chewable,sodium fluoride|8ZYQ1474W7|
# Sodium Fluoride Summary
For once daily self-applied systemic use as a dental caries preventive in pediatric patients. It has been established that ingestion of fluoridated drinking water (1 ppm F¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. Sodium Fluoride Chewable Tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm F¯. A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators....
---
Sodium Nitroprusside|EAO03PE1TC|
# Sodium Nitroprusside Summary
Sodium nitroprusside is also indicated for the treatment of acute congestive heart failure.
Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.
Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery.
---
SODIUM PHENYLACETATE and SODIUM BENZOATE,sodium phenylacetate|48N6U1781G|
# Sodium Phenylacetate Summary
Sodium Phenylacetate and Sodium Benzoate Injection, 10%/10% is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
---
SODIUM PHENYLACETATE and SODIUM BENZOATE,sodium benzoate|OJ245FE5EU|
# Sodium Benzoate Summary
Sodium Phenylacetate and Sodium Benzoate Injection, 10%/10% is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
---
Sodium Phosphates,sodium phosphate, dibasic, anhydrous|22ADO53M6F|
# Sodium Phosphate, Dibasic, Anhydrous Summary
Sodium Phosphates Injection, USP, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake.
---
Sodium Polystyrene Sulfonate|1699G8679Z|
# Sodium Polystyrene Sulfonate Summary
Sodium polystyrene sulfonate is indicated for the treatment of hyperkalemia.
---
Sofdra,sofpironium bromide|7B2Y1932XU|
# Sofpironium Bromide Summary
SOFDRA is indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
---
Solifenacin Succinate|KKA5DLD701|
# Solifenacin Succinate Summary
Solifenacin succinate tablets is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Solifenacin Succinate Tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
---
Soliqua 100/33,insulin glargine|2ZM8CX04RZ|
# Insulin Glargine Summary
SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
Soliqua 100/33,lixisenatide|74O62BB01U|
# Lixisenatide Summary
SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
---
Solu-Cortef,hydrocortisone sodium succinate|50LQB69S1Z|
# Hydrocortisone Sodium Succinate Summary
When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-CORTEF Sterile Powder is indicated as follows: Neoplastic diseases: For the palliative management of leukemias and lymphomas.
For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.
Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, select cases of secondary thrombocytopenia.
---
Methylprednisolone sodium succinate,SOLU-MEDROL|LEC9GKY20K|
# Methylprednisolone Sodium Succinate Summary
When oral therapy is not feasible, and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of methylprednisolone sodium succinate for injection, USP is indicated as follows: Renal diseases : To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia.
For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.
---
Spinraza,nusinersen|5Z9SP3X666|
# Nusinersen Summary
SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
---
Spiriva HandiHaler,SpirivaHandiHaler,tiotropium bromide monohydrate|L64SXO195N|
# Tiotropium Bromide Monohydrate Summary
SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
SPIRIVA HANDIHALER is indicated to reduce exacerbations in COPD patients.
---
Spironolactone and Hydrochlorothiazide,spironolactone|27O7W4T232|
# Spironolactone Summary
Spironolactone and hydrochlorothiazide tablets are indicated for: Edematous conditions for patients with:
---
Spravato,esketamine hydrochloride|L8P1H35P2Z|
# Esketamine Hydrochloride Summary
SPRAVATO is indicated for the treatment of: Treatment-resistant depression (TRD) in adults as monotherapy or in conjunction with an oral antidepressant Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior in conjunction with an oral antidepressant
---
INSULIN DILUTING MEDIUM FOR Kirsty,Sterile Water,WINREVAIR,aqua|059QF0KO0R|
# Aqua Summary
Sterile Water for Injection USP is indicated for use in adults and pediatric patients as a diluent or solvent in the aseptic preparation of parenteral solutions or as a vehicle for drug administration.
WINREVAIR™ is indicated for the treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to increase exercise capacity, improve WHO functional class (FC), and reduce the risk of clinical worsening events.
KIRSTY is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
---
STRENSIQ,asfotase alfa|Z633861EIM|
# Asfotase Alfa Summary
STRENSIQ ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
---
STYPTSTIX,silver nitrate|95IT3W8JZE|
# Silver Nitrate Summary
For cauterization of skin or mucous membrane and for removing warts and granulated tissue.
---
STYPTSTIX,potassium nitrate|RU45X2JN0Z|
# Potassium Nitrate Summary
For cauterization of skin or mucous membrane and for removing warts and granulated tissue.
---
Succinylcholine Chloride|I9L0DDD30I|
# Succinylcholine Chloride Summary
Succinylcholine chloride injection is indicated in adults and pediatric patients:
---
Sucralfate|XX73205DH5|
# Sucralfate Summary
Sucralfate tablets, USP are indicated in: Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
Sucralfate is indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer.
---
Sulfamethoxazole and Trimethoprim,trimethoprim|AN164J8Y0X|
# Trimethoprim Summary
Limitations: Sulfamethoxazole and trimethoprim tablets are not indicated for prophylactic or prolonged administration in otitis media at any age.
Shigellosis: For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated.
Limitations: Sulfamethoxazole and trimethoprim is not indicated for prophylactic or prolonged administration in otitis media at any age.
Urinary Tract Infections: For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli , Klebsiella species, Enterobacter species, Morganella morganii , Proteus mirabilis and Proteus vulgaris .
For the treatment of traveler’s diarrhea due to susceptible strains of enterotoxigenic E.
---
Sulfamethoxazole and Trimethoprim,sulfamethoxazole|JE42381TNV|
# Sulfamethoxazole Summary
Acute Otitis Media For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated.
Limitations: Sulfamethoxazole and trimethoprim tablets are not indicated for prophylactic or prolonged administration in otitis media at any age.
Shigellosis: For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated.
For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents.
For the treatment of documented Pneumocystis jirovecii pneumonia and for prophylaxis against P.
---
Sulfasalazine|3XC8GUZ6CB|
# Sulfasalazine Summary
SULFASALAZINE DELAYED RELEASE Tablets, USP are indicated: a)in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis;b)for the prolongation of the remission period between acute attacks of ulcerative colitis;c)in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g., an insufficient therapeutic response to, or intolerance of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs); andd)in the treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs.
Sulfasalazine tablets are indicated:
---
SULINDAC|184SNS8VUH|
# Sulindac Summary
Acute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis) Sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 3.
---
Sumatriptan|8R78F6L9VO|
# Sumatriptan Summary
Sumatriptan nasal spray is indicated for the acute treatment of migraine with or without aura in adults.
Limitations: Limitations of Use: Use only if a clear diagnosis of migraine headache has been established.
Limitations: Sumatriptan nasal spray is not indicated for the prevention of migraine attacks.
---
Sumatriptan,Sumatriptan and Naproxen Sodium,SUMATRIPTAN SUCCINATE|J8BDZ68989|
# Sumatriptan Succinate Summary
Limitations: Sumatriptan is not indicated for the prevention of migraine attacks.
Limitations: Limitations of Use: Sumatriptan injection is not indicated for the prevention of migraine or cluster headache attacks.
Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache.
Limitations of Use Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache.
Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.
---
Sunlenca,Yeztugo,lenacapavir sodium|BDT58WJ9WE|
# Lenacapavir Sodium Summary
SUNLENCA, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 whose current antiretroviral regimen is failing due to resistance, intolerance, or safety considerations.
YEZTUGO is indicated for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition.
---
SUPPRELINLA,histrelin acetate|QMG7HLD1ZE|
# Histrelin Acetate Summary
SUPPRELIN LA (histrelin acetate) subcutaneous implant is indicated for the treatment of children with central precocious puberty (CPP).
---
SUSTOL,granisetron|WZG3J2MCOL|
# Granisetron Summary
SUSTOL is indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens.
---
Syfovre,pegcetacoplan|TO3JYR3BOU|
# Pegcetacoplan Summary
SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
---
Meloxicam,SYMBRAVO|VG2QF83CGL|
# Meloxicam Summary
SYMBRAVO is indicated for the acute treatment of migraine with or without aura in adults.
Limitations: SYMBRAVO is not indicated for the preventive treatment of migraine attacks.
Limitations: Limitations of Use Meloxicam capsules are indicated for management of osteoarthritis pain.
SYMBRAVO is not indicated for the treatment of cluster headache.
---
SYMPROIC,naldemedine tosylate|V1N8F1RVVO|
# Naldemedine Tosylate Summary
SYMPROIC is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
---
TachoSil,human thrombin|6K15ABL77G|
# Human Thrombin Summary
TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.
Limitations for Use Not for use in children under one month of age.
TachoSil cannot safely or effectively be used in place of sutures or other form of mechanical ligation for the treatment of major arterial or venous bleeding.
---
TachoSil,fibrinogen human|N94833051K|
# Fibrinogen Human Summary
Limitations: Limitations for Use TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.
Not for use in children under one month of age.
TachoSil cannot safely or effectively be used in place of sutures or other form of mechanical ligation for the treatment of major arterial or venous bleeding.
---
Tamsulosin hydrochloride|11SV1951MR|
# Tamsulosin Hydrochloride Summary
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14) ] .
Limitations: Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension.
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see ] .
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [ see Clinical Studies (14) ].
Tamsulosin hydrochloride capsules, USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14 )].
---
Tavaborole|K124A4EUQ3|
# Tavaborole Summary
Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophyte.
---
Technescan HDP,oxidronate disodium|H852YK87WP|
# Oxidronate Disodium Summary
Technescan HDP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients.
---
Technescan PYP,stannous chloride|1BQV3749L5|
# Stannous Chloride Summary
Technescan PYP, in conjunction with sodium pertechnetate Tc 99m injection for red blood cell (RBC) labeling, is indicated for gated cardiac blood pool imaging and for the detection of gastrointestinal bleeding sites in adults.
Technescan PYP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for: • Skeletal imaging to demonstrate areas of altered osteogenesis in adults • Cardiac imaging as an adjunct in the diagnosis of acute myocardial infarction in adults (See WARNINGS )
---
Technescan PYP,sodium pyrophosphate|O352864B8Z|
# Sodium Pyrophosphate Summary
Technescan PYP, in conjunction with sodium pertechnetate Tc 99m injection for red blood cell (RBC) labeling, is indicated for gated cardiac blood pool imaging and for the detection of gastrointestinal bleeding sites in adults.
Technescan PYP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for: • Skeletal imaging to demonstrate areas of altered osteogenesis in adults • Cardiac imaging as an adjunct in the diagnosis of acute myocardial infarction in adults (See WARNINGS )
---
TECVAYLI,teclistamab|54534MX6Z9|
# Teclistamab Summary
TECVAYLI is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody.
---
telmisartan,TELMISARTAN AND HYDROCHLOROTHIAZIDE|U5SYW473RQ|
# Telmisartan Summary
Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure.
Limitations: Telmisartan and hydrochlorothiazide tablets are not indicated for initial therapy for the treatment of hypertension [see Dosage and Administration ( 2.1 )].
Telmisartan tablets, USP are indicated for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
Temazepam|CHB1QD2QSS|
# Temazepam Summary
Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days).
Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days).
Temazepam Capsules USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days).
---
TEPEZZA,teprotumumab|Y64GQ0KC0A|
# Teprotumumab Summary
TEPEZZA is indicated for the treatment of Thyroid Eye Disease regardless of Thyroid Eye Disease activity or duration.
---
Terazosin,Terazosin hydrochloride|D32S14F082|
# Terazosin Hydrochloride Summary
Terazosin capsules are also indicated for the treatment of hypertension.
Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH).
---
Terbinafine,Terbinafine Hydrochloride|012C11ZU6G|
# Terbinafine Hydrochloride Summary
Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).
Terbinafine tablets, USP are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).
---
TERBUTALINE SULFATE|576PU70Y8E|
# Terbutaline Sulfate Summary
Terbutaline sulfate tablets are indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
Terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
---
Terconazole,TerconazoleVaginal Cream 0.8%|0KJ2VE664U|
# Terconazole Summary
Terconazole vaginal cream 0.8% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis).
Terconazole Vaginal Cream, is indicated for the treatment of vulvovaginal candidiasis in adult females.
Terconazole vaginal cream 0.4% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis).
---
Teriflunomide|1C058IKG3B|
# Teriflunomide Summary
Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Teriflunomide tablet is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
---
AndroGel,nasal gel,Testim,Testosterone|3XMK78S47O|
# Testosterone Summary
Testosterone gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation.
Limitations: Limitations of use: Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation.
Testosterone gel 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Safety and efficacy of AndroGel 1.62% in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
---
AZMIRO,Depo-Testosterone,Testosterone Cypionate|M0XW1UBI14|
# Testosterone Cypionate Summary
Testosterone Cypionate Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
DEPO-Testosterone Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
Testosterone Cypionate Injection, USP is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
---
Tetrabenazine|Z9O08YRN8O|
# Tetrabenazine Summary
Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington’s disease.
Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington's disease.
---
Tetracaine Hydrochloride|5NF5D4OPCI|
# Tetracaine Hydrochloride Summary
Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic.
---
Tetracycline Hydrochloride|P6R62377KV|
# Tetracycline Hydrochloride Summary
Tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: Tularemia caused by Francisella tularensis.
(Tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) Infections caused by rickettsia including Rocky Mountain spotted fever, typhus group infections, Q fever, rickettsialpox.
When penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections: Vincent's infection caused by Fusobacterium fusiforme, In severe acne, adjunctive therapy with tetracycline may be useful.
---
Theophylline,Theophylline(Anhydrous),TheophyllineAnhydrous,theophylline anhydrous|0I55128JYK|
# Theophylline Anhydrous Summary
Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
Theophylline oral solution is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
---
Adult Infuvite Multiple Vitamins,Pediatric Infuvite Multiple Vitamins,THIAMINE HYDROCHLORIDE,Virexa|M572600E5P|
# Thiamine Hydrochloride Summary
Thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be given.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.
Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.
---
Thiola,Thiola EC,tiopronin|C5W04GO61S|
# Tiopronin Summary
THIOLA EC is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.
THIOLA is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone.
---
TEPADINA,Thiotepa|905Z5W3GKH|
# Thiotepa Summary
TEPADINA is indicated to reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia [see Clinical Studies ( 14 ) ] .
TEPADINA is indicated for treatment of adenocarcinoma of the breast or ovary.
However, the most consistent results have been seen in the following tumors: TEPADINA is indicated for treatment of superficial papillary carcinoma of the urinary bladder.
For the treatment of superficial papillary carcinoma of the urinary bladder.
---
Tiagabine Hydrochloride|DQH6T6D8OY|
# Tiagabine Hydrochloride Summary
Tiagabine HCl is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.
---
TICE BCG,bacillus calmette-guerin substrain tice live antigen|2XQ558L16Z|
# Bacillus Calmette-Guerin Substrain Tice Live Antigen Summary
Limitations: TICE ® BCG is indicated for: Limitations of Use: the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR) TICE BCG is not indicated for papillary tumors of stages higher than T1.
---
Riluzole,TIGLUTIK|7LJ087RS6F|
# Riluzole Summary
TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
---
Tinidazole|033KF7V46H|
# Tinidazole Summary
Tinidazole is indicated for the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, or anaerobic vaginosis) in adult women [see Use in Specific Populations (8.1) and Clinical Studies (14.5)].
Tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by Entamoeba histolytica in both adults and pediatric patients older than three years of age.
Limitations: It is not indicated in the treatment of asymptomatic cyst passage [see Clinical Studies (14.3, 14.4)].
1.5 Usage 1.3 Amebiasis Tinidazole is indicated for the treatment of giardiasis caused by Giardia duodenalis (also termed G.
1.4 Bacterial Vaginosis Tinidazole is indicated for the treatment of trichomoniasis caused by Trichomonas vaginalis .
---
TISSUEBLUE,brilliant blue g|M1ZRX790SI|
# Brilliant Blue G Summary
TissueBlue 0.025% is indicated to selectively stain the internal limiting membrane (ILM).
---
TIVDAK,tisotumab vedotin|T41737F88A|
# Tisotumab Vedotin Summary
TIVDAK ® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
---
Tizanidine,Tizanidine HCL,tizanidine hydrochloride,Zanaflex|B53E3NMY5C|
# Tizanidine Hydrochloride Summary
Tizanidine tablets are indicated for the treatment of spasticity in adults.
Tizanidine hydrochloride is a central alpha-2-adrenergic agonist indicated for the management of spasticity.
Tizanidine hydrochloride is indicated for the treatment of spasticity in adults.
Tizanidine is indicated for the treatment of spasticity in adults.
---
DEXAMETHASONE,Dexycu,MAXITROL,Neomycin and Polymyxin B Sulfates and Dexamethasone,Neomycin Polymyxin B Sulfates and Dexamethasone,neomycin sulfate, polymyxin b sulfate and dexamethasone,TobraDex,TOBRAMYCIN AND DEXAMETHASONE|7S5I7G3JQL|
# Dexamethasone Summary
INDICATIONS AND USAGE: TOBRADEX (tobramycin and dexamethasone ophthalmic ointment) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation.
For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.
Anterior segment inflammation DEXYCU (dexamethasone intraocular suspension) 9% is indicated for the treatment of postoperative inflammation.
---
Tobramycin,tobramycin sulfate|HJT0RXD7JK|
# Tobramycin Sulfate Summary
Limitations: Aminoglycosides, including tobramycin sulphate, are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics having less potential toxicity.
Tobramycin is indicated for the treatment of serious bacterial infections caused by susceptible strains of the designated microorganisms in the diseases listed below: Lower respiratory tract infections caused by P.
Limitations: Aminoglycosides, including tobramycin sulfate, are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics having less potential toxicity.
Tobramycin may be considered in serious staphylococcal infections when penicillin or other potentially less toxic drugs are contraindicated and when bacterial susceptibility testing and clinical judgment indicate its use.
---
TobraDex,Tobramycin,TOBRAMYCIN AND DEXAMETHASONE|VZ8RRZ51VK|
# Tobramycin Summary
INDICATIONS AND USAGE: Tobramycin and dexamethasone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation.
The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa .
---
Tolterodine Tartrate,Tolterodine Tartrate Extended Release|5T619TQR3R|
# Tolterodine Tartrate Summary
Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES (14) ].
Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see Clinical Studies (14) ] .
---
SAMSCA,tolvaptan|21G72T1950|
# Tolvaptan Summary
Tolvaptan is indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium &lt;125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction), including patients with heart failure and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
SAMSCA ® is indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium &lt;125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction), including patients with heart failure and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
---
toremifene citrate|2498Y783QT|
# Toremifene Citrate Summary
Toremifene citrate tablets are estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.
---
Bosentan,Tracleer|Q326023R30|
# Bosentan Summary
TRACLEER is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): Bosentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): • in adults to improve exercise ability and to decrease clinical worsening.
---
Tradjenta,linagliptin|3X29ZEJ4R2|
# Linagliptin Summary
TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .
---
TRAMADOL HCL AND ACETAMINOPHEN,Tramadol Hydrochloride,Tramadol Hydrochloride and Acetaminophen|9N7R477WCK|
# Tramadol Hydrochloride Summary
Tramadol hydrochloride extended-release tablet is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids.
Limitations: Limitations of Use •Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosages or duration, and persist over the course of therapy, [see Warnings and Precautions (5.1)], reserve opioid analgesics, including tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options are ineffective, not tolerated or would be otherwise inadequate to provide sufficient management of pain.
Limitations: •Tramadol hydrochloride extended-release tablet is not indicated as an as-needed (prn) analgesic.
---
Cyklokapron,Tranexamic Acid,tranexamic acid in sodium chloride|6T84R30KC1|
# Tranexamic Acid Summary
Tranexamic Acid Injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Tranexamic Acid Tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential [see Clinical Studies ( 14 )].
---
Tranylcypromine Sulfate|7ZAT6ES870|
# Tranylcypromine Sulfate Summary
Tranylcypromine sulfate tablets are indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants.
Limitations: Tranylcypromine sulfate tablets are not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [see Contraindications (4), Warnings and Precautions (5) , and Drug Interactions (7)].
---
Travoprost,Travoprost Ophthalmic Solution|WJ68R08KX9|
# Travoprost Summary
Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.
Travoprost ophthalmic solution 0.004% (ionic buffered solution) is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
---
Trazodone Hydrochloride|6E8ZO8LRNM|
# Trazodone Hydrochloride Summary
Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
---
Trelstar,triptorelin pamoate|08AN7WA2G0|
# Triptorelin Pamoate Summary
TRELSTAR is indicated for the treatment of advanced prostate cancer [ see Clinical Studies (14) ].
---
Atralin,Clindamycin Phosphate 1.2% and Tretinoin 0.025%,Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%,Retin-A MICRO,Tretinoin,Twyneo,ZIANA|5688UTC01R|
# Tretinoin Summary
Tretinoin Gel is indicated for topical treatment of acne vulgaris.
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older.
Tretinoin gel (microsphere) is a retinoid indicated for topical application in the treatment of acne vulgaris.
Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.
---
KOURZEQ,Nystatin and Triamcinolone Acetonide,Triamcinolone Acetonide|F446C597KA|
# Triamcinolone Acetonide Summary
Triamcinolone Acetonide Dental Paste USP, 0.1% is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Nystatin and Triamcinolone Acetonide Ointment, USP is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.
---
Triamterene,Triamterene and Hydrochlorothiazide|WS821Z52LQ|
# Triamterene Summary
Limitations: This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked.
Diuretics are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy.
Triamterene and hydrochlorothiazide tablets are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone.
Triamterene and hydrochlorothiazide capsules are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone.
Triamterene and hydrochlorothiazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone.
---
Halcion,Triazolam|1HM943223R|
# Triazolam Summary
Triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
Halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
---
Trientine Hydrochloride|HC3NX54582|
# Trientine Hydrochloride Summary
Limitations: Trientine hydrochloride is not indicated for treatment of biliary cirrhosis.
Trientine hydrochloride is indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine.
---
Trihexyphenidyl Hydrochloride|AO61G82577|
# Trihexyphenidyl Hydrochloride Summary
This drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic).
Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
---
Tigan,Trimethobenzamide Hydrochloride|WDQ5P1SX7Q|
# Trimethobenzamide Hydrochloride Summary
Tigan ® is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.
Trimethobenzamide hydrochloride capsules are indicated in adults for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.
Trimethobenzamide hydrochloride capsules are not recommended for use in pediatric patients due to the risk of extrapyramidal signs and symptoms and other serious central nervous system (CNS) effects, and the risk of exacerbation of the underlying disease in pediatric patients with Reye’s syndrome or other hepatic impairment.
---
Trintellix,vortioxetine hydrobromide|TKS641KOAY|
# Vortioxetine Hydrobromide Summary
TRINTELLIX is indicated for the treatment of major depressive disorder (MDD) in adults.
---
TRIPTODUR,triptorelin|9081Y98W2V|
# Triptorelin Summary
TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).
---
Dovato,EPIVIR,LAMIVUDINE,Triumeq,Triumeq PD|2T8Q726O95|
# Lamivudine Summary
TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg.
Limitations: Limitations of Use: The dosage of this product is for HIV-1 and not for HBV.
Lamivudine tablets are a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Lamivudine tablets (HBV) are indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation [ see Clinical Studies ( 14.1 , 14.2 ) ].
---
Triumeq,Triumeq PD,abacavir sulfate|J220T4J9Q2|
# Abacavir Sulfate Summary
TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg.
Limitations: Limitations of Use:
---
TROMETHAMINE|023C2WHX2V|
# Tromethamine Summary
Tromethamine Injection is indicated for the prevention and correction of metabolic acidosis.
In the following conditions it may help to sustain vital functions and thus provide time for treatment of the primary disease: Correction of Acidity of ACD Blood in Cardiac Bypass Surgery.
---
Tropicamide|N0A3Z5XTC6|
# Tropicamide Summary
For mydriasis and cycloplegia for diagnostic procedures.
---
TROSPIUM CHLORIDE|1E6682427E|
# Trospium Chloride Summary
Trospium Chloride Extended-Release Capsules are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
---
Trubrexa,capsaicin|S07O44R1ZM|
# Capsaicin Summary
Trubrexa TM Transdermal Patch is indicated in adults over the age of 12 years old for the treatment of acute and chronic pain in muscles and joints associated with muscle soreness, strains, sprains, arthritis, simple backache, muscle stiffness, and more.
---
TRUQAP,capivasertib|WFR23M21IE|
# Capivasertib Summary
TRUQAP, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN -alteration as detected by an FDA-approved test following progression on at least one endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy.
---
TYKERB,lapatinib ditosylate|G873GX646R|
# Lapatinib Ditosylate Summary
Limitations: Limitations of Use : Patients should have disease progression on trastuzumab prior to initiation of treatment with TYKERB in combination with capecitabine.
TYKERB ® is indicated in combination with: letrozole for the treatment of postmenopausal women with hormone receptor-positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated.
capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2) and who have received prior therapy, including an anthracycline, a taxane, and trastuzumab.
TYKERB in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
---
Ultravist,iopromide|712BAC33MZ|
# Iopromide Summary
ULTRAVIST ® Injection is an iodinated contrast agent indicated for:
---
Umeclidinium and Vilanterol Ellipta,vilanterol trifenatate|40AHO2C6DG|
# Vilanterol Trifenatate Summary
Umeclidinium and Vilanterol ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Limitations: Umeclidinium and Vilanterol ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma.
Limitations: Limitations of Use
---
Incruse Ellipta,Umeclidinium and Vilanterol Ellipta,umeclidinium bromide|7AN603V4JV|
# Umeclidinium Bromide Summary
Limitations: Limitations of Use INCRUSE ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Umeclidinium and Vilanterol ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Limitations: Umeclidinium and Vilanterol ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma.
---
UNLOXCYT,cosibelimab|PNW7GBB44P|
# Cosibelimab Summary
UNLOXCYT is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.
---
UPNEEQ,oxymetazoline hydrochloride|K89MJ0S5VY|
# Oxymetazoline Hydrochloride Summary
UPNEEQ is indicated for the treatment of acquired blepharoptosis in adults.
---
DERMACURE,Urea,Urea 40%|8W8T17847W|
# Urea Summary
INDICATIONS AND USES: Urea 45% Cream is indicated for use in the topical treatment for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar.
Urea is useful for the treatment of hyperkeratotic conditions such as dry rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.
Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged and ingrown nails.
---
URELLE,phenyl salicylate|28A37T47QO|
# Phenyl Salicylate Summary
Urelle ® is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
---
Sodium Phosphates,URELLE,sodium phosphate, monobasic, monohydrate|593YOG76RN|
# Sodium Phosphate, Monobasic, Monohydrate Summary
Urelle ® is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
---
UROCIT-K,potassium citrate|EE90ONI6FF|
# Potassium Citrate Summary
Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)].
1.1 Renal Tubular Acidosis (RTA) with Calcium Stones 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)].
1.3 Uric Acid Lithiasis with or without Calcium Stones Potassium citrate is indicated for the management of Uric acid lithiasis with or without calcium stones [see Clinical Studies (14.3)].
---
UROGESIC BLUE,sodium phosphate, monobasic, unspecified form|3980JIH2SW|
# Sodium Phosphate, Monobasic, Unspecified Form Summary
UROGESIC-BLUE™ is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
---
URELLE,UROGESIC BLUE,methenamine|J50OIX95QV|
# Methenamine Summary
UROGESIC-BLUE™ is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Urelle ® is indicated for the treatment of symptoms of irritative voiding.
---
METHYLENE BLUE,URELLE,UROGESIC BLUE|T42P99266K|
# Methylene Blue Summary
UROGESIC-BLUE™ is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Urelle ® is indicated for the treatment of symptoms of irritative voiding.
Methylene blue injection is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
---
Ursodiol|724L30Y2QR|
# Ursodiol Summary
Ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones &lt; 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery.
Ursodiol tablets 250 mg and 500 mg are indicated for the treatment of patients with primary biliary cholangitis (PBC).
Ursodiol tablets are indicated for the treatment of patients with primary biliary cholangitis (PBC).
---
VABYSMO,faricimab|QC4F7FKK7I|
# Faricimab Summary
VABYSMO is a vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) inhibitor indicated for the treatment of patients with:
---
Valacyclovir,valacyclovir hydrochloride|G447S0T1VC|
# Valacyclovir Hydrochloride Summary
1.1 Adult Patients Valacyclovir tablets are indicated for the treatment of chickenpox in immunocompetent pediatric patients aged 2 to less than 18 years.
Cold Sores (Herpes Labialis) Herpes Zoster 1.2 Pediatric Patients Reduction of Transmission: Valacyclovir tablets are indicated for the reduction of transmission of genital herpes in immunocompetent adults.
Suppressive Therapy: Valacyclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in immunocompetent and in HIV-1-infected adults.
Valacyclovir tablets are indicated for treatment of cold sores (herpes labialis).
Initial Episode: Valacyclovir tablets are indicated for treatment of the initial episode of genital herpes in immunocompetent adults.
---
Vardenafil Hydrochloride|5M8S2CU0TS|
# Vardenafil Hydrochloride Summary
Vardenafil hydrochloride tablets are indicated for the treatment of erectile dysfunction.
---
CHANTIX,Varenicline,Varenicline tartrate|82269ASB48|
# Varenicline Tartrate Summary
Varenicline tablets are indicated for use as an aid to smoking-cessation treatment.
CHANTIX is indicated for use as an aid to smoking-cessation treatment.
Varenicline tablets are indicated for use as an aid to smoking cessation treatment.
---
Vasopressin,Vasopressin in 0.9% Sodium Chloride|Y4907O6MFD|
# Vasopressin Summary
Vasopressin in Sodium Chloride Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.
Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.
---
Vecuronium Bromide|7E4PHP5N1D|
# Vecuronium Bromide Summary
Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
---
Veklury,remdesivir|3QKI37EEHE|
# Remdesivir Summary
VEKLURY is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (birth to less than 18 years of age weighing at least 1.5 kg) who are [see Clinical Studies (14) ] : Hospitalized, or
---
Velsipity,etrasimod arginine|MXE5EMA09L|
# Etrasimod Arginine Summary
VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
---
Venlafaxine,Venlafaxine Hydrochloride|7D7RX5A8MO|
# Venlafaxine Hydrochloride Summary
The efficacy of venlafaxine tablets in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ).
The efficacy of venlafaxine tablets, USP in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ).
---
VEOPOZ,pozelimab|0JJ21K6L2I|
# Pozelimab Summary
VEOPOZ is indicated for the treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease.
---
verapamil hydrochloride|V3888OEY5R|
# Verapamil Hydrochloride Summary
Verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure.
Verapamil hydrochloride sustained-release capsules are indicated for the treatment of hypertension, to lower blood pressure.
Verapamil Hydrochloride Injection, USP is indicated for the following: Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
---
Cyclosporine,CycloSPORINE, Modfied,Restasis MultiDose,VEVYE|83HN0GTJ6D|
# Cyclosporine Summary
VEVYE indicated for the treatment of the signs and symptoms of dry eye disease.
Cyclosporine capsules (modified) is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants.
Rheumatoid Arthritis Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
Cyclosporine capsules (modified) is indicated for the treatment of adult, nonimmunocompromised patients with severe (i.e., extensive and/or disabling), recalcitrant, plaque psoriasis who have failed to respond to at least one systemic therapy (e.g., PUVA, retinoids, or methotrexate) or in patients for whom other systemic therapies are contraindicated or cannot be tolerated.
---
Viberzi,eluxadoline|45TPJ4MBQ1|
# Eluxadoline Summary
VIBERZI is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D).
---
VIJOICE,alpelisib|08W5N2C97Q|
# Alpelisib Summary
VIJOICE is indicated for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
---
Vilazodone Hydrochloride|U8HTX2GK8J|
# Vilazodone Hydrochloride Summary
Vilazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] .
---
VIMIZIM,elosulfase alfa|ODJ69JZG85|
# Elosulfase Alfa Summary
VIMIZIM (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
---
Creon,Viokace,Zenpep,pancrelipase protease|3560D81V50|
# Pancrelipase Protease Summary
VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults.
CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
---
VIRACEPT,nelfinavir mesylate|98D603VP8V|
# Nelfinavir Mesylate Summary
VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
---
Virazole,ribavirin|49717AWG6K|
# Ribavirin Summary
VIRAZOLE ® (Ribavirin for Inhalation Solution, USP) is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to RSV.
---
Virexa,nicotinamide adenine dinucleotide|0U46U6E8UK|
# Nicotinamide Adenine Dinucleotide Summary
Virexa is a multivitamin with folic acid dispensed by prescription only.
---
Virexa,ubiquinone|EJ27X76M46|
# Ubiquinone Summary
Virexa is a multivitamin with folic acid dispensed by prescription only.
---
Embriva,PaxLyte,Virexa,pyridoxal phosphate anhydrous|F06SGE49M6|
# Pyridoxal Phosphate Anhydrous Summary
PaxLyte is indicated in the TREATMENT of vitamin deficiency – specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate.
---
Visudyne,verteporfin|0X9PA28K43|
# Verteporfin Summary
VISUDYNE ® (verteporfin for injection) therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration (AMD), pathologic myopia or presumed ocular histoplasmosis.
There is insufficient evidence to indicate VISUDYNE for the treatment of predominantly occult subfoveal CNV.
---
Vizamyl,flutemetamol f-18|L49M066S0O|
# Flutemetamol F-18 Summary
VIZAMYL is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products
---
Vizimpro,dacomitinib|5092U85G58|
# Dacomitinib Summary
VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test [see Dosage and Administration (2.1) ] .
---
VIZZ,aceclidine hydrochloride|3B22O325Q6|
# Aceclidine Hydrochloride Summary
VIZZ is indicated for the treatment of presbyopia in adults.
---
Vonjo,pacritinib|G22N65IL3O|
# Pacritinib Summary
VONJO is indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) with a platelet count below 50 × 10 9 /L.
---
VOXZOGO 0.4mg,VOXZOGO 0.4mg  Vial,VOXZOGO 0.56mg,VOXZOGO 0.56mg  Vial,VOXZOGO 1.2mg,VOXZOGO 1.2mg vial,vosoritide|7SE5582Q2P|
# Vosoritide Summary
VOXZOGO is indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses.
---
VOYXACT,sibeprenlimab|GHX28QZ7DD|
# Sibeprenlimab Summary
VOYXACT is indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression.
---
ELUCIREM,Vueway,gadopiclenol|S276568KOY|
# Gadopiclenol Summary
the central nervous system (brain, spine, and associated tissues), ELUCIREM TM is indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: Vueway® is indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in:
---
Vyepti,eptinezumab|8202AY8I7H|
# Eptinezumab Summary
VYEPTI is indicated for the preventive treatment of migraine in adults.
---
Vyleesi,bremelanotide acetate|PV2WI7495P|
# Bremelanotide Acetate Summary
Limitations: Limitations of Use VYLEESI is not indicated for the treatment of HSDD in postmenopausal women or in men.
Limitations: VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: A co-existing medical or psychiatric condition, Problems with the relationship, or VYLEESI is not indicated to enhance sexual performance.
---
Ezetimibe,Nexlizet,VYTORIN,Zetia|EOR26LQQ24|
# Ezetimibe Summary
ZETIA ® is indicated: When ZETIA is used in combination with a statin, fenofibrate, or other LDL-C lowering therapies, refer to the Prescribing Information of these products for information on the safe and effective use.
Bempedoic acid, a component of NEXLIZET, is indicated: Simvastatin, when used as a component of VYTORIN, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events.
---
VYVGART Hytrulo,hyaluronidase (human recombinant)|743QUY4VD8|
# Hyaluronidase (Human Recombinant) Summary
generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive VYVGART HYTRULO is indicated for the treatment of adult patients with: chronic inflammatory demyelinating polyneuropathy (CIDP)
---
VYVGART,VYVGART Hytrulo,efgartigimod alfa|961YV2O515|
# Efgartigimod Alfa Summary
generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive VYVGART HYTRULO is indicated for the treatment of adult patients with: VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
---
Wakix,pitolisant hydrochloride|YV33CH63HI|
# Pitolisant Hydrochloride Summary
WAKIX is indicated for the:
treatment of excessive daytime sleepiness (EDS) in pediatric patients 6 years of age and older with narcolepsy.
treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy.
---
Warfarin Sodium|6153CWM0CL|
# Warfarin Sodium Summary
Warfarin sodium tablets are indicated for: Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement.
Limitations: Limitations of Use Warfarin sodium tablets, USP are indicated for: Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
Limitations: Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage.
Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).
---
WAYRILZ,rilzabrutinib|NWN58M4F5T|
# Rilzabrutinib Summary
WAYRILZ is indicated for the treatment of adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
---
WEGOVY,semaglutide|53AXN4NNHX|
# Semaglutide Summary
Limitations: WEGOVY is indicated in combination with a reduced calorie diet and increased physical activity: Limitations of Use to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with obesity to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with obesity to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.
---
WINREVAIR,sotatercept|0QI90BTJ37|
# Sotatercept Summary
WINREVAIR™ is indicated for the treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to increase exercise capacity, improve WHO functional class (FC), and reduce the risk of clinical worsening events.
---
Xadago,safinamide mesylate|YS90V3DTX0|
# Safinamide Mesylate Summary
XADAGO is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes.
---
XELSTRYM,dextroamphetamine|TZ47U051FI|
# Dextroamphetamine Summary
XELSTRYM ® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see CLINICAL STUDIES (14) ] .
Limitations: Limitations of Use
---
XENPOZYME,olipudase alfa|6D5766Q4OP|
# Olipudase Alfa Summary
XENPOZYME is indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.
---
Xermelo,telotristat ethyl|8G388563M7|
# Telotristat Ethyl Summary
Xermelo is indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
---
XIFAXAN,rifaximin|L36O5T016N|
# Rifaximin Summary
To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
---
Xiidra,lifitegrast|038E5L962W|
# Lifitegrast Summary
Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
---
Lignospan Forte,Lignospan Standard,MARCAINE WITH EPINEPHRINE,Xylocaine,epinephrine bitartrate|30Q7KI53AK|
# Epinephrine Bitartrate Summary
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Limitations: Limitations of Use MARCAINE / MARCAINE WITH EPINEPHRINE is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.
LIGNOSPAN Solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques.
---
Lidocaine Hydrochloride,Xylocaine,lidocaine hydrochloride anhydrous|EC2CNF7XFP|
# Lidocaine Hydrochloride Anhydrous Summary
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
---
XYOSTED,testosterone enanthate|7Z6522T8N9|
# Testosterone Enanthate Summary
Limitations: Limitations of Use: XYOSTED (testosterone enanthate) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
---
Zafirlukast|XZ629S5L50|
# Zafirlukast Summary
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.
---
ZAVZPRET,zavegepant hydrochloride|000QCM6HAL|
# Zavegepant Hydrochloride Summary
Limitations: ZAVZPRET is not indicated for the preventive treatment of migraine.
ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults.
Limitations: Limitations of Use
---
Zegalogue,dasiglucagon|AD4J2O47FQ|
# Dasiglucagon Summary
ZEGALOGUE ® is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above.
---
Creon,Viokace,Zenpep,pancrelipase amylase|YOJ58O116E|
# Pancrelipase Amylase Summary
ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults.
CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
---
Geodon,ziprasidone,ziprasidone hydrochloride|216X081ORU|
# Ziprasidone Hydrochloride Summary
Ziprasidone capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder.
Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions ( 5.3 ) ] Ziprasidone capsules are indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies ( 14.2 ) ].
Ziprasidone capsules are indicated for the treatment of schizophrenia in adults [see Clinical Studies ( 14.1 ) ].
---
Azithromycin,Azithromycin Dihydrate,ZITHROMAX|5FD1131I7S|
# Azithromycin Dihydrate Summary
ZITHROMAX is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
[see Dosage and Administration (2) ] Azithromycin for oral suspension is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below.
---
Zolmitriptan OD,zolmitriptan|2FS66TH3YW|
# Zolmitriptan Summary
Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults.
Limitations: Limitations of Use Safety and effectiveness of zolmitriptan orally disintegrating tablets have not been established for cluster headache.
Limitations: Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks.
---
Zonegran,ZONISADE,Zonisamide|459384H98V|
# Zonisamide Summary
ZONEGRAN is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.
ZONISADE is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years and older.
Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.
Zonisamide capsules USP are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.
---
ZTALMY,ganaxolone|98WI44OHIQ|
# Ganaxolone Summary
ZTALMY is indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older.
---
ZYFLO,zileuton|V1L22WVE2S|
# Zileuton Summary
ZYFLO is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.
---
ZYPITAMAG,pitavastatin|M5681Q5F9P|
# Pitavastatin Summary
ZYPITAMAG is indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia.
---
ZYPREXARelprevv,olanzapine pamoate|X7S6Q4MHCB|
# Olanzapine Pamoate Summary
ZYPREXA RELPREVV is available only through a restricted distribution program [see Warnings and Precautions ( 5.2 )] . ZYPREXA RELPREVV must not be dispensed directly to a patient. For a patient to receive treatment, the prescriber, healthcare facility, patient, and pharmacy must all be enrolled in the ZYPREXA RELPREVV Patient Care Program. To enroll, call 1-877-772-9390.
---
